Updated on 2025/08/22

写真a

 
TSUJI Yoshihisa
 
Organization
School of Medicine Department of Community and General Medicine Professor
Title
Professor
External link

Degree

  • 医学博士

Research Interests

  • Severe acute pancreatitis

  • Perfusion CT

  • Medical Education

  • 地域医療

  • Acute pancreatitis

  • 総合診療

Research Areas

  • Life Science / Radiological sciences

  • Life Science / Gastroenterology

  • Life Science / Immunology

  • Life Science / Medical management and medical sociology

Education

  • 京都大学大学院医学研究科 博士課程

    2010.4 - 2014.3

      More details

  • 高知医科大学医学科

    1995.4 - 2001.3

      More details

Research History

  • Shiga University of Medical Science

    2022

      More details

    Country:Japan

    researchmap

  • Sapporo Medical University

    2020

      More details

  • Sapporo Medical University

    2020

      More details

  • Sapporo Medical University   Professor

    2020

      More details

  • Shiga University of Medical Science

    2022

      More details

  • Sapporo Medical University

    2022

      More details

  • Sapporo Medical University

    2021

      More details

  • Sapporo Medical University

    2021

      More details

  • Sapporo Medical University

    2021 - 2022

      More details

  • Shiga University of Medical Science

    2019.4 - 2020.3

      More details

    Country:Japan

    researchmap

  • Shiga University of Medical Science   Head

    2019.4 - 2020.3

      More details

  • Shiga University of Medical Science

    2016.4 - 2020.3

      More details

  • Shiga University of Medical Science   Associate Professor

    2016.4 - 2019.3

      More details

  • 倉敷中央病院   消化器内科   医長

    2016 - 2017

      More details

  • 京都大学医学部附属病院   消化器内科   外来副医長

    2015 - 2016

      More details

  • JDWNR Hospital, Bhutan Kingdom   Instructor in internal medicine and Gastroenterology,

    2014.7

      More details

    Country:Bhutan

    researchmap

  • 京都大学医学部附属病院   消化器内科   助教

    2014 - 2015

      More details

  • 京都大学医学部附属病院   消化器内科   医員

    2013 - 2014

      More details

  • Mayo Clinic, Rochester   Department of Radiology   Clinical Research Fellow

    2011 - 2013

      More details

    Country:United States

    researchmap

  • Japan Society for the Promotion of Science

    2010.4 - 2013.3

      More details

    Country:Japan

    researchmap

  • Mayo Clinic, Rochester   Pancreas Interest Group, Division of Gastroenterology   GI Trainee

    2010 - 2011

      More details

    Country:United States

    researchmap

  • Japan Society for the Promotion of Science

    2007.4 - 2010.3

      More details

    Country:Japan

    researchmap

  • 倉敷中央病院   消化器内科   シニアレジデント

    2003.4 - 2007.3

      More details

  • 倉敷中央病院   内科   レジデント

    2002.4 - 2003.3

      More details

  • 京都大学医学部附属病院   内科   レジデント

    2001.4 - 2002.3

      More details

▼display all

Committee Memberships

  • 地域医療連携推進法人 オホーツク西紋別医療ケアネットワーク   評議員  

    2024   

      More details

    Committee type:Municipal

    researchmap

  • 日本プライマリ・ケア連合学会   大学ネットワーク委員会 副委員長  

    2024   

      More details

    Committee type:Academic society

    researchmap

  • 日本総合診療日本病院総合診療医学会   北海道地区幹事  

    2024   

      More details

    Committee type:Academic society

    researchmap

  • 日本膵臓学会   評議員  

    2024   

      More details

    Committee type:Academic society

    researchmap

  •   Academic Editor  

    2024   

      More details

    Committee type:Academic society

    researchmap

  • 大学教育質保証・評価センター   2023年度大学機関別認証評価 専門委員  

    2024   

      More details

    Committee type:Academic society

    researchmap

  • 日本専門医機構   総合診療専門領域 作問委員  

    2023   

      More details

    Committee type:Academic society

    researchmap

  • 日本プライマリ・ケア連合学会   大学ネットワーク委員会 委員  

    2023   

      More details

    Committee type:Academic society

    researchmap

  • 公益社団法人医療系大学間教養試験実施評価機構   医学系OSCE委員会委員  

    2022   

      More details

    Committee type:Academic society

    researchmap

  • 日本胆膵病態・生理研究会   常任世話人  

    2022   

      More details

    Committee type:Academic society

    researchmap

  • 日本胆膵病態・生理研究会   世話人  

    2021   

      More details

    Committee type:Academic society

    researchmap

  •   Member of Editorial Board  

    2021   

      More details

    Committee type:Academic society

    researchmap

  • 北海道総合医療協議会   地域医療専門委員会 委員  

    2020.5   

      More details

    Committee type:Municipal

    researchmap

  • 北海道 地域医療対策協議会   専門医制度等に関する検討委員会, 地域医療を担う医師の確保に関する検討委員会, 地域枠医師キャリア形成支援検討委員会 委員  

    2020   

      More details

    Committee type:Municipal

    researchmap

  • 北海道医学会   評議員  

    2020   

      More details

    Committee type:Academic society

    researchmap

  • 全国地域医療教育協議会   代議員・世話人  

    2020   

      More details

  • International Association of Pancreas   Chair of Image section, Acute pancreatitis guideline  

    2018   

      More details

    Committee type:Academic society

    researchmap

  • Pancreatology, Official Journal of International Association of Pancreas   Member of Editorial Board  

    2017.4   

      More details

    Committee type:Academic society

    researchmap

  • 日本膵臓学会   急性膵炎分科会委員  

    2017.4   

      More details

    Committee type:Academic society

    researchmap

  • 日本膵臓学会   膵疾患臨床研究促進委員会委員  

    2017.4 - 2023.3   

      More details

    Committee type:Academic society

    researchmap

  • AGA DDW   Invited visitor for the AGA Institute Council’s Poster Visiting program at DDW  

    2017.4 - 2020.3   

      More details

    Committee type:Academic society

    researchmap

  • 厚生労働省難治性膵疾患研究班   研究協力者  

    2014.4 - 2016.4   

      More details

    Committee type:Government

    researchmap

  • American Gastroenterological Association   Member of DDW abstract review comitee  

    2013.11   

      More details

    Committee type:Academic society

    researchmap

▼display all

Papers

  • International Association of Pancreatology Revised Guidelines on Acute Pancreatitis 2025: Supported and Endorsed by the American Pancreatic Association, European Pancreatic Club, Indian Pancreas Club, and Japan Pancreas Society Reviewed

    Andrea Párniczky, Alexandra Mikó, Aliye Uc, Anand Narayan Singh, Anshuman Elhence, Ashok Saluja, Atsushi Masamune, Barham K. Abu Dayyeh, Brian Davidson, Charles Mel Wilcox, Chris Forsmark, David Whitcomb, Deepak Gunjan, Dhiraj Yadav, Djuna Cahen, D. Nageshwar Reddy, Douglas Adler, Douglas Pleskow, En-Qiang Mao, Enrique de-Madaria, Enver Zerem, Federico Bolado, Fredrick Gorelick, Georgios Papachristou, Greg Cote, Guru Trikudanathan, Hana Alguel, Hjalmar Santvoort, James Buxbaum, Jens Werner, Ji Young Bang, John Neoptolemos, John Windsor, Julia Mayerle, Jun-Ho Choi, Kasper Overbeek, Kazuhiro Kikuta, Katsuya Kitamura, Luca Frulloni, Madhusudan K, Marc Besselink, Marco Bruno, Mark Lowe, Markus Lerch, Martin Freeman, Matthias Löhr, Morihisa Hirota, Mouen Khashab, Nicholas Zyromski, Nalini Guda, Namrata Singh, Niladri Baneerjee, Olaf J. Bakker, Panu Mentula, Peter Banks, Peush Sahni, Peter Hegyi, Peter Szatmary, Pramod Garg, Rajesh Gupta, Raju Sharma, Rakesh Kochhar, Robert Sutton, Rodrigo Cartin-Ceba, Rupjyoti Talukdar, Samagra Agarwal, Sohail Husain, Santhi Vege, Shuji Isaji, Shyam Varadarajulu, Shivanand Gamanagatti, Soumya Jagannath, Surinder Rana, Stefan Bouwense, Steve Pandol, Subodh Kumar, Sudipta Dhar Chowdhury, Sundeep Lakhtakia, Suresh Chari, Takao Itoi, Thilo Hackert, Thomas Bollen, Thomas Gress, Timothy Gardner, Vijay Singh, Vikas Dudeja, Vikesh Singh, Vinciane Rebours, Walter Park, Wei Huang, Wen-Hua He, Yi-No Kang, Yoshihisa Tsuji, Yoshifumi Takeyama

    Pancreatology   2025.7

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.pan.2025.04.020

    researchmap

  • Three Molecular Developmental Pathways of Remnant Pancreatic Cancer After Resection: A Nationwide Project Study of Japan Pancreas Society. Reviewed International journal

    Shuji Suzuki, Yuko Omori, Yusuke Ono, Katsuya Hirose, Taito Itoh, Hidenori Karasaki, Mitsugi Shimoda, Yuichi Nagakawa, Ryota Higuchi, Itaru Endo, Toshiki Rikiyama, Michiaki Unno, Tsutomu Fujii, Yuki Sunagawa, Hidetoshi Eguchi, Hideki Sasanuma, Takahiro Akahori, Keiichi Okano, Masaji Tani, Satoshi Hirano, Yasuhiro Shimizu, Minoru Kitago, Shugo Mizuno, Tomohisa Yamamoto, Masayuki Furukawa, Masayuki Ohtsuka, Motokazu Sugimoto, Akira Matsushita, Kenichi Hakamada, Hisato Igarashi, Tamotsu Kuroki, Satoshi Tanno, Yoshihisa Tsuji, Atsushi Masamune, Kazuhiro Mizumoto, Yoshiki Hirooka, Hiroki Yamaue, Kazuichi Okazaki, Sohei Satoi, Yoshifumi Takeyama, Yusuke Mizukami, Toru Furukawa

    Annals of surgery   281 ( 6 )   1015 - 1025   2025.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: To clarify the molecular mechanism of remnant pancreatic cancer (PC) development after primary PC resection. BACKGROUND: Molecular mechanisms of the development of remnant PCs after primary PC resection are largely unknown. METHODS: Forty-three patients undergoing remnant PC resection after primary PC resection between 2001 and 2017 at 26 institutes were retrospectively analyzed. Clinicopathologic features and molecular alterations detected by targeted amplicon sequencing of 36 PC-associated genes were evaluated. RESULTS: These patients showed significantly lower body mass indices and higher hemoglobin A1c values at remnant PC resection than at primary PC resection. A comparison of the molecular features between primary and remnant PCs indicated that remnant PCs were likely to develop through 3 different molecular pathways: successional, showing identical and accumulated alterations (n = 14); phylogenic, showing identical and distinct alterations (n = 26); and distinct, showing independent distinctive alterations (n = 3). The similarity of gene alterations was associated with time to the remnant PC development ( r = 0.384, P = 0.0173). Phylogenic pathways were significantly associated with the intraductal spread of carcinoma ( P = 0.007). Patient survival did not differ significantly depending on these molecular pathways. CONCLUSIONS: Molecular profiling uncovered 3 pathways for the development of remnant PCs, namely, successional, phylogenic, and distinct pathways. The vast majority of remnant PCs are likely to be molecularly associated with primary PCs either in the successional or phylogenic way. This information could impact the design of a strategy for monitoring and treating remnant PCs.

    DOI: 10.1097/SLA.0000000000006444

    PubMed

    researchmap

  • Participation-based clinical clerkships contribute to increased medical student confidence in community emergency care: a cohort study. Reviewed International journal

    Hiroshi Mihara, Atsushi Jinno, Kenta Sato, Kazuhito Nomura, Takao Wakabayashi, Yoshihisa Tsuji

    BMC medical education   25 ( 1 )   734 - 734   2025.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: The Community-based assessment for Clinical and Emergency Practice (C-CEP) scale is a validated tool comprising 15 items across four components: "Attitude and Communication in Emergency Medicine," "Basic Clinical Skills," "Knowledge about Community Medicine," and "Knowledge in Evidence-Based Medicine." The C-CEP scale enables medical students' self-assessment of their confidence in clinical and emergency care. This study aimed to evaluate whether a two-week comprehensive general practice clerkship would improve C-CEP scores and to identify the specific training elements contributing to increased confidence in primary care, particularly in emergency responses. METHODS: After obtaining ethical approval and written informed consent, fifth-year medical students at Sapporo Medical University who participated in two-week off-campus clerkships at external healthcare facilities (hospitals) during the 2023 academic year were included. Pre- and post-clerkship C-CEP scores were collected. Changes in the baseline and average scores were analyzed across facilities accepting more than four trainees. Text mining was conducted on students' reflective portfolios from the facilities with significant findings to identify frequent and co-occurring words related to confidence-building activities. RESULTS: Out of 115 eligible participants, 97 students were included in the analysis (84.3% participation rate). The data from seven facilities accepting more than four trainees, representing 74 students in total, were analyzed. These facilities averaged 243 beds, were located 147 km from the medical school, and had an emergency admission rate of 84.6%. C-CEP scores showed significant improvement across all components post-clerkship (p < 0.05). Although pre-clerkship scores did not differ significantly across facilities, post-clerkship score increases varied. Multivariate analysis identified Facilities D and F as exhibiting significant differences in confidence improvement compared with the other facilities (R² = 0.20, p = 0.0379). Text mining highlighted that Facility F emphasized active learning activities such as "interviews," "examinations," and "conferences," whereas Facility D focused on passive activities such as "observation", which were associated with limited impact on trainee confidence. CONCLUSION: The C-CEP effectively measured confidence improvements in primary care and emergency responses among fifth-year medical students following their clinical clerkships. The C-CEP scale's ability to detect inter-facility differences highlights its potential to inform and refine clinical education programs, ensuring more targeted and effective training.

    DOI: 10.1186/s12909-025-07317-1

    PubMed

    researchmap

  • 急性膵炎患者における長期入院の予測因子 Reviewed

    上野 真行, 羽田 綾子, 辻 喜久

    胆膵の病態生理   41 ( 1 )   65 - 69   2025.5

     More details

  • Diagnostic accuracy of endoscopic ultrasonographic shear wave elastography for assessing early chronic pancreatitis using the Japanese diagnostic criteria 2019. Reviewed International journal

    Shuhei Shintani, Osamu Inatomi, Takuya Okamoto, Kosuke Hiroe, Takaaki Eguchi, Yuki Tomozawa, Akitoshi Inoue, Hidenori Kimura, Atsushi Nishida, Yoshihisa Tsuji, Yoshiyuki Watanabe, Akira Andoh

    DEN open   5 ( 1 )   e387   2025.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND AND AIM: Endoscopic ultrasound shear wave elastography (EUS-SWE) can facilitate an objective evaluation of pancreatic fibrosis. Although it is primarily applied in evaluating chronic pancreatitis, its efficacy in assessing early chronic pancreatitis (ECP) remains underinvestigated. This study evaluated the diagnostic accuracy of EUS-SWE for assessing ECP diagnosed using the Japanese diagnostic criteria 2019. METHODS: In total, 657 patients underwent EUS-SWE. Propensity score matching was used, and the participants were classified into the ECP and normal groups. ECP was diagnosed using the Japanese diagnostic criteria 2019. Pancreatic stiffness was assessed based on velocity (Vs) on EUS-SWE, and the optimal Vs cutoff value for ECP diagnosis was determined. A practical shear wave Vs value of ≥50% was considered significant. RESULTS: Each group included 22 patients. The ECP group had higher pancreatic stiffness than the normal group (2.31 ± 0.67 m/s vs. 1.59 ± 0.40 m/s, p < 0.001). The Vs cutoff value for the diagnostic accuracy of ECP, as determined using the receiver operating characteristic curve, was 2.24m/s, with an area under the curve of 0.82 (95% confidence interval: 0.69-0.94). A high Vs was strongly correlated with the number of EUS findings (rs = 0.626, p < 0.001). Multiple regression analysis revealed that a history of acute pancreatitis and ≥2 EUS findings were independent predictors of a high Vs. CONCLUSIONS: There is a strong correlation between EUS-SWE findings and the Japanese diagnostic criteria 2019 for ECP. Hence, EUS-SWE can be an objective and invaluable diagnostic tool for ECP diagnosis.

    DOI: 10.1002/deo2.387

    PubMed

    researchmap

  • Initiatives for Continuing Medical Education of Internists in Provincial Mid-Sized Hospitals Reviewed

    Mihara Hiroshi, Jinno Atsushi, Nagahata Ken, Miyanishi Shuji, Hattori Tetsuo, Tsuji Yoshihisa

    Igaku Kyoiku / Medical Education (Japan)   56 ( 1 )   46 - 47   2025.2

     More details

    Language:Japanese   Publisher:Japan Society for Medical Education  

    DOI: 10.11307/mededjapan.56.1_46

    CiNii Research

    researchmap

  • The Challenge of Automatic Visualization of IR Information Reviewed

    Shinozaki Jun, Takatsuka Shintaro, Mihara Hiroshi, Yamamoto Takeshi, Ukai Wataru, Koyama Masayuki, Ogawa Tadashi, Kimura Minami, Sato Nao, Fukagawa Shuhei, Yokoyama Kazuki, Neki Toru, Tsuji Yoshihisa

    Proceedings of the Meeting on Japanese Institutional Research   13   80 - 84   2024.11

     More details

    Language:Japanese   Publisher:Japan Association for Institutional Research  

    DOI: 10.50956/mjir.13.0_80_1

    CiNii Research

    researchmap

  • Efficacy and safety of elobixibat in combination with or switched from conventional treatments of chronic constipation: A retrospective observational study. Reviewed International journal

    Takaaki Eguchi, Osamu Inatomi, Shuhei Shintani, Kenji Momose, Tomoya Sako, Megumi Takagi, Daiki Fumihara, Kazuki Inoue, Norio Katayama, Toshiyuki Morisawa, Takumi Ota, Yoshihisa Tsuji

    JGH open : an open access journal of gastroenterology and hepatology   8 ( 8 )   e70019   2024.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND AND AIM: Elobixibat is a triple mode of action laxative that increases water secretion into the colon, promotes colonic motility, and reestablishes the defecation desire. This study aims to evaluate the effectivity and safety of elobixibat in chronic constipation (CC) patients refractory to conventional laxatives. METHODS: A single-center retrospective observational study was conducted in refractory CC patients diagnosed according to the Rome IV criteria and received elobixibat between April 2018 and June 2022 at Osaka Saiseikai Nakatsu Hospital. Data were collected for spontaneous bowel movement (SBM), Bristol stool form scale (BSFS) scores, abdominal symptoms, and adverse events. RESULTS: Eligible 311 patients were selected for the analysis. Two-week Elobixibat treatment significantly increased SBM (times/week) from 2.9 ± 1.9 to 4.3 ± 1.9 (P < 0.0001). The BSFS score improved significantly from 3.2 ± 1.7 to 4.4 ± 1.4 (P < 0.0001). The percentages of patients with hard stool were decrease and that with normal stools were increase. Improvements in abdominal symptoms (sensation of incomplete bowel evacuation, straining, abdominal pain and distention, and difficulty defecating) were also significant (P < 0.05). These constipation symptoms were improved irrespective of patient characteristics or previous laxatives. The 43.9% of previous laxatives were discontinued at the start of or after starting elobixibat treatment. A few adverse events were observed, elobixibat was well tolerated. CONCLUSION: Elobixibat was effective in patients who were refractory to other laxatives, irrespective of previous therapy or patient characteristics. Elobixibat may contribute to resolving polypharmacy with single mode of action laxatives.

    DOI: 10.1002/jgh3.70019

    PubMed

    researchmap

  • 在宅終末期ケアにおける訪問診療同行看護師の役割検討 同行看護師および多職種、患者家族を対象としたインタビュー(会議録) Reviewed

    奥岡 由美, 本田 日奈子, 古山 悦子, 神野 敦, 市来 智子, 日下 勝博, 辻 喜久, 辻 喜久

    Palliative Care Research   19 ( Suppl. )   S.555 - S.555   2024.6

     More details

    Language:Japanese   Publisher:(NPO)日本緩和医療学会  

    Ichushi

    J-GLOBAL

    researchmap

  • The Challenge of Automatic Visualization of IR Information Reviewed

    篠崎淳, 高塚伸太朗, 三原弘, 山本武志, 鵜飼渉, 小山雅之, 小川宰司, 木村心南, 佐藤直, 深川周平, 横山和樹, 根木亨, 辻喜久

    大学情報・機関調査研究集会論文集(Web)   13   2024

  • The Role of the Nurse Who co-visit Home Care Doctor in Palliative Care: A Qualitative Study Reviewed

    奥岡由美, 本田日奈子, 古山悦子, 神野敦, 市来智子, 日下勝博, 辻喜久, 辻喜久

    木村看護教育振興財団看護研究集録   31 ( 31 )   1 - 24   2024

  • Clinical Significance of Recombinant Human Soluble Thrombomodulin (rTM) Administration in Patients with Acute Pancreatitis Reviewed

    江口考明, 江口考明, 辻喜久, 辻喜久, 稲富理

    胆膵の病態生理   40 ( 1 )   7 - 11   2024

  • Clinical characteristics of patients experiencing stroke after initiation of chemotherapy for pancreatic cancer Reviewed

    羽田綾子, 上野真行, 上野真行, 辻喜久

    胆膵の病態生理   40 ( 1 )   107 - 112   2024

  • 便秘症治療難治抵抗例に対するエロビキシバット併用・切替え治療における治療有効な背景因子の検討 Reviewed

    江口考明, 江口考明, 迫智也, 稲富理, 辻喜久

    日本消化器病学会雑誌(Web)   121   2024

  • Gut microbiota and metabolites in patients with COVID-19 are altered by the type of SARS-CoV-2 variant. Reviewed International journal

    Yoshihiro Yokoyama, Tomoko Ichiki, Tsukasa Yamakawa, Yoshihisa Tsuji, Koji Kuronuma, Satoshi Takahashi, Eichi Narimatsu, Akio Katanuma, Hiroshi Nakase

    Frontiers in microbiology   15   1358530 - 1358530   2024

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    INTRODUCTION: Patients with COVID-19 have dysbiosis of the intestinal microbiota with altered metabolites in the stool. However, it remains unclear whether the differences among SARS-CoV-2 variants lead to differences in intestinal microbiota and metabolites. Thus, we compared the microbiome and metabolome changes for each SARS-CoV-2 variant in patients with COVID-19. MATERIALS AND METHODS: We conducted a multicenter observational study of patients with COVID-19 and performed fecal microbiome, metabolome, and calprotectin analyses and compared the results among the different SARS-CoV-2 variants. RESULTS: Twenty-one patients with COVID-19 were enrolled and stratified according to the SARS-CoV-2 strain: six with the Alpha, 10 with the Delta, and five with the Omicron variant. Fecal microbiome analysis showed that α-diversity was reduced in the order of the Omicron, Delta, and Alpha variants (p = 0.07). Linear discriminant analysis revealed differences in the abundance of short-chain fatty acid-producing gut microbiota for each SARS-CoV-2 variant. Fecal metabolome analysis showed that the Omicron and Delta variants had markedly reduced propionic and lactic acid levels compared to the Alpha strain (p < 0.05). CONCLUSION: The intestinal microbiota of patients with COVID-19 varies depending on the SARS-CoV-2 variant. Dysbiosis of the intestinal microbiota due to differences in SARS-CoV-2 variants causes a decrease in intestinal short-chain fatty acids.

    DOI: 10.3389/fmicb.2024.1358530

    PubMed

    researchmap

  • Trauma-related thyroid storm in adolescents: A case report. Reviewed International journal

    Atsushi Jinno, Naofumi Bunya, Junya Hagiwara, Kai Takao, Keigo Sawamoto, Akira Ishii, Takeshi Tsugawa, Eichi Narimatsu, Yoshihisa Tsuji

    Acute medicine & surgery   11 ( 1 )   e70004   2024

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Because of a scant report, it is little known that thyroid storms can occur after trauma, even in adolescence. Significantly, this increases the risk of delaying diagnosis resulting in life-threatening. CASE PRESENTATION: A 13-year-old girl was admitted to the emergency department after a traffic accident. Despite receiving comprehensive trauma care, the patient developed hyperthermia and tachycardia that did not respond to temperature management therapy. On the 10th day of her admission, she was diagnosed with a thyroid storm. Treatment for thyroid storm was initiated; thereby, her condition was totally improved. CONCLUSION: We experienced a case of an adolescent girl, who developed a thyroid storm during the treatment of trauma and could save her life. Clinicians should consider thyroid storm in post-traumatic hyperthermia and tachycardia patients, even in children.

    DOI: 10.1002/ams2.70004

    PubMed

    researchmap

  • Rural Medical Education Design in Minami-Hiyama Reviewed

    辻喜久, 辻喜久, 辻喜久

    医学教育   54 ( 5 )   467 - 473   2023.10

  • Sex-based differences in metabolic protection by the ANP genetic variant rs5068 in the general population. Reviewed International journal

    Tomoko Ichiki, Valentina Cannone, Christopher G Scott, Seethalakshmi R Iyer, S Jeson Sangaralingham, Kent R Bailey, Jens P Goetze, Yoshihisa Tsuji, Richard J Rodeheffer, John C Burnett Jr

    American journal of physiology. Heart and circulatory physiology   325 ( 3 )   H545-H552   2023.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) are produced in the heart and secreted into the circulation. As hormones, both peptides activate the guanylyl cyclase receptor A (GC-A), playing a role in blood pressure (BP) regulation. A significant role for ANP and BNP includes favorable actions in metabolic homeostasis. Sex-based high prevalence of risk factors for cardiovascular disease in males compared with females is well established, but sex-based differences on cardiometabolic protection have not been investigated in relation to ANP (NPPA) and BNP (NPPB) gene variants. We included 1,146 subjects in the general population from Olmsted County, Minnesota. Subjects were genotyped for the ANP gene variant rs5068 and BNP gene variant rs198389. Cardiometabolic parameters and medical records were reviewed. In the presence of the minor allele of rs5068, diastolic BP, creatinine, body mass index (BMI), waist measurement, insulin, and prevalence of obesity and metabolic syndrome were lower, whereas HDL was higher in males with only trends observed in females. We observed no associations of the minor allele with echocardiographic parameters in either males or females. Regarding rs198389 genotype, the minor allele was not associated with any BP, metabolic, renal, or echocardiographic parameters in either sex. In the general community, the minor allele of the ANP gene variant rs5068 is associated with a favorable metabolic phenotype in males. No associations were observed with the BNP gene variant rs198389. These studies support a protective role of the ANP pathway on metabolic function and underscore the importance of sex in relationship to natriuretic peptide responses.NEW & NOTEWORTHY Males are characterized by lower ANP and BNP with greater prevalence of cardiometabolic disease. The ANP genetic variant rs5068 was associated with less metabolic dysfunction in males, whereas no metabolic profile was related to the BNP genetic variant rs198389 in the general population. ANP may play a more biological role in metabolic homeostasis compared with BNP in the general population with greater physiological metabolic actions in males compared with females.

    DOI: 10.1152/ajpheart.00321.2023

    PubMed

    researchmap

  • The diagnostic accuracy of endoscopic ultrasound-shear wave elastography in multiple pancreatic regions for chronic pancreatitis based on the Rosemont criteria. Reviewed

    Shuhei Shintani, Osamu Inatomi, Kosuke Hiroe, Yuki Tomozawa, Akitoshi Inoue, Hidenori Kimura, Atsushi Nishida, Yoshihisa Tsuji, Yoshiyuki Watanabe, Akira Andoh

    Journal of medical ultrasonics (2001)   50 ( 4 )   485 - 492   2023.8

     More details

    Language:English   Publisher:The Japan Society of Ultrasonics in Medicine  

    PURPOSE: Although endoscopic ultrasound (EUS) has been widely used for diagnosing chronic pancreatitis (CP), the assessment of fibrosis using the Rosemont criteria (RC) is generally subjective. Shear wave elastography using EUS (EUS-SWE) has been advocated as an objective approach to evaluating pancreatic fibrosis; however, it is unknown which pancreatic region should be selected for measurement. This study aims to compare the diagnostic accuracy in diagnosing CP by measurement site. METHODS: Fifty patients with CP or suspected CP who underwent EUS-SWE were retrospectively analyzed. As per the RC, they were classified into two groups: CP and non-CP. Pancreatic stiffness was evaluated by measuring the velocities of the shear wave (Vs) in addition to determining the relevant cutoff value of Vs for diagnosing CP. The correlation between Vs and RC, and the RC factors affecting pancreatic stiffness were evaluated. RESULTS: In the CP group, the Vs were notably higher in all regions (P < 0.001). The Vs for diagnostic accuracy of CP were highest in the body [area under the curve (AUC): 0.87]. A significant correlation was seen between the number of RC and Vs in all regions, with the correlation coefficient being highest in the pancreatic body (rs = 0.55). Multivariate analysis revealed that lobularity with honeycombing was an independent factor for pancreatic stiffness (P = 0.02). CONCLUSION: The pancreatic body is a suitable region for assessing pancreatic stiffness using EUS-SWE. Additionally, quantifying Vs is a valuable objective indicator for diagnosing CP.

    DOI: 10.1007/s10396-023-01350-7

    CiNii Research

    PubMed

    researchmap

  • Impact of S‐1 adjuvant chemotherapy longer than 6 months on survival in patients with resected pancreatic cancer: a nationwide survey by the Japan Pancreas Society based on real‐world data Reviewed International journal

    Yoshito Tomimaru, Hidetoshi Eguchi, Yosuke Inoue, Yuichi Nagakawa, Akihiro Ohba, Hideki Takami, Michiaki Unno, Tomohisa Yamamoto, Shoji Kawakatsu, Tsuyoshi Hayashi, Ryota Higuchi, Hirohisa Kitagawa, Satoshi Hattori, Tsutomu Fujii, Yoshiki Hirooka, Hisato Igarashi, Masayuki Kitano, Tamotsu Kuroki, Atsushi Masamune, Yasuhiro Shimizu, Masaji Tani, Satoshi Tanno, Yoshihisa Tsuji, Hiroki Yamaue, Sohei Satoi, Yoshifumi Takeyama

    Cancer   129 ( 5 )   728 - 739   2022.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    BACKGROUND: Based on the Japan Adjuvant Study Group of Pancreatic Cancer 01 study, the standard duration of adjuvant chemotherapy with S-1 (an oral 5-fluorouracil prodrug consisting of tegafur, gimeracil, and oteracil) in patients with resected pancreatic ductal adenocarcinoma (PDAC) was considered to be 6 months, but the impact of increasing its duration on postoperative survival was unknown. Here, the authors investigated this question by reviewing real-world data from a large cohort of patients with PDAC. METHODS: In total, 3949 patients who underwent surgery for PDAC during the study period followed by S-1 adjuvant chemotherapy in board-certified institutions were included. Based on the duration of S-1 chemotherapy, two subgroups were defined: a standard-duration group that included patients who were treated for 180 ± 30 days and a longer duration group that included patients who received treatment for >210 days. RESULTS: The median duration of S-1 chemotherapy was 167 days, with a mean ± standard deviation of 200 ± 193 days. After excluding patients who had a recurrence within 210 days after the initiation of adjuvant chemotherapy, postoperative recurrence-free survival (RFS) and overall survival (OS) in the standard-duration group (n = 1473) and the longer duration group (n = 975) were compared. RFS and OS did not differ significantly between the standard-duration and longer duration groups (5-year RFS: 37.8% vs. 36.2% respectively; p = .6186; 5-year OS: 52.8% vs. 53.4%, respectively; p = .5850). The insignificant difference was verified by multivariate analysis and propensity-score matching analysis. CONCLUSIONS: The current findings suggest that extending S-1 adjuvant chemotherapy beyond 6 months has no significant additional effect on survival in patients with PDAC. This could be useful in determining whether to extend S-1 chemotherapy in patients who have completed the standard 6-month treatment.

    Other Link: https://onlinelibrary.wiley.com/doi/full-xml/10.1002/cncr.34580

    DOI: 10.1002/cncr.34580

    PubMed

    researchmap

  • Self-assessment scale for the community-based and emergency practice. Reviewed International journal

    Takao Wakabayashi, Yoshihisa Tsuji, Takeshi Yamamoto, Hitoshi Sohma, Wari Yamamoto

    BMC medical education   22 ( 1 )   799 - 799   2022.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: For current medical education, community-based primary care for the elderly is an essential topic. This study aimed to establish a scale of community-based assessment for clinical and emergency practice (C-CEP). METHODS: A self-assessment scale for C-CEP was developed according to four steps. Initially, we reviewed publications from the societies of the United States, British, and Japan regarding educational goals. In addition, we searched MEDLINE for educational goals regarding attitude, skills, and knowledge. Getting together, we established 23 items as the educational goals of the C-CEP. Second, we collected responses for these 23 items from 5th-grade medical students (n = 195). Third, we conducted an exploratory factor analysis (EFA) using their responses to determine the fundamental structure of the self-assessment scale. Finally, a confirmatory factor analysis (CFA) was performed to assess the fitness of the self-assessment scale developing the EFA, resulting in modification of the items. RESULTS: In EFA and CFA results, C-CEP Scale consisted of four factors with 15 items: "Attitude and communication in emergency care," Basic clinical skills," "Knowledge of community healthcare," and "Knowledge of evidence-based medicine perseverance." The model fit indices were acceptable (Goodness of Fix Index = 0.928, Adjusted Goodness of Fit Index = 0.900, Comparative Fit Index = 0.979, and Root Mean Square Error of Approximation = 0.045). The values of McDonald's omega as an estimate of scale reliability were more than 0.7 in all four factors. As for test-retest reliability, the intraclass correlation coefficients were ≥ 0.58 for all factors. All four factors of the C-CEP Scale correlated positively with the Medical Professionalism Evaluation Scale subscales. CONCLUSIONS: We developed a valid and reliable self-assessment scale to assess student competence.

    DOI: 10.1186/s12909-022-03848-z

    PubMed

    researchmap

  • Natriuretic Peptide-Based Novel Therapeutics: Long Journeys of Drug Developments Optimized for Disease States. Reviewed International journal

    Tomoko Ichiki, Atsushi Jinno, Yoshihisa Tsuji

    Biology   11 ( 6 )   2022.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The field of natriuretic peptides (NPs) as an endocrine hormone has been developing since 1979. There are three peptides in humans: atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP), which bind to the guanylyl cyclase-A (GC-A) receptor (also called natriuretic peptide receptor-A (NPR-A)), and C-type natriuretic peptide (CNP), which binds to the GC-B receptor (also called the NPR-B) and then synthesizes intracellular cGMP. GC-A receptor stimulation has natriuretic, vasodilatory, cardiorenal protective and anti-renin-angiotensin-aldosterone system actions, and GC-B receptor stimulation can suppress myocardial fibrosis and can activate bone growth before epiphyseal plate closure. These physiological effects are useful as therapeutics for some disease states, such as heart failure, hypertension, and dwarfism. To optimize the therapeutics for each disease state, we must consider drug metabolism, delivery systems, and target receptor(s). We review the cardiac NP system; new designer NPs, such as modified/combined NPs and modified peptides that can bind to not only NP receptors but receptors for other systems; and oral drugs that enhance endogenous NP activity. Finally, we discuss prospective drug discoveries and the development of novel NP therapeutics.

    DOI: 10.3390/biology11060859

    PubMed

    researchmap

  • Clinical relevance of reduced skeletal muscle mass in pancreatic diseases Reviewed

    上野真行, 上野真行, 辻喜久, 宇座徳光, 妹尾浩

    胆膵の病態生理   38 ( 1 )   1 - 6   2022.6

     More details

  • Blue Foreign Body in the Esophagus. Reviewed International journal

    Ryosuke Tomiyama, Tomoko Ichiki, Yoshihisa Tsuji

    Gastroenterology   162 ( 7 )   e14-e15   2022.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1053/j.gastro.2021.11.025

    PubMed

    researchmap

  • Two Types of Immune Checkpoint Inhibitor-related Pancreatitis. Reviewed

    Tomoko Ichiki, Yasuki Hori, Yoshihisa Tsuji

    Internal medicine (Tokyo, Japan)   61 ( 10 )   1477 - 1478   2022.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.2169/internalmedicine.8452-21

    PubMed

    researchmap

  • Estimated tumor blood flow as a predictive imaging indicator of therapeutic response in pancreatic ductal adenocarcinoma: use of three-phase contrast-enhanced computed tomography. Reviewed

    Hiromitsu Maehira, Yoshihisa Tsuji, Hiroya Iida, Haruki Mori, Nobuhito Nitta, Takeru Maekawa, Sachiko Kaida, Toru Miyake, Masaji Tani

    International journal of clinical oncology   27 ( 2 )   373 - 382   2022.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Preoperative chemotherapy or chemoradiotherapy is a common strategy for treating pancreatic ductal adenocarcinoma (PDAC). This study aimed to assess the association between the therapeutic response in PDAC and tumor blood circulation. METHODS: The medical records of patients who underwent chemotherapy or chemoradiotherapy prior to pancreatectomy for PDAC were reviewed. Of these, patient data that included three-phase contrast-enhanced computed tomography (CECT) findings before treatments were used in this study. We evaluated the estimated tumor blood flow (eTBF) using CECT. According to the therapeutic histopathological response defined by the Evans classification, patients were divided into poor (grade I/IIa) and good (grade IIb/III/IV) responder groups. The variables, including eTBF, were compared between the two groups. RESULTS: Thirty patients were enrolled in this study. Of these, 13 (43.3%) (grade IIB/III/IV: 8/4/1 patients) were categorized into the good responder group and 17 patients (56.7%) (grade I/IIA: 4/13 patients) were categorized into the poor responder group. eTBF was significantly higher in the good responder group (0.39 s-1 vs. 0.32 s-1, p = 0.007). An eTBF ≥ 0.36 s-1 was found to be an independent predictive factor for the destruction of over 50% of tumor cells (p = 0.036; odds ratio, 9.71; 95% confidence interval, 1.16-81.30). CONCLUSIONS: eTBF can be used to predict the therapeutic histopathological response in PDAC prior to treatment.

    DOI: 10.1007/s10147-021-02066-9

    PubMed

    researchmap

  • Larger Volume and Higher Fat Content of the Pancreatic Head Are Predictive Factors for Postendoscopic Retrograde Cholangiopancreatography Pancreatitis Reviewed International journal

    Shuhei Shintani, Osamu Inatomi, Shigeki Bamba, Yoshiya Takeda, Takehide Fujimoto, Shinichi Ota, Yoshihisa Tsuji, Hiromu Kutsumi, Yoshiyuki Watanabe, Akira Andoh

    Pancreas   51 ( 1 )   28 - 34   2022.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Other Link: https://journals.lww.com/10.1097/MPA.0000000000001957

    DOI: 10.1097/MPA.0000000000001957

    CiNii Research

    PubMed

    researchmap

  • IMPORTANCE OF MEDICAL EDUCATION IN GASTROINTESTINAL ENDOSCOPY Reviewed

    TSUJI Yoshihisa

    GASTROENTEROLOGICAL ENDOSCOPY   64 ( 1 )   7 - 18   2022.1

  • 感染性walled-off necrosisの上腸間膜静脈内への穿破に対し、保存的治療で救命しえた1例 Reviewed

    上西 陽介, 上野 真行, 辻 喜久, 上山 伸也, 小山 貴, 池田 有希, 戸川 文子, 羽田 綾子, 眞野 俊史, 石田 悦嗣, 山本 博, 水野 元夫

    日本病院総合診療医学会雑誌   18 ( 1 )   20 - 27   2022.1

  • 改定Atlanta分類と本邦ガイドラインを組み合わせた急性壊死性貯留の新診断基準の有用性検討 Reviewed

    江口考明, 辻喜久, 児玉裕三

    日本消化器病学会雑誌(Web)   119   2022

  • Rupture of infected walled off necrosis into the superior mesenteric vein Reviewed

    上西陽介, 上野真行, 上野真行, 辻喜久, 上山伸也, 小山貴, 池田有希, 戸川文子, 羽田綾子, 眞野俊史, 石田悦嗣, 山本博, 水野元夫

    日本病院総合診療医学会雑誌(Web)   18 ( 1 )   2022

  • The usefulness of early administration of recombinant human soluble thrombomoduline for improving pancreatic blood flow in acute pancreatitis Reviewed

    江口考明, 辻喜久, 岡田明彦

    日本外科感染症学会雑誌(Web)   19 ( 1 )   2022

  • Impaired tryptophan metabolism in the gastrointestinal tract of patients with critical coronavirus disease 2019. Reviewed International journal

    Yoshihiro Yokoyama, Tomoko Ichiki, Tsukasa Yamakawa, Yoshihisa Tsuji, Koji Kuronuma, Satoshi Takahashi, Eichi Narimatsu, Hiroshi Nakase

    Frontiers in medicine   9   941422 - 941422   2022

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    INTRODUCTION: Coronavirus disease 2019 (COVID-19) is still causing a global pandemic. But the mechanism of COVID-19 severity is not well elucidated. MATERIALS AND METHODS: We conducted two single-center observational studies of patients with COVID-19. In the first study, the enrolled patients were distinguished based on critical vs. non-critical COVID-19. We collected blood samples from the patients at admission to measure markers related to inflammation and thrombosis and stool samples to analyze the fecal microbiome, metabolome, and calprotectin level. In the second study, we collected ileum and colon tissue samples from patients with critical COVID-19 who required colonoscopy due to severe gastrointestinal symptoms and analyzed mucosal gene expression. RESULTS: A total of 19 blood samples and 10 stool samples were collected. Interleukin (IL)-6 was the only serum inflammatory marker with significantly higher levels in the critical group than in the non-critical group. The fecal calprotectin level in the critical group was significantly higher than that in the non-critical group (P = 0.03), regardless of the presence of gastrointestinal symptoms. Stool metabolomic analysis showed that the level of indole-3-propionic acid, a ligand for aryl hydrocarbon receptor (AhR), was markedly decreased in the critical group compared to that in the non-critical group (P = 0.01). The expression of genes involved in tryptophan metabolism, including ACE2, AHR, CARD9, and IL22, was downregulated in the ileum of critical COVID-19 patients who required a colonoscopy. DISCUSSION: Critical COVID-19 patients have gastrointestinal inflammation potentially caused by impaired tryptophan metabolism in the small intestine due to decreased expression of genes involved in tryptophan metabolism.

    DOI: 10.3389/fmed.2022.941422

    PubMed

    researchmap

  • 急性膵炎におけるDICとトロンボモジュリン製剤早期投与による有効性の検討 Reviewed

    江口考明, 辻喜久, 岡田明彦

    日本腹部救急医学会雑誌   42 ( 2 )   2022

  • IMPORTANCE OF MEDICAL EDUCATION IN GASTROINTESTINAL ENDOSCOPY Reviewed

    辻喜久, 辻喜久

    Gastroenterological Endoscopy (Web)   64 ( 1 )   2022

  • Fatal Immune Checkpoint Inhibitor-related Pancreatitis. Reviewed

    Masayuki Ueno, Yoshihisa Tsuji, Toshihide Yokoyama, Takashi Koyama, Yosuke Uenishi, Etsuji Ishida, Motowo Mizuno

    Internal medicine (Tokyo, Japan)   60 ( 24 )   3905 - 3911   2021.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We herein report a case of fatal pancreatitis induced by an immune checkpoint inhibitor. A 62-year-old man with cancer of unknown primary was treated with pembrolizumab. After 12 cycles, immune-related pneumonitis developed and was treated with prednisolone. Three months later, pancreatitis developed, which was successfully treated with hydration and protease inhibitors. Eight months later, another attack of pancreatitis occurred, which did not respond to therapy, including high-dose corticosteroids, and he eventually died. This is the first report describing fatal immune checkpoint inhibitor-related pancreatitis. Despite the rarity of this complication, attention should be paid to its potential severity and treatment.

    DOI: 10.2169/internalmedicine.7366-21

    PubMed

    researchmap

  • Utility and safety of a new uneven double-lumen sphincterotome in cases of difficult biliary cannulation Reviewed International journal

    Shuhei Shintani, Osamu Inatomi, Yoshiya Takeda, Hiroshi Matsumoto, Takehide Fujimoto, Yoshihisa Tsuji, Hiromu Kutsumi, Akira Andoh

    BMC Gastroenterology   21 ( 1 )   102 - 102   2021.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s12876-021-01689-6

    CiNii Research

    PubMed

    researchmap

  • The clinical efficacy of azathioprine as maintenance treatment for autoimmune pancreatitis: a systematic review and meta-analysis.

    Yoshiharu Masaki, Hiroshi Nakase, Yoshihisa Tsuji, Masanori Nojima, Kyoko Shimizu, Nobumasa Mizuno, Tsukasa Ikeura, Kazushige Uchida, Akio Ido, Yuzo Kodama, Hiroshi Seno, Kazuichi Okazaki, Seiji Nakamura, Atsushi Masamune

    Journal of gastroenterology   56 ( 10 )   869 - 880   2021.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The effectiveness of azathioprine (AZA) in preventing relapse and maintaining autoimmune pancreatitis (AIP) remission has been reported; however, most of these studies are case series with no randomized control trials available in the literature. Therefore, this study performed a systematic review and meta-analysis of the existing literature on this subject to determine the clinical efficacy of AZA as maintenance therapy for AIP patients. A systematic search was performed to identify studies on the clinical efficacy of AZA as maintenance therapy in AIP patients. The crude multiple relapse rate was estimated to assess the ability of AZA to control relapses in AIP. Pooled estimates were obtained using a random-effects model with the DerSimonian-Laird method. We identified AIP patients who did not respond to initial steroid treatment, experienced steroid weaning failure, or those who relapsed during remission as refractory cases. After reviewing the studies, ten articles fulfilled the inclusion criteria and were selected for meta-analysis. Of all 4504 patients, 3534 patients were treated with steroids, and 346 patients were treated with AZA for relapsed AIP. In this meta-analysis, 14/73 (19.2%) patients receiving AZA for refractory AIP relapsed. Meanwhile, 14/47 (29.8%) patients without AZA experienced relapse. The integrated odds ratio for relapse risk in patients receiving AZA was estimated to be 0.52 (p = 0.15). This systematic review and meta-analysis demonstrated the efficacy of AZA in preventing relapse of AIP, which supports the use of AZA as a maintenance treatment in patients with AIP who relapse upon withdrawal of steroid therapy.

    DOI: 10.1007/s00535-021-01817-9

    PubMed

    researchmap

  • International comparison of clinical guidelines for acute pancreatitis

    TSUJI Yoshihisa, SATO Kenta

    Suizo   36 ( 4 )   226 - 232   2021.8

     More details

    Language:Japanese   Publisher:Japan Pancreas Society  

    Guidelines for the treatment of patients with acute pancreatitis have recently been published in various countries. In this paper, we compared the recommendations and evidence ratings of eight guidelines collected based on the following, (1) published within the last 10 years (2010-2020), (2) written in English, (3) published by domestic and foreign medical associations and societies, and (4) using the GRADE system. Of 30 items in 7 major categories, 26 were in general agreement, but there was disagreement on 4 items. One of the reasons for the divergent recommendations was the lack of sufficient evidence. The evaluation of the quality of evidence was greatly divided even within items. From the above, it was thought that the level of recommendation would be unified to some extent in the future as new accurate evidence is accumulated.

    Other Link: https://search.jamas.or.jp/link/ui/2022020659

    DOI: 10.2958/suizo.36.226

    CiNii Research

    researchmap

  • Reducing the risk of developing walled-off necrosis in patients with acute necrotic collection using recombinant human soluble thrombomodulin.

    Takaaki Eguchi, Yoshihisa Tsuji, Akihiko Okada, Dai Inoue, Hironobu Tokumasu, Kosuke Iwane, Yoshitaka Nakai, Toshihiro Kusaka, Yoshito Uenoyama, Koichi Fujita, Masataka Yokode, Yukimasa Yamashita, Yugo Sawai, Masanori Asada, Takao Mikami, Chiharu Kawanami, Yasushi Kudo, Shujiro Yazumi, Tsuyoshi Sanuki, Arata Sakai, Toshihiro Morita, Yojiro Sakuma, Norimitsu Uza, Yutaka Takada, Toshinao Itani, Katsutoshi Kuriyama, Kazuyoshi Matsumura, Kazuki Ikeda, Hitoshi Someda, Eiji Funatsu, Shinji Katsushima, Yuzo Kodama, Hiroshi Seno

    Journal of hepato-biliary-pancreatic sciences   28 ( 9 )   788 - 797   2021.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND/PURPOSE: The purpose of the present study was to investigate the possibility of reducing clinical impacts of acute necrotic collection (ANC) on patients with acute pancreatitis (AP) using recombinant human soluble thrombomodulin (rTM). METHODS: In this retrospective multicenter study, 233 consecutive AP patients with ANC and acute peripancreatic fluid collection (APFC) from 2012 to 2016 were enrolled. To assess clinical impacts of ANC, severity on admission (JPN score, JPN CT grade, and Modified CT severity index), development of walled-off necrosis (WON), imaging costs for follow-up, and mortality were recorded. Finally, we investigated whether rTM could reduce the clinical impacts, adjusting the severity using propensity analysis with Inverse probability of treatment weighting. RESULTS: Patients with ANC developed WON with higher ratio than APFC (58/98 [59.2%] vs 20/135 [14.8%], OR = 8.3, P < .01]. Severity on admission and imaging costs for follow-up in ANC patients were significantly higher than those in APFC (P < .01). However, regarding mortality, there was no significant difference between patients with ANC and APFC (P = .41). Adjusting severity, it was revealed that rTM administration significantly reduced the risk of ANC developed WON (OR = 0.23, P = .01). CONCLUSIONS: While ANC had a higher clinical impact than that of APFC, we found that early administration of rTM may reduce the impact.

    DOI: 10.1002/jhbp.1015

    PubMed

    researchmap

  • Diagnosing Biliary Strictures: Distinguishing IgG4-Related Sclerosing Cholangitis From Cholangiocarcinoma and Primary Sclerosing Cholangitis. International journal

    Yasuki Hori, Suresh T Chari, Yoshihisa Tsuji, Naoki Takahashi, Dai Inoue, Phil A Hart, Takeshi Uehara, Masayasu Horibe, Satoshi Yamamoto, Akira Satou, Lizhi Zhang, Kenji Notohara, Itaru Naitoh, Takahiro Nakazawa

    Mayo Clinic proceedings. Innovations, quality & outcomes   5 ( 3 )   535 - 541   2021.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Biliary strictures caused by inflammation or fibrosis lead to jaundice and cholangitis which often make it difficult to distinguish malignant strictures. In cases when malignancy cannot be excluded, surgery is often performed. The concept of immunoglobulin G4 (IgG4)-related sclerosing cholangitis (SC) as a benign biliary stricture was recently proposed. The high prevalence of the disease in Asian countries has resulted in multiple diagnostic and treatment guidelines; however, there is need to formulate a standardized diagnostic strategy among various countries considering the utility, invasiveness, and cost-effectiveness. We evaluated accuracies of various diagnostic modalities for biliary strictures comparing pathology in the Delphi meetings which were held in Rochester, MN. The diagnostic utility for each modality was graded according to the experts, including gastroenterologists, endoscopists, radiologists, and pathologists from the United States and Japan. Diagnostic utility of 10 modalities, including serum IgG4 level, noninvasive imaging, endoscopic ultrasound, endoscopic retrograde cholangiopancreatography-related diagnostic procedures were advocated and the reasons were specified. Serum IgG4 level, noninvasive imaging, diagnostic endoscopic ultrasound and intraductal ultrasonography under endoscopic retrograde cholangiopancreatography were recognized as useful modalities for the diagnosis. The information in this article will aid in the diagnosis of biliary strictures particularly for distinguishing IgG4-SC from cholangiocarcinoma and/or primary SC.

    DOI: 10.1016/j.mayocpiqo.2021.03.005

    PubMed

    researchmap

  • 一般内科における入院患者の入院日数の延長に関するリスクの検討

    若林 崇雄, 山本 武志, 相馬 仁, 辻 喜久, 山本 和利

    日本病院総合診療医学会雑誌   17 ( 3 )   274 - 281   2021.5

     More details

    Language:Japanese   Publisher:一般社団法人 日本病院総合診療医学会  

    【目的】一般内科における患者の入院日数の延長に関連する因子を検討する。
    【方法】2016 年 4 月 1 日から 2017 年 3 月 31 日まで 200 床規模のA病院総合診療科に即日入院した患者 289 名を対象とした。入院期間に影響を及ぼす要因として 12 項目の説明変数を選定し,比例Coxハザード分析を用いて入院日数の延長と関連する因子を検討した。
    【結果】在院日数の中央値は 10 日だった。入院前の住居と退院先の相違(ハザード比(HR)2.25,95%信頼区間(95% CI);1.35-3.75)であり,次いでBMI低値(HR 1.70,95% CI;1.18-2.45),要介護(HR 1.56,95% CI;1.07-2.27),ポリファーマシー(HR 1.48,95% CI;1.08-2.04)が入院日数の延長と正の相関を示した。
    【結論】入院日数の延長と関連する因子が示唆された。今後は本検討を基に多施設前向き研究で妥当性を確保する必要がある。

    DOI: 10.60227/jhgmwabun.17.3_274

    CiNii Research

    researchmap

  • Non-compliance to practice guidelines still exist in the early management of acute pancreatitis: Time for reappraisal? International journal

    Rupjyoti Talukdar, Yoshihisa Tsuji, Nitin Jagtap, R Pradeep, G V Rao, D Nageshwar Reddy

    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]   2021.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    INTRODUCTION: Earlier national surveys on the management of acute pancreatitis (AP) had reported non-compliance to practice guidelines. In the past decade, several guidelines were revised based on new evidence. In this multicenter international survey, we aimed to evaluate the practice patterns of early management of AP and compliance to the revised treatment guidelines across different disciplines and practice environments. METHODS: A structured questionnaire was sent via email to a target population of 654 that constituted of medical and surgical gastroenterologists, physicians and general surgeons, paediatricians from academic and non-academic centres across 30 countries. Other than demographic variables, the questionnaire contained items pertaining to early management of AP, such as, assessment at admissions and within first 72 h s, details regarding analgesics, IV hydration, oral/enteral feeding and antibiotic use. RESULTS: The response rate was 46.2% and after exclusions, a total of 297 participant's responses were analysed. Majority of the participants were from Asia, followed by Europe and the Americas. 181 (60.9%) claimed to follow practice guidelines, out of which 59 (32.6%) followed more than one. On further probing, only 41.9% were actually compliant to feeding and 59.7% to antibiotic guidelines. Even though participants opted for aggressive hydration, early feeding and avoidance of prophylactic antibiotics, there were non-compliance and discrepancies in titration of fluid therapy, indications of feeding and antibiotic use. DISCUSSION: Discrepancies and non-compliance still appear to exist in the early management of AP due to lack of strong evidence. We discuss ways that could improve compliance to the existing guidelines until stronger evidence comes to the fore.

    DOI: 10.1016/j.pan.2021.05.301

    PubMed

    researchmap

  • 急性膵炎発症後3か月における心身の負担と社会復帰の現状

    辻喜久, 石上敬介, 上野真行, 上野真行

    膵臓(Web)   36 ( 3 )   2021

  • Analysis of the risk of prolongation of hospital stay for patients hospitalized on an emergency basis in the department of general medicine of an acute care hospital

    若林崇雄, 山本武志, 山本武志, 相馬仁, 辻喜久, 山本和利, 山本和利

    日本病院総合診療医学会雑誌(Web)   17 ( 3 )   2021

  • International comparison of clinical guidelines for acute pancreatitis

    辻喜久, 佐藤健太

    膵臓(Web)   36 ( 4 )   2021

  • Dilemma of physician-mothers faced with an increased home burden and clinical duties in the hospital during the COVID-19 pandemic. International journal

    Sachiyo Nishida, Kanna Nagaishi, Masayo Motoya, Ayako Kumagai, Noriko Terada, Ai Kasuga, Narumi Kubota, Kotoe Iesato, Motonobu Kimizuka, Satsuki Miyajima, Masayuki Koyama, Hirofumi Ohnishi, Eichi Narimatsu, Naoya Masumori, Kazufumi Tsuchihashi, Taiji Tsukamoto, Yoshihisa Tsuji

    PloS one   16 ( 6 )   e0253646   2021

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: Since December 2019, coronavirus disease 2019 (COVID-19) has spread rapidly across the world. During the pandemic, physicians in our hospital have had to respond both to the issue of treating the patients and the increasing domestic burden associated with social disruption. The purpose of this study was to assess how much the burden on our doctors, especially female doctors, was increasing. MATERIAL AND METHODS: The Physicians' Career Support Committee in Sapporo Medical University conducted a questionnaire survey. The questionnaire inquired about a wide range of subjects with regard to working style and family life during the first and second waves of the COVID-19 pandemic, and was sent to all medical/dental physicians working in Sapporo Medical University. RESULTS: A total of 266 (42.7%) physicians in our hospital responded to our questionnaire and the data for 264 data were analyzed. The total numbers of males, females, and others, including those who did not want to specify, were 178 (67.4%), 82 (31.0%), and 4 (1.5%), respectively. Among them, 62 (23.5%) and 23 (8.7%) answered that their domestic burden was slightly or markedly increased. The increase in the domestic burden showed a significant difference between genders (p = 0.04). Even after correction for background differences using multivariate analysis, being female (p<0.001), having child dependents (p<0.001), and treating COVID-19 patients (p = 0.03) were significantly related to an increased domestic burden. Regarding family style, 58.1% of the physician-fathers were from two-income families (i.e., families with both parents in employment), and they answered that their partner mainly cared for the children. In contrast, 97.3% of physician-mothers were from two-income families, and 94.6% of the physician-mothers had to take care of children by themselves. CONCLUSION: Physician-mothers are caught in a dilemma between an increased home burden and clinical duties in the hospital, with a significantly higher ratio than physician-fathers during the pandemic. As we showed, female doctors could have not continued their careers and take responsible positions in the same way as male doctors. This is a social risk in the timing of a crisis, such as a pandemic.

    DOI: 10.1371/journal.pone.0253646

    PubMed

    researchmap

  • FileMakerによる情報共有システムの構築 アンプロフェッショナル学生への対応

    石井 真理子, 辻 喜久, 伊藤 俊之

    医学教育   51 ( Suppl. )   217 - 217   2020.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    Ichushi

    researchmap

  • Optimal Treatment for Octogenarians With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study. International journal

    Sohei Satoi, Tomohisa Yamamoto, Kazushige Uchida, Tsutomu Fujii, Toshifumi Kin, Satoshi Hirano, Keiji Hanada, Takao Itoi, Yoshiaki Murakami, Hisato Igarashi, Hidetoshi Eguchi, Tamotsu Kuroki, Yasuhiro Shimizu, Masaji Tani, Satoshi Tanno, Yoshihisa Tsuji, Yoshiki Hirooka, Atsushi Masamune, Toshio Shimokawa, Hiroki Yamaue, Kazuichi Okazaki

    Pancreas   49 ( 6 )   837 - 844   2020.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVES: The objective of this study was to clarify the role of pancreatectomy for patients with resectable and borderline resectable pancreatic ductal adenocarcinoma aged 80 years or older using a nationwide audit by the Japan Pancreas Society. METHODS: Data were collected from 39 institutions from 2007 to 2014. The primary endpoint was overall survival, and secondary endpoints were surgical outcomes and predictive factors for prognosis. RESULTS: Data were obtained from 556 octogenarians who underwent pancreatectomy (n = 369, 66%), chemo(radio)therapy (n = 99, 18%), and palliative therapy (n = 88, 16%). Median survival times were 20.6, 18.6, and 8.8 months in each group, respectively. Even after propensity score matching, median survival time in the surgery group (22.8 months) was significantly higher than that in the chemotherapy group (18.5 months; hazard ratio, 0.64 [95% confidence interval, 0.44-0.93]; P = 0.020). Significant independent prognostic factors were body mass index, lymph node metastasis, and tumor diameter in the surgery group, and serum albumin level, American Society of Anesthesiologists classification, body mass index, modified Glasgow prognostic score, second-line chemotherapy, and tumor diameter in the chemotherapy group. CONCLUSIONS: Octogenarians with resectable/borderline resectable pancreatic ductal adenocarcinoma can be recommended for pancreatectomy according to mental and physical fitness for surgical procedures.

    DOI: 10.1097/MPA.0000000000001579

    PubMed

    researchmap

  • Nutrition support for pancreatic disease and its relationship with sarcopenia

    UENO Masayuki, TSUJI Yoshihisa, HIRA Daichi, ISHIDA Etsuji, MORIMOTO Youichi, MIZUNO Motowo

    Suizo   35 ( 2 )   166 - 173   2020.4

     More details

    Language:Japanese   Publisher:Japan Pancreas Society  

    Nutrition support is often required for patients with pancreatic disease, because exocrine and endocrine insufficiency can lead to malabsorption and diabetes. There is substantial evidence supporting nutritional therapy for patients with chronic pancreatitis, and an individualized approach based on disease severity and stage is recommended. To provide appropriate nutritional support, evaluation of skeletal muscle volume and physical function is important. A decreased volume of skeletal muscle and sarcopenia are associated with lower quality of life (QOL) and an increased risk of hospitalization and mortality. Evidence for the use of nutritional therapy in patients with acute pancreatitis (subacute or later phase) and pancreatic cancer is still poor, but our studies suggest that adequate nutritional support is also important for patients with these diseases. This article reviews the clinical relevance of nutritional therapy for patients with chronic pancreatitis, acute pancreatitis, and pancreatic cancer, showing some of the results of our recent research.

    Other Link: https://search.jamas.or.jp/link/ui/2021069964

    DOI: 10.2958/suizo.35.166

    CiNii Research

    researchmap

  • History of Japanese and Western Medical Professionalism Developed in the Context of Social Structure

    辻喜久, 辻喜久

    医学教育   51 ( 1 )   15 - 28   2020

     More details

    Language:Japanese   Publisher:Japan Society for Medical Education  

    Introduction: Currently, there is confusion about what constitutes medical professionalism in Japan. Method: We compared the histories of the development professionalism in western countries and Japan based on the stage theory of economic development and a literature review. Using the information we gathered, we discuss the reasons why the confusion occurred. Result: In most of western countries, medical professionalism was affected by the industrial revolution and Protestantism. As Weber noted, for Protestants, working industriously and using the gift of one’s talent to earn much money was consistent with the teachings of God. Thus, reward was an important proof of their faith. Meanwhile, the Japanese social system and professionalism were developed independently from the industrial revolution. Since Japan was less influenced by the industrial revolution, knowledge was not subdivided. This resulted in undeveloped specialist jobs and the continuation of classical education based on Buddhism and Confucianism. Japanese professionalism, which included sacrificial altruism, differed from western professionalism, particularly with regard to the concept of reward. Discussion: Due to globalization, Japanese society now has two types of professionalism: one from western ideals and another from classical Japanese ideals. Because these two types of professionalism conflict on certain points, such as the concept of reward, there is confusion about what constitutes Japanese professionalism.

    Other Link: https://ndlsearch.ndl.go.jp/books/R000000004-I030297746

    DOI: 10.11307/mededjapan.51.1_15

    CiNii Research

    J-GLOBAL

    researchmap

  • Prognostic importance of peritoneal washing cytology in patients with otherwise resectable pancreatic ductal adenocarcinoma who underwent pancreatectomy: A nationwide, cancer registry-based study from the Japan Pancreas Society. Reviewed International journal

    Hiroyoshi Tsuchida, Tsutomu Fujii, Masamichi Mizuma, Sohei Satoi, Hisato Igarashi, Hidetoshi Eguchi, Tamotsu Kuroki, Yasuhiro Shimizu, Masaji Tani, Satoshi Tanno, Yoshihisa Tsuji, Yoshiki Hirooka, Atsushi Masamune, Kazuhiro Mizumoto, Takao Itoi, Shinichi Egawa, Yuzo Kodama, Shin Hamada, Michiaki Unno, Hiroki Yamaue, Kazuichi Okazaki

    Surgery   166 ( 6 )   997 - 1003   2019.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: The importance of peritoneal washing cytology status both as a sign of irresectability and as a prognostic factor for pancreatic ductal adenocarcinoma remains controversial. The purpose of this nationwide, cancer registry-based study was to clarify the clinical implications of operative resection in patients who had positive cytology status. METHODS: Clinical data from 1,970 patients who underwent tumor resection were collected from the Pancreatic Cancer Registry in Japan. Clinicopathologic factors and overall survival curves were analyzed, and multivariate Cox proportional hazard models were evaluated. RESULTS: Among the 1,970 patients analyzed, positive cytology status was found in 106 patients and negative cytology status was found in 1,864 patients. The positive cytology status group had a greater frequency of pancreatic body and tail cancer and greater preoperative serum carbohydrate antigen 19-9 levels than the negative cytology status group (P < .001 each). The ratio of peritoneal recurrence tended to be greater in the positive cytology status group (14% vs 43%; P < .001). Overall median survival times were less in the positive cytology status group (17.5 months vs 29.4 months; P < .001). The 5-year survival rates were 13.7% and 31.1% in the positive cytology status and negative cytology status groups, respectively. Multivariate analysis of positive cytology status patients revealed that adjuvant chemotherapy was an independent prognostic factor. CONCLUSION: Positive cytology status was an adverse prognostic factor in patients who underwent resection for pancreatic ductal adenocarcinoma but did not preclude attempted curative resection. Curative resection followed by adjuvant chemotherapy may contribute to long-term prognosis in patients with positive cytology status.

    DOI: 10.1016/j.surg.2019.06.023

    PubMed

    researchmap

  • 消化器画像診断における時間軸画像の有用性—TIME AXIS IMAGING FOR DIAGNOSIS OF DIGESTIVE DISEASE—生涯教育セミナー記録 平成30年度 第26回日本外科学会生涯教育セミナー 最新の診断技術 ; 中部地区 Invited Reviewed

    辻 喜久

    日本外科学会雑誌 = Journal of Japan Surgical Society / 日本外科学会 編   120 ( 2 )   261 - 263   2019

     More details

    Language:Japanese   Publisher:東京 : 日本外科学会  

    Other Link: https://ndlsearch.ndl.go.jp/books/R000000004-I029573031

    CiNii Research

    researchmap

  • 消化器画像診断における時間軸画像の有用性

    辻喜久

    日本外科学会雑誌   120 ( 2 )   2019

  • Chemokine CXCL16 mediates acinar cell necrosis in cerulein induced acute pancreatitis in mice. Reviewed International journal

    Yojiro Sakuma, Yuzo Kodama, Takaaki Eguchi, Norimitsu Uza, Yoshihisa Tsuji, Masahiro Shiokawa, Takahisa Maruno, Katsutoshi Kuriyama, Yoshihiro Nishikawa, Yuki Yamauchi, Motoyuki Tsuda, Tatsuki Ueda, Tomoaki Matsumori, Toshihiro Morita, Teruko Tomono, Nobuyuki Kakiuchi, Atsushi Mima, Yuko Sogabe, Saiko Marui, Takeshi Kuwada, Akihiko Okada, Tomohiro Watanabe, Hiroshi Nakase, Tsutomu Chiba, Hiroshi Seno

    Scientific reports   8 ( 1 )   8829 - 8829   2018.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Severe acute pancreatitis is a lethal inflammatory disease frequently accompanied by pancreatic necrosis. We aimed to identify a key regulator in the development of pancreatic necrosis. A cytokine/chemokine array using sera from patients with acute pancreatitis (AP) revealed that serum CXCL16 levels were elevated according to the severity of pancreatitis. In a mouse model of AP, Cxcl16 expression was induced in pancreatic acini in the late phase with the development of pancreatic necrosis. Cxcl16-/- mice revealed similar sensitivity as wild-type (WT) mice to the onset of pancreatitis, but better resisted development of acinar cell necrosis with attenuated neutrophil infiltration. A cytokine array and immunohistochemistry revealed lower expression of Ccl9, a neutrophil chemoattractant, in the pancreatic acini of Cxcl16-/- mice than WT mice. Ccl9 mRNA expression was induced by stimulation with Cxcl16 protein in pancreatic acinar cells in vitro, suggesting a Cxcl16/Ccl9 cascade. Neutralizing antibody against Cxcl16 ameliorated pancreatic injury in the mouse AP model with decreased Ccl9 expression and less neutrophil accumulation. In conclusion, Cxcl16 expressed in pancreatic acini contributes to the development of acinar cell necrosis through the induction of Ccl9 and subsequent neutrophil infiltration. CXCL16 could be a new therapeutic target in AP.

    Other Link: https://www.nature.com/articles/s41598-018-27200-y

    DOI: 10.1038/s41598-018-27200-y

    CiNii Research

    PubMed

    researchmap

  • Erratum to: Early diagnosis of pancreatic necrosis based on perfusion CT to predict the severity of acute pancreatitis. Reviewed

    Yoshihisa Tsuji, Naoki Takahashi, Hiroyoshi Isoda, Koji Koizumi, Sho Koyasu, Miho Sekimoto, Yuichi Imanaka, Shujiro Yazumi, Masanori Asada, Yoshihiro Nishikawa, Hiroshi Yamamoto, Osamu Kikuchi, Tsukasa Yoshida, Tetsuro Inokuma, Shinji Katsushima, Naoki Esaka, Akihiro Okano, Chiharu Kawanami, Nobuyuki Kakiuchi, Masahiro Shiokawa, Yuzo Kodama, Ichiro Moriyama, Takafumi Kajitani, Yoshikazu Kinoshita, Tsutomu Chiba

    Journal of gastroenterology   52 ( 10 )   1147 - 1148   2017.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Perfusion CT can diagnose pancreatic necrosis in early stage of severe acute pancreatitis, accurately. However, no study to date has examined whether early diagnosis of pancreatic necrosis is useful in predicting persistent organ failure (POF). METHODS: We performed a multi-center prospective observational cohort study to investigate whether perfusion CT can predict the development of POF in the early stage of AP, based on early diagnosis of the development of pancreatic necrosis (PN). From 2009 to 2012, we examined patients showing potential early signs of severe AP (n = 78) on admission. Diagnoses for the development of PN were made prospectively by on-site physicians on the admission based on perfusion CT (diagnosis 1). Blinded retrospective reviews were performed by radiologists A and B, having 8 and 13 years of experience as radiologists (diagnosis 2 and 3), respectively. Positive diagnosis for the development of PN were assumed equivalent to positive predictions for the development of POF. We then calculated the area under the curve (AUC) of the receiver operating characteristic for POF predictions. RESULTS: Fourteen (17.9%) and 23 patients (29.5%) developed PN and POF, respectively. For diagnoses 1, 2, and 3, AUCs for POF predictions were 74, 68, and 73, respectively. CONCLUSIONS: Perfusion CT diagnoses pancreatic necrosis and on that basis predicts the development of POF; http://www.umin.ac.jp/ctr/index-j.htm,UMIN000001926 .

    DOI: 10.1007/s00535-017-1343-0

    PubMed

    researchmap

  • Early diagnosis of pancreatic necrosis based on perfusion CT to predict the severity of acute pancreatitis. Reviewed

    Yoshihisa Tsuji, Naoki Takahashi, Hiroyoshi Isoda, Koji Koizumi, Sho Koyasu, Miho Sekimoto, Yuichi Imanaka, Shujiro Yazumi, Masanori Asada, Yoshihiro Nishikawa, Hiroshi Yamamoto, Osamu Kikuchi, Tsukasa Yoshida, Tetsuro Inokuma, Shinji Katsushima, Naoki Esaka, Akihiro Okano, Chiharu Kawanami, Nobuyuki Kakiuchi, Masahiro Shiokawa, Yuzo Kodama, Ichiro Moriyama, Takafumi Kajitani, Yoshikazu Kinoshita, Tsutomu Chiba

    Journal of gastroenterology   52 ( 10 )   1130 - 1139   2017.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Perfusion CT can diagnose pancreatic necrosis in early stage of severe acute pancreatitis, accurately. However, no study to date has examined whether early diagnosis of pancreatic necrosis is useful in predicting persistent organ failure (POF). METHODS: We performed a multi-center prospective observational cohort study to investigate whether perfusion CT can predict the development of POF in the early stage of AP, based on early diagnosis of the development of pancreatic necrosis (PN). From 2009 to 2012, we examined patients showing potential early signs of severe AP (n = 78) on admission. Diagnoses for the development of PN were made prospectively by on-site physicians on the admission based on perfusion CT (diagnosis 1). Blinded retrospective reviews were performed by radiologists A and B, having 8 and 13 years of experience as radiologists (diagnosis 2 and 3), respectively. Positive diagnosis for the development of PN were assumed equivalent to positive predictions for the development of POF. We then calculated the area under the curve (AUC) of the receiver operating characteristic for POF predictions. RESULTS: Fourteen (17.9%) and 23 patients (29.5%) developed PN and POF, respectively. For diagnoses 1, 2, and 3, AUCs for POF predictions were 74, 68, and 73, respectively. CONCLUSIONS: Perfusion CT diagnoses pancreatic necrosis and on that basis predicts the development of POF; http://www.umin.ac.jp/ctr/index-j.htm,UMIN000001926 .

    DOI: 10.1007/s00535-017-1330-5

    PubMed

    researchmap

  • 膵炎の病態解明を目指した最新の基礎研究 ケモカインCXCL16は壊死性膵炎の形成に重要である Reviewed

    佐久間 洋二朗, 児玉 裕三, 宇座 徳光, 辻 喜久, 塩川 雅広, 渡邉 智裕, 仲瀬 裕志, 千葉 勉, 妹尾 浩

    膵臓   32 ( 3 )   339 - 339   2017.5

     More details

    Language:Japanese   Publisher:日本膵臓学会  

    Ichushi

    J-GLOBAL

    researchmap

  • 膵臓Perfusion CTの撮影条件を最適化するためのデジタルファントムを用いたノイズと腫瘍径に関する検討 Reviewed

    小泉幸司, 小泉幸司, 小澤聡, 松田晃, 東村享治, 辻喜久, 上野智弘, 富樫かおり, 杉本直三

    電子情報通信学会技術研究報告   116 ( 393(MI2016 71-121) )   2017

  • Dual Energy Computed Tomography Analysis of Pancreatic Stones in a Patient with Chronic Pancreatitis

    塚本純, 山崎辰洋, 日野真太郎, 石田悦嗣, 辻喜久

    倉敷中央病院年報   79   2017

  • 造影ダイナミックCTとフッ素18フルオロミソニダゾール陽電子放出断層撮像法を用いた、腫瘍間質の評価および腫瘍低酸素との関連性の評価

    子安 翔, 辻 喜久, 原田 浩, 中本 裕士, 野橋 智美, 木村 寛之, 佐野 紘平, 小泉 幸司, 濱路 政嗣, 富樫 かおり

    JSMI Report   10 ( 1 )   63 - 66   2016.12

     More details

    Language:Japanese   Publisher:日本分子イメージング学会  

    Ichushi

    J-GLOBAL

    researchmap

  • Pathogenicity of IgG in patients with IgG4-related disease. Reviewed International journal

    Masahiro Shiokawa, Yuzo Kodama, Katsutoshi Kuriyama, Kenichi Yoshimura, Teruko Tomono, Toshihiro Morita, Nobuyuki Kakiuchi, Tomoaki Matsumori, Atsushi Mima, Yoshihiro Nishikawa, Tatsuki Ueda, Motoyuki Tsuda, Yuki Yamauchi, Ryuki Minami, Yojiro Sakuma, Yuji Ota, Takahisa Maruno, Akira Kurita, Yugo Sawai, Yoshihisa Tsuji, Norimitsu Uza, Kazuyoshi Matsumura, Tomohiro Watanabe, Kenji Notohara, Tatsuaki Tsuruyama, Hiroshi Seno, Tsutomu Chiba

    Gut   65 ( 8 )   1322 - 32   2016.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: IgG4-related disease (IgG4-RD) is a systemic disease characterised by elevated serum IgG4 and IgG4-positive lymphoplasmacytic infiltration in the affected tissues. The pathogenic role of IgGs, including IgG4, in patients with IgG4-RD, however, is unknown. DESIGN: We examined the pathogenic activity of circulating IgGs in patients with IgG4-RD by injecting their IgGs into neonatal male Balb/c mice. Binding of patient IgGs to pancreatic tissue was also analysed in an ex vivo mouse organ culture model and in tissue samples from patients with autoimmune pancreatitis (AIP). RESULTS: Subcutaneous injection of patient IgG, but not control IgG, resulted in pancreatic and salivary gland injuries. Pancreatic injury was also induced by injecting patient IgG1 or IgG4, with more destructive changes induced by IgG1 than by IgG4. The potent pathogenic activity of patient IgG1 was significantly inhibited by simultaneous injection of patient IgG4. Binding of patient IgG, especially IgG1 and IgG4, to pancreatic tissue was confirmed in both the mouse model and AIP tissue samples. CONCLUSIONS: IgG1 and IgG4 from patients with IgG4-RD have pathogenic activities through binding affected tissues in neonatal mice.

    DOI: 10.1136/gutjnl-2015-310336

    PubMed

    researchmap

  • Experience of Endoscopy in the Kingdom of Bhutan

    Nikaido Mitsuhiro, Miyamoto Shin'ichi, Kodama Yuzo, Uza Norimitsu, Tsuji Yoshihisa, Tsunoda Shigeru, Uemura Tadahiro, Okajima Hideaki, Maeda Sae, Takahashi Yoko, Muramoto Kanami, Ishii Ayuko, Nishi Yoko, Higuchi Hirokazu, Muto Manabu, Matsubara Kazuo, Chiba Tsutomu

    17   77 - 84   2016.3

     More details

    Language:Japanese   Publishing type:Research paper (bulletin of university, research institution)   Publisher:The Association for the Studies of Himalaya, Kyoto University ; Kyoto University Bhutan Friendship Program ; The Leading Graduate Program for Primatology and Wildlife Science, Kyoto University  

    We provided medical care in the Kingdom of Bhutan from January to March in 2014 through the international medical support program of Kyoto University Hospital. Bhutan is a small, developing country with a population of about 700, 000 citizens located at the southern foot of the Himalayas. There are only 244 medical doctors in Bhutan (one-tenth of the number of doctors relative to population in Japan). Because of the shortage of doctors and the limited medical resources, patients with difficult-to-treat conditions are transferred to India or other countries. Gastrointestinal endoscopy is performed by the country's only gastroenterologist and six surgeons, mainly in Jigme Dorji Wangchuk National Referral Hospital (JDWNRH) at Thimphu. Several years before, a Bhutanese surgeon had learned to perform endoscopic retrograde cholangiopancreatography (ERCP) in Thailand. However, ERCP cannot be established in Bhutanese routine clinical practice because of its technical difficulty. Although a duodenoscope and some devices for ERCP are available, at least one patient who needs ERCP is transferred to India every month. In this context, I was asked to reintroduce ERCP into JDWNRH. ERCP was performed in 23 cases involving 17 patients with the cooperation of Bhutanese doctors, nurses, and technicians. My experience leads me to believe that we can build a platform to continue ERCP in JDWNRH. During the 10 weeks, I also helped to perform about 900 endoscopies, mainly esophagogastroduodenoscopy, and I taught endoscopic techniques and diagnostic approaches to Bhutanese doctors. In this report, I describe the current status of endoscopy in Bhutan including the incidence of Bhutanese gastrointestinal disorders and the experience specifically related to introducing ERCP.

    DOI: 10.14989/HSM.17.77

    CiNii Research

    researchmap

  • Evaluation of Tumor-associated Stroma and Its Relationship with Tumor Hypoxia Using Dynamic Contrast-enhanced CT and (18)F Misonidazole PET in Murine Tumor Models. Reviewed International journal

    Sho Koyasu, Yoshihisa Tsuji, Hiroshi Harada, Yuji Nakamoto, Tomomi Nobashi, Hiroyuki Kimura, Kohei Sano, Koji Koizumi, Masatsugu Hamaji, Kaori Togashi

    Radiology   278 ( 3 )   734 - 41   2016.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: To determine the relationship between the fractional interstitial volume (Fis), as calculated at dynamic contrast material-enhanced (DCE) computed tomography (CT), and tumor-associated stroma and to analyze its spatial relationship with tumor hypoxia in several xenograft tumor models. MATERIALS AND METHODS: All animal experiments were approved by the animal research committee. Mice with three different xenograft tumors (U251, CFPAC-1, and BxPC-3; n = 6, n = 8, and n = 6, respectively) underwent DCE CT then hypoxia imaging with fluorine 18 ((18)F) fluoromisonidazole (FMISO) positron emission tomography (PET) within 24 hours. Immunohistochemical analysis was performed in harvested tumors to detect hypoxia markers and to quantify microvascular and stromal density. Two DCE CT parameters (amount of interstitial space associated with the amount of stroma [Fis] and flow velocity [Fv]) were identified and quantitatively validated by using immunohistochemistry. FMISO uptake within the tumor was also assessed in relation to DCE CT parameters. Imaging and immunohistochemical parameters were assessed by using the Kruskal-Wallis test, Wilcoxon rank-sum test with Bonferroni correction, and Pearson correlation coefficient. RESULTS: Almost no α-smooth muscle actin-positive cells were found in the U251 xenograft, while abundant stroma was found in the entire BxPC-3 xenograft and in the periphery of the CFPAC-1 xenograft. Quantitative analysis showed a significant correlation (R = 0.83, P < .0001) between Fis and stromal density. FMISO uptake had a negative correlation with Fis (R = -0.58, P < .0001) and Fv (R = -0.53, P < .0001). CONCLUSION: DCE CT can be used to quantify parameters associated with tumor-associated stroma. Tumor hypoxia was Complementarily localized in tumor-associated stroma in these models.

    DOI: 10.1148/radiol.2015150416

    PubMed

    researchmap

  • Acute Pancreatitis-Progress and Challenges: A Report on an International Symposium. Reviewed International journal

    Elham Afghani, Stephen J Pandol, Tooru Shimosegawa, Robert Sutton, Bechien U Wu, Santhi Swaroop Vege, Fred Gorelick, Morihisa Hirota, John Windsor, Simon K Lo, Martin L Freeman, Markus M Lerch, Yoshihisa Tsuji, Gil Y Melmed, Wahid Wassef, Julia Mayerle

    Pancreas   44 ( 8 )   1195 - 210   2015.11

     More details

    Language:English  

    An international symposium entitled "Acute pancreatitis: progress and challenges" was held on November 5, 2014 at the Hapuna Beach Hotel, Big Island, Hawaii, as part of the 45th Anniversary Meeting of the American Pancreatic Association and the Japanese Pancreas Society. The course was organized and directed by Drs. Stephen Pandol, Tooru Shimosegawa, Robert Sutton, Bechien Wu, and Santhi Swaroop Vege. The symposium objectives were to: (1) highlight current issues in management of acute pancreatitis, (2) discuss promising treatments, (3) consider development of quality indicators and improved measures of disease activity, and (4) present a framework for international collaboration for development of new therapies. This article represents a compilation and adaptation of brief summaries prepared by speakers at the symposium with the purpose of broadly disseminating information and initiatives.

    DOI: 10.1097/MPA.0000000000000500

    PubMed

    researchmap

  • Efficacy of recombinant human soluble thrombomodulin in preventing walled-off necrosis in severe acute pancreatitis patients Reviewed International journal

    Takaaki Eguchi, Yoshihisa Tsuji, Hiroshi Yamashita, Takumi Fukuchi, Atsushi Kanamori, Kei Matsumoto, Takashi Hasegawa, Akio Koizumi, Ryuki Kitada, Masahiro Tsujimae, Taro Lwatsubo, Shintaro Koyama, Satoshi Ubukata, Mikio Fujita, Akihiko Okada

    PANCREATOLOGY   15 ( 5 )   485 - 490   2015.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.pan.2015.08.002

    PubMed

    Web of Science

    researchmap

  • Activation-Induced Cytidine Deaminase Contributes to Pancreatic Tumorigenesis by Inducing Tumor-Related Gene Mutations. Reviewed International journal

    Yugo Sawai, Yuzo Kodama, Takahiro Shimizu, Yuji Ota, Takahisa Maruno, Yuji Eso, Akira Kurita, Masahiro Shiokawa, Yoshihisa Tsuji, Norimitsu Uza, Yuko Matsumoto, Toshihiko Masui, Shinji Uemoto, Hiroyuki Marusawa, Tsutomu Chiba

    Cancer research   75 ( 16 )   3292 - 301   2015.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Pancreatic ductal adenocarcinoma (PDAC) develops via an accumulation of various gene mutations. The mechanism underlying the mutations in PDAC development, however, is not fully understood. Recent insight into the close association between the mutation pattern of various cancers and specific mutagens led us to investigate the possible involvement of activation-induced cytidine deaminase (AID), a DNA editing enzyme, in pancreatic tumorigenesis. Our immunohistochemical findings revealed AID protein expression in human acinar ductal metaplasia, pancreatic intraepithelial neoplasia, and PDAC. Both the amount and intensity of the AID protein expression increased with the progression from precancerous to cancerous lesions in human PDAC tissues. To further assess the significance of ectopic epithelial AID expression in pancreatic tumorigenesis, we analyzed the phenotype of AID transgenic (AID Tg) mice. Consistent with our hypothesis that AID is involved in the mechanism of the mutations underlying pancreatic tumorigenesis, we found precancerous lesions developing in the pancreas of AID Tg mice. Using deep sequencing, we also detected Kras and c-Myc mutations in our analysis of the whole pancreas of AID Tg mice. In addition, Sanger sequencing confirmed the presence of Kras, c-Myc, and Smad4 mutations, with the typical mutational footprint of AID in precancerous lesions in AID Tg mice separated by laser capture microdissection. Taken together, our findings suggest that AID contributes to the development of pancreatic precancerous lesions by inducing tumor-related gene mutations. Our new mouse model without intentional manipulation of specific tumor-related genes provides a powerful system for analyzing the mutations involved in PDAC.

    DOI: 10.1158/0008-5472.CAN-14-3028

    PubMed

    researchmap

  • Usefulness of Adalimumab for Treating a Case of Intestinal Behçet's Disease With Trisomy 8 Myelodysplastic Syndrome. Reviewed International journal

    Masamichi Kimura, Yoshihisa Tsuji, Masako Iwai, Masahiro Inagaki, Ali Madian, Takuya Yoshino, Minoru Matsuura, Hiroshi Nakase

    Intestinal research   13 ( 2 )   166 - 9   2015.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Behçet's disease (BD) is a systemic vasculitis, while myelodysplastic syndrome (MDS) is a heterogeneous group of clonal hematologic disorders characterized by ineffective hematopoiesis. Some studies suggest a relationship between MDS and BD, especially intestinal BD, and trisomy 8 seems to play an important role in both diseases. There are several reports on patients with BD comorbid with MDS involving trisomy 8 that frequently have intestinal lesions refractory to conventional medical therapies. Tumor necrosis factor (TNF)-α is strongly involved in the pathophysiology of several autoimmune diseases such as rheumatoid arthritis, inflammatory bowel disease, and BD. In addition, TNF-α plays an important role in the pathophysiology of MDS by inhibiting normal hematopoiesis and inducing the programmed cell death of normal total bone marrow cells and normal CD34+ cells. Recent clinical reports demonstrate the favorable effect of TNF-α antagonists in patients with refractory intestinal BD and in those with MDS. We present the case of a patient with intestinal BD and MDS involving trisomy 8 who was successfully treated with adalimumab.

    DOI: 10.5217/ir.2015.13.2.166

    PubMed

    researchmap

  • Role of Early Prediction of Pancreatic Necrosis in Evaluating Severity of Acute Pancreatitis in the Early Stage

    Yoshihisa Tsuji, Yuzo Kodama, Tsutomu Chiba

    GASTROENTEROLOGY   148 ( 4 )   S683 - S683   2015.4

     More details

    Language:English  

    Web of Science

    researchmap

  • Evaluation of tumour hypoxia and cancer stroma using F-18-misonidazole PET and dynamic contrast enhanced CT in tumor-bearing mice models Reviewed

    S. Koyasu, Y. Nakamoto, H. Harada, Y. Tsuji, H. Kimura, K. Sano, T. Nobashi, K. Togashi

    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING   41   S387 - S387   2014.10

     More details

    Language:English  

    Web of Science

    researchmap

  • Evaluation of intratumoral microenvironment with 18F-misonidazole PET and dynamic contrast enhanced CT in tumor-bearing mice models Reviewed

    Sho Koyasu, Yuji Nakamoto, Hiroshi Harada, Hiroyuki Kimura, Kohei Sano, Koji Koizumi, Yoshihisa Tsuji, Tomomi Nobashi, Kensuke Kurihara, Kaori Togashi

    JOURNAL OF NUCLEAR MEDICINE   55   2014.5

     More details

    Language:English  

    Web of Science

    researchmap

  • Long-term efficacy of infliximab for refractory ulcerative colitis: results from a single center experience. Reviewed International journal

    Satoshi Yamada, Takuya Yoshino, Minoru Matsuura, Naoki Minami, Takahiko Toyonaga, Yusuke Honzawa, Yoshihisa Tsuji, Hiroshi Nakase

    BMC gastroenterology   14   80 - 80   2014.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: The long-term efficacy of infliximab (IFX) for patients with refractory ulcerative colitis (UC) is unclear. The aim of this study was to assess the long-term outcomes of IFX treatment in patients with refractory UC. METHODS: Thirty-three patients with refractory UC who received IFX treatment at Kyoto University Hospital between 2003 and 2013 were retrospectively evaluated. IFX intensification was defined as a dose escalation (up to 10 mg/kg) and/or shorter intervals between infusions (every 4-6 weeks). RESULTS: Of the 33 patients who received scheduled infusions of IFX, 24 (72.7%) achieved clinical remission within 8 weeks after initiating IFX treatment. Of these 24 responders, 17 (70.8%) experienced a relapse of UC and required IFX intensification, and 16 (66.7%) eventually maintained clinical remission with IFX treatment, including IFX intensification. Of the 33 patients, 6 (18.2%) underwent colectomy during IFX treatment. Multivariate regression analysis showed that a serum C-reactive protein (CRP) concentration <5 mg/L two weeks after starting IFX was a predictor of a positive clinical response to IFX induction therapy. No severe adverse events occurred in UC patients treated with IFX. CONCLUSION: IFX intensification was necessary for long-term maintenance of remission and to prevent colectomy in patients with refractory UC.

    DOI: 10.1186/1471-230X-14-80

    PubMed

    researchmap

  • Subtraction color map of contrast-enhanced and unenhanced CT for the prediction of pancreatic necrosis in early stage of acute pancreatitis. Reviewed International journal

    Yoshihisa Tsuji, Naoki Takahashi, Joel G Fletcher, David M Hough, Brendan P McMenomy, David M Lewis, Santhi S Vege, Suresh T Chari, Cynthia H McCollough, Katharine L Grant, Ernst Klotz

    AJR. American journal of roentgenology   202 ( 4 )   W349-56   2014.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: The objective of our study was to evaluate the accuracy of subtraction color-map images created from contrast-enhanced CT (CECT) and unenhanced CT for the diagnosis of pancreatic necrosis in the early stage of acute pancreatitis. MATERIALS AND METHODS: Forty-eight patients underwent unenhanced CT and CECT within 72 hours from the onset of acute pancreatitis. Subtraction color-map images were created from unenhanced CT and CECT using a 3D nonrigid registration method. Three radiologists reviewed two image sets: CECT alone and subtraction color-map images in conjunction with CECT. Readers evaluated each image set for the presence of pancreatic necrosis. The reference standard for pancreatic necrosis was CT or MRI 1 week or more after the onset of acute pancreatitis. The performance of each image set for the prediction of pancreatic necrosis was calculated and compared using the McNemar test. RESULTS: Eleven of the 48 patients developed pancreatic necrosis. There were no technical failures creating the subtraction images. The sensitivity, specificity, and accuracy for predicting pancreatic necrosis with CECT were 64%, 97%, and 90%, respectively, for reader 1; 73%, 87%, and 83% for reader 2; and 73%, 87%, and 83% for reader 3. The sensitivity, specificity, and accuracy for predicting pancreatic necrosis with the subtraction color maps were 100%, 100%, and 100%, respectively, for reader 1; 100%, 95%, and 96% for reader 2; and 82%, 92%, and 90% for reader 3. Accuracy significantly improved with the addition of subtraction color maps compared with CECT alone for reader 1 (p = 0.03) and reader 2 (p = 0.02) but not for reader 3 (p = 0.37). CONCLUSION: A subtraction color map is accurate in the diagnosis of pancreatic necrosis in the early stage of acute pancreatitis.

    DOI: 10.2214/AJR.13.10957

    PubMed

    researchmap

  • Acute pancreatitis and innate immunity Invited Reviewed

    WATANABE Tomohiro, TSUJI Yoshihisa, CHIBA Tsutomu

    Suizo   29 ( 1 )   45 - 50   2014

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:Japan Pancreas Society  

    It has been generally accepted that pathogenic intra-acinar trypsinogen activation followed by auto-digestion of the pancreas plays a critical role in the development of acute pancreatitis. However, recent studies suggest that auto-digestion by activated trypsin alone cannot fully account for the pathogenesis of acute pancreatitis since experimental acute pancreatitis is successfully induced even without the full-activation of trypsinogen. Although intra-acinar trypsinogen activation followed by auto-digestion of the pancreas is an initial step of acute pancreatitis, pathogenic immune reactions are involved in the sustained pancreatic inflammation. In this regard, recent studies highlight the importance of innate immune responses mediated by intestinal microflora translocated into the pancreas and by endogenous auto-antigens released from the necrotic pancreatic tissue.<br>

    DOI: 10.2958/suizo.29.45

    CiNii Research

    J-GLOBAL

    researchmap

  • 膵perfusion CTの現状と今後 Reviewed

    辻喜久

    Japanese Journal of Diagnostic Imaging   32 ( 1 )   2014

  • Comparative Analysis of Perfusion CT Algorithms in the Detection of Early-Stage Pancreatic Necrosis

    吉田司, 三谷洋介, 熊谷健, 松枝和宏, 山本博, 辻喜久, 渡邊祐司

    倉敷中央病院年報   76   2014

  • Perfusion in the tissue surrounding pancreatic cancer and the patient's prognosis. Reviewed International journal

    Yoshihiro Nishikawa, Yoshihisa Tsuji, Hiroyoshi Isoda, Yuzo Kodama, Tsutomu Chiba

    BioMed research international   2014   648021 - 648021   2014

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: The objective was to investigate the relationship between prognosis in case of pancreatic cancer and perfusion in tissue surrounding pancreatic cancer using perfusion CT. METHODS: We enrolled 17 patients diagnosed with inoperable pancreatic adenocarcinoma. All patients were examined by perfusion CT and then underwent chemotherapy using gemcitabine. The time density curve (TDC) of each CT pixel was analyzed to calculate area under the curve (AUC) and blood flow (BF) using a mathematical algorithm based on the single-compartment model. To measure the AUC and BF of tumor (AUCT and BFT) and peritumoral tissue (AUCPTT and BFPTT), regions of interest were manually placed on the cancer and in pancreatic tissue within 10 mm of proximal pancreatic parenchyma. Survival days from the date of perfusion CT were recorded. Correlation between AUC or BF and survival days was assessed. RESULTS: We found a significant correlation between AUCPTT or BFPTT and survival days (P = 0.04 or 0.0005). Higher AUCPTT or BFPTT values were associated with shorter survival. We found no significant correlation between AUCT or BFT and survival. CONCLUSIONS: Our results suggest that assessments of perfusion in pancreatic tissue within 10 mm of proximal pancreatic parenchyma may be useful in predicting prognosis.

    DOI: 10.1155/2014/648021

    PubMed

    researchmap

  • Pancreatic Blood Flow Measurements in the Pig Pancreatitis Model Using Perfusion CT with Deconvolution Method Reviewed

    Yoshihisa Tsuji, Kazutaka Yamada, Miori Kisimoto, Shujiro Yazumi, Hiroyoshi Isoda, Tsutomu Chiba

    ABDOMINAL IMAGING: COMPUTATIONAL AND CLINICAL APPLICATIONS   8676   94 - 102   2014

     More details

    Language:English   Publishing type:Research paper (international conference proceedings)  

    Other Link: https://dblp.uni-trier.de/db/conf/miccai/abdi2014.html#TsujiYKYIC14

    DOI: 10.1007/978-3-319-13692-9_9

    Web of Science

    DBLP ID

    researchmap

  • Risk of cancer in patients with autoimmune pancreatitis. Reviewed International journal

    Masahiro Shiokawa, Yuzo Kodama, Kenichi Yoshimura, Chiharu Kawanami, Jun Mimura, Yukitaka Yamashita, Masanori Asada, Masataka Kikuyama, Yoshihiro Okabe, Tetsuro Inokuma, Masaya Ohana, Hiroyuki Kokuryu, Kazuo Takeda, Yoshihisa Tsuji, Ryuki Minami, Yojiro Sakuma, Katsutoshi Kuriyama, Yuji Ota, Wataru Tanabe, Takahisa Maruno, Akira Kurita, Yugo Sawai, Norimitsu Uza, Tomohiro Watanabe, Hironori Haga, Tsutomu Chiba

    The American journal of gastroenterology   108 ( 4 )   610 - 7   2013.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVES: Although simultaneous occurrences of autoimmune pancreatitis (AIP) and cancer are occasionally observed, it remains largely unknown whether cancer and AIP occur independently or these disorders are interrelated. The aim of this study was to examine the relationship between AIP and cancer. METHODS: We conducted a multicenter, retrospective cohort study. One hundred and eight patients who met the Asian diagnostic criteria for AIP were included in the study. We calculated the proportion, standardized incidence ratio (SIR), relative risk, and time course of cancer development in patients with AIP. We also analyzed the clinicopathological characteristics of AIP patients with cancer in comparison with those without cancer. RESULTS: Of the 108 AIP patients, 18 cancers were found in 15 patients (13.9%) during the median follow-up period of 3.3 years. The SIR of cancer was 2.7 (95% confidence interval (CI) 1.4-3.9), which was stratified into the first year (6.1 (95% CI 2.3-9.9)) and subsequent years (1.5 (95% CI 0.3-2.8)) after AIP diagnosis. Relative risk of cancer among AIP patients at the time of AIP diagnosis was 4.9 (95% CI 1.7-14.9). In six of eight patients whose cancer lesions could be assessed before corticosteroid therapy for AIP, abundant IgG4-positive plasma cell infiltration was observed in the cancer stroma. These six patients experienced no AIP relapse after successful cancer treatment. CONCLUSIONS: Patients with AIP are at high risk of having various cancers. The highest risk for cancer in the first year after AIP diagnosis and absence of AIP relapse after successful treatment of the coexisting cancers suggest that AIP may develop as a paraneoplastic syndrome in some patients.

    DOI: 10.1038/ajg.2012.465

    PubMed

    researchmap

  • Technique and clinical applications of hepatic perfusion ct with dual-input algorithms

    Sho Koyasu, Yoshihisa Tsuji

    Computed Tomography: New Research   65 - 73   2013.3

     More details

    Language:English   Publishing type:Part of collection (book)   Publisher:Nova Science Publishers, Inc.  

    researchmap

  • Relationship between pancreatic perfusion parameters and clinical complications of severe acute pancreatitis. Reviewed International journal

    Tsubasa Watanabe, Yoshihisa Tsuji, Naoki Takahashi, Tsukasa Yoshida, Masashi Tamaoki, Osamu Kikuchi, Yuji Watanabe, Yuzo Kodama, Hiroyoshi Isoda, Hiroshi Yamamoto, Tsutomu Chiba

    Pancreas   42 ( 1 )   180 - 2   2013.1

     More details

  • 原発性硬化性胆管炎として長期経過観察されたIgG4関連硬化性胆管炎の3例

    南竜城, 栗田亮, 栗山勝利, 佐久間洋二朗, 大田悠司, 田邊渉, 丸野貴久, 塩川雅広, 澤井勇悟, 辻喜久, 宇座徳光, 児玉裕三

    胆道   27 ( 3 )   2013

  • Sensing of commensal organisms by the intracellular sensor NOD1 mediates experimental pancreatitis. Reviewed International journal

    Yoshihisa Tsuji, Tomohiro Watanabe, Masatoshi Kudo, Hidenori Arai, Warren Strober, Tsutomu Chiba

    Immunity   37 ( 2 )   326 - 38   2012.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The intracellular sensor NOD1 has important host-defense functions relating to a variety of pathogens. Here, we showed that this molecule also participates in the induction of a noninfectious pancreatitis via its response to commensal organisms. Pancreatitis induced by high-dose cerulein (a cholecystokinin receptor agonist) administration depends on NOD1 stimulation by gut microflora. To analyze this NOD1 activity, we induced pancreatitis by simultaneous administration of a low dose of cerulein (that does not itself induce pancreatitis) and FK156, an activator of NOD1 that mimics the effect of gut bacteria that have breached the mucosal barrier. The pancreatitis was dependent on acinar cell production of the chemokine MCP-1 and the intrapancreatic influx of CCR2(+) inflammatory cells. Moreover, MCP-1 production involved activation of the transcription factors NF-κB and STAT3, each requiring complementary NOD1 and cerulein signaling. These studies indicate that gut commensals enable noninfectious pancreatic inflammation via NOD1 signaling in pancreatic acinar cells.

    DOI: 10.1016/j.immuni.2012.05.024

    PubMed

    researchmap

  • Hepatic arterial perfusion increases in the early stage of severe acute pancreatitis patients: evaluation by perfusion computed tomography. Reviewed International journal

    Sho Koyasu, Hiroyoshi Isoda, Yoshihisa Tsuji, Hiroshi Yamamoto, Kazuhiro Matsueda, Yuji Watanabe, Tsutomu Chiba, Kaori Togashi

    European journal of radiology   81 ( 1 )   43 - 6   2012.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: Although hepatic perfusion abnormalities have been reported in patients with acute pancreatitis, hepatic perfusion with severe acute pancreatitis (SAP) has not been quantitatively evaluated in humans. Therefore, we investigated hepatic perfusion in patients with SAP using perfusion CT. MATERIALS AND METHODS: Hepatic perfusion CT was performed in 67 patients with SAP within 3 days after symptom onset. The patients were diagnosed as having SAP according to the Atlanta criteria. Fifteen cases were established as a control group. Perfusion CT was obtained for 54s beginning with a bolus injection of 40 ml of contrast agent (600-630 mgI/kg) at a flow rate of 4 ml/s. Perfusion data were analyzed by the dual-input maximum slope method to obtain hepatic arterial perfusion (HAP) and hepatic portal perfusion (HPP). Finally, we compared HAP and HPP in SAP patients with those in the control group, respectively. RESULTS: Average HAP was significantly higher in SAP patients than in the control group (75.1 ± 38.0 vs. 38.2 ± 9.0 ml/min/100ml; p<0.001). There was no significant difference in average HPP between SAP patients and the control group (206.7 ± 54.9 vs. 204.4 ± 38.5 ml/min/100ml; p=0.92). CONCLUSION: Using quantitative analysis on perfusion CT, we first demonstrated an increase of HAP in the right hepatic lobe in SAP patients.

    DOI: 10.1016/j.ejrad.2010.11.013

    PubMed

    researchmap

  • Perfusion CT is useful for the differential diagnosis of autoimmune pancreatitis from pancreatic cancer

    HIROTA Morihisa, TAKIKAWA Tetsuya, HAYASHI Shintaro, MIURA Shin, CHIBA Tsutomu, MASAMUNE Atsushi, SHIMOSEGAWA Tooru, TSUDA Masashi, TSUJI Yoshihisa, KANNO Atsushi, KIKUTA Kazuhiro, KUME Kiyoshi, HAMADA Shin, UNNO Jun, ARIGA Hiroyuki

    Suizo   27 ( 4 )   601 - 607   2012

     More details

    Language:Japanese   Publisher:Japan Pancreas Society  

    Radiological findings of autoimmune pancreatitis (AIP) are sometimes similar to those of pancreatic cancer (PC). The aim of this study was to clarify the utility of perfusion computed tomography (CT) for the differential diagnosis of AIP from PC. Perfusion CT was performed in 12 patients with AIP and 22 patients with PC. All AIP patients were diagnosed as type 1. Parameters including pancreatic volumetric blood flow F<sub>V</sub>, volume of distribution V<sub>D</sub> and blood perfusion pattern R<sup>2</sup> were determined from a single-compartment kinetic model. Pancreatic F<sub>V</sub> values of the 12 AIP patients (81.3/min) were significantly higher than those of 22 PC patients (19.3/min, <i>p</i>=0.0005). Pancreatic V<sub>D</sub> values of the AIP patients (28.8) were significantly lower than those of the PC patients (93.6, <i>p</i>=0.0084). Moreover, pancreatic R<sup>2</sup> values of the AIP patients (0.659) were significantly higher than those of the PC patients (0.250, <i>p</i><0.0001). Perfusion CT is useful to distinguish AIP from PC by the comparison of the parameters of blood flow, distribution and blood perfusion pattern.<br>

    Other Link: https://search.jamas.or.jp/link/ui/2013018296

    DOI: 10.2958/suizo.27.601

    CiNii Research

    J-GLOBAL

    researchmap

  • Perfusion computed tomography findings of autoimmune pancreatitis. Reviewed International journal

    Morihisa Hirota, Masashi Tsuda, Yoshihisa Tsuji, Atsushi Kanno, Kazuhiro Kikuta, Kiyoshi Kume, Shin Hamada, Jun Unno, Hiromichi Ito, Hiroyuki Ariga, Tsutomu Chiba, Atsushi Masamune, Kennichi Satoh, Tooru Shimosegawa

    Pancreas   40 ( 8 )   1295 - 301   2011.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVES: The aim of this study was to clarify the pancreatic blood perfusion in patients with autoimmune pancreatitis (AIP) and the changes after steroid treatment. METHODS: Perfusion computed tomography was performed in 11 patients with AIP and 12 control subjects. Pancreatic volumetric blood flow (F(V)), volume of distribution (V(D)), and blood transit time τ were determined from a single-compartment kinetic model. Nine patients with AIP were reexamined by perfusion computed tomography after corticosteroid administration. RESULTS: The pancreatic F(V) values of the 11 patients with AIP (82.7/min) were significantly lower than those of control subjects (163.5/min, P = 0.0006). On the other hand, the pancreatic V(D) and τ values were not significantly different between AIP and normal. After steroid treatment, the F(V) values of 9 reexamined patients with AIP (76.2/min) were significantly elevated (109.8/min, P = 0.0391). However, the changes of the values after the treatment differed in degree among individuals. The values of 4 patients were dramatically elevated to greater than 100/min, whereas those of 4 other patients did not improve well. The value of the remaining patient whose initial F(V) value was normal (168.09/min) did not change after the treatment. CONCLUSIONS: Pancreatic volumetric perfusion was attenuated in AIP patients. The perfusion was improved after the steroid treatment.

    DOI: 10.1097/MPA.0b013e31821fcc4f

    PubMed

    researchmap

  • Relationship between serum angiopoietin-2 level and perfusion CT parameters in severe acute pancreatitis. Reviewed International journal

    Tsubasa Watanabe, Yoshihisa Tsuji, Yuzo Kodama, Hiroyoshi Isoda, Hiroshi Yamamoto, Tsutomu Chiba

    The American journal of gastroenterology   106 ( 10 )   1859 - 61   2011.10

     More details

  • Ischemic penumbra in early stage of severe acute pancreatitis Reviewed

    辻喜久, 辻喜久, 渡邉翼, 塩川雅広, 栗田亮, 澤井勇悟, 上野憲司, 塩せいじ, 宇座徳光, 児玉裕三, 小泉幸司, 磯田裕義, 渡邊祐司, 山本博, 千葉勉

    Suizo   26 ( 1 )   59 - 65   2011.2

  • Measurement of canine pancreatic perfusion using dynamic computed tomography: influence of input-output vessels on deconvolution and maximum slope methods. Reviewed International journal

    Miori Kishimoto, Yoshihisa Tsuji, Nana Katabami, Junichiro Shimizu, Ki-Ja Lee, Toshiroh Iwasaki, Yoh-Ichi Miyake, Shujiro Yazumi, Tsutomu Chiba, Kazutaka Yamada

    European journal of radiology   77 ( 1 )   175 - 81   2011.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVE: We investigated whether the prerequisite of the maximum slope and deconvolution methods are satisfied in pancreatic perfusion CT and whether the measured parameters between these algorithms are correlated. METHODS: We examined nine beagles injected with iohexol (200 mgI kg(-1)) at 5.0 ml s(-1). The abdominal aorta and splenic and celiac arteries were selected as the input arteries and the splenic vein, the output veins. For the maximum slope method, we determined the arterial contrast volume of each artery by measuring the area under the curve (AUC) and compared the peak enhancement time in the pancreas with the contrast appearance time in the splenic vein. For the deconvolution method, the artery-to-vein collection rate of contrast medium was calculated. We calculated the pancreatic tissue blood flow (TBF), tissue blood volume (TBV), and mean transit time (MTT) using both algorithms and investigated their correlation based on vessel selection. RESULTS: The artery AUC significantly decreased as it neared the pancreas (P<0.01). In all cases, the peak time of the pancreas (11.5±1.6) was shorter than the appearance time (14.1±1.6) in the splenic vein. The splenic artery-vein combination exhibited the highest collection rate (91.1%) and was the only combination that was significantly correlated between TBF, TBV, and MTT in both algorithms. CONCLUSION: Selection of a vessel nearest to the pancreas is considered as a more appropriate prerequisite. Therefore, vessel selection is important in comparison of the semi-quantitative parameters obtained by different algorithms.

    DOI: 10.1016/j.ejrad.2009.06.016

    PubMed

    researchmap

  • Severe Acute Pancreatitis and Non Occlusive Mesenteric Ischemia Reviewed

    辻喜久, 辻喜久, 山本博, 能登原憲司, 児玉祐三, 千葉勉

    日本腹部救急医学会雑誌   31 ( 7 )   1029 - 1037   2011

     More details

    Language:Japanese   Publisher:Japanese Society for Abdominal Emergency Medicine  

    The mechanism and pathology of patients with severe acute pancreatitis with non-occlusive mesenteric ischemia (NOMI) are still unclear. Currently, there are some reports that vasoconstriction associated factors (angiopoietin-2, endothelin-1 and VEGF et al. ) have important role in the development of NOMI with severe acute pancreatitis. In our experience, one of characteristic pathological findings of NOMI is the non-consecutive enterointestinal damage. The diagnosis of NOMI is not easy in the early stage, so we attempt to use hepatic perfusion CT to diagnose it. Hepatic perfusion CT can evaluate hepatic portal flow (HPF) and hepatic arterial flow (HAF), separately. In our study, HPF of acute pancreatitis patients with NOMI was significantly slower than those without NOMI. Therefore, evaluation of hepatic perfusion in the early stage might be extremely helpful in the diagnosis of NOMI. In this paper, we would like to report the mechanism, pathology, diagnosis and treatment of NOMI in severe acute pancreatitis.

    DOI: 10.11231/jaem.31.1029

    CiNii Research

    J-GLOBAL

    researchmap

  • Perfusion CT is superior to angiography in predicting pancreatic necrosis in patients with severe acute pancreatitis. Reviewed

    Yoshihisa Tsuji, Kyoko Hamaguchi, Yuji Watanabe, Akira Okumura, Hiroyoshi Isoda, Naoki Yamamoto, Osamu Kikuchi, Hiroyuki Yamamoto, Kazuhiro Matsueda, Kenji Ueno, Shinsuke Tada, Kaori Togashi, Hiroshi Yamamoto, Tsutomu Chiba

    Journal of gastroenterology   45 ( 11 )   1155 - 62   2010.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: We performed perfusion computed tomography (P-CT) and angiography of the pancreas in patients with severe acute pancreatitis (SAP) and compared the usefulness of these two methods in predicting the development of pancreatic necrosis. METHODS: We compared P-CT and angiography results taken within 3 days after symptom onset in 21 SAP patients. We divided the pancreas into three areas, the head, body, and tail, and examined each area for perfusion defects (via P-CT) and arterial vasospasms (by angiography). Three weeks later, all patients underwent contrast-enhanced CT to determine whether pancreatic necrosis had developed. RESULTS: Of the 21 SAP patients, 16 exhibited perfusion defects, while 17 proved positive for vasospasms in at least one area. Fourteen patients developed pancreatic necrosis. Of the 63 pancreatic areas from the 21 SAP patients, perfusion defects appeared in 25 areas (39.7%), 24 of which showed vasospasms (96.0%). Angiography showed 33 areas with vasospasms (52.4%), of which 24 showed perfusion defects (72.7%). Of the 25 areas with perfusion defects, 21 developed pancreatic necrosis (84.0%). Of the 33 areas with vasospasms, 21 developed necrosis (63.6%). Pancreatic necrosis developed only in the areas positive both for perfusion defects and for vasospasms. No areas without perfusion defect or vasospasms developed pancreatic necrosis. P-CT predicted the development of pancreatic necrosis with significantly higher accuracy than angiography. CONCLUSION: While both P-CT and angiography are useful in predicting the development of pancreatic necrosis in patients with SAP, P-CT appears to be more accurate for this purpose.

    Other Link: http://link.springer.com/article/10.1007/s00535-010-0267-8/fulltext.html

    DOI: 10.1007/s00535-010-0267-8

    CiNii Research

    PubMed

    researchmap

  • NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. Reviewed International journal

    Tomohiro Watanabe, Naoki Asano, Stefan Fichtner-Feigl, Peter L Gorelick, Yoshihisa Tsuji, Yuko Matsumoto, Tsutomu Chiba, Ivan J Fuss, Atsushi Kitani, Warren Strober

    The Journal of clinical investigation   120 ( 5 )   1645 - 62   2010.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Nucleotide-binding oligomerization domain 1 (NOD1) is an intracellular epithelial cell protein known to play a role in host defense at mucosal surfaces. Here we show that a ligand specific for NOD1, a peptide derived from peptidoglycan, initiates an unexpected signaling pathway in human epithelial cell lines that results in the production of type I IFN. Detailed analysis revealed the components of the signaling pathway. NOD1 binding to its ligand triggered activation of the serine-threonine kinase RICK, which was then able to bind TNF receptor-associated factor 3 (TRAF3). This in turn led to activation of TANK-binding kinase 1 (TBK1) and IkappaB kinase epsilon (IKKepsilon) and the subsequent activation of IFN regulatory factor 7 (IRF7). IRF7 induced IFN-beta production, which led to activation of a heterotrimeric transcription factor complex known as IFN-stimulated gene factor 3 (ISGF3) and the subsequent production of CXCL10 and additional type I IFN. In vivo studies showed that mice lacking the receptor for IFN-beta or subjected to gene silencing of the ISGF3 component Stat1 exhibited decreased CXCL10 responses and increased susceptibility to Helicobacter pylori infection, phenotypes observed in NOD1-deficient mice. These studies thus establish that NOD1 can activate the ISGF3 signaling pathway that is usually associated with protection against viral infection to provide mice with robust type I IFN-mediated protection from H. pylori and possibly other mucosal infections.

    DOI: 10.1172/JCI39481

    PubMed

    researchmap

  • The radiological exposure of pancreatic perfusion computed tomography. Reviewed International journal

    Yoshihisa Tsuji, Koji Koizumi, Hiroyoshi Isoda, Kenji Ueno, Shinsuke Tada, Tsutomu Chiba, Ryuichirou Doi

    Pancreas   39 ( 4 )   541; author reply 541-3   2010.5

     More details

  • 膵蔵Perfusion-CTにおける装置間の違い-自作ファントムにおける検討-

    梶谷尊郁, 辻喜久, 山本浩之, 森山一郎, 矢田伸広, 氏平武樹, 奥井彰二, 小松明夫

    日本放射線技術学会雑誌   66 ( 9 )   2010

  • 急性膵炎の重症化に関わる自然免疫担当分子の同定とその分子機序の解明

    辻喜久, 渡邉智裕, 千葉勉

    日本消化器病学会雑誌   107   2010

  • 重症急性膵炎に合併したNOMIの病理所見と治療選択についての考察

    辻喜久, 辻喜久, 能登原憲司, 山本博, 千葉勉

    日本消化器病学会雑誌   107   2010

  • Perfusion CTによる自己免疫性膵炎と膵癌の鑑別

    廣田衛久, 辻喜久, 下瀬川徹

    日本消化器病学会雑誌   107   2010

  • 重症急性膵炎発症早期における“Ischemia penumbra”について

    辻喜久, 山本博, 千葉勉

    日本消化器病学会雑誌   107   2010

  • Spontaneous rupture of liver plasmacytoma mimicking hepatocellular carcinoma. Reviewed

    Kosuke Ueda, Hiroyuki Matsui, Tomohiro Watanabe, Junya Seki, Tatsuo Ichinohe, Yoshihisa Tsuji, Kayoko Matsumura, Yugo Sawai, Hiroshi Ida, Yoshihide Ueda, Tsutomu Chiba

    Internal medicine (Tokyo, Japan)   49 ( 7 )   653 - 7   2010

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Extramedullary plasmacytoma of the liver is rare. Here, we report a case presenting with rupture of extramedullary plasmacytoma of the liver. She had a past history of multiple myeloma with IgA lambda type. Her serum was positive for hepatitis C virus infection and exhibited elevated levels of serum protein induced by vitamin K absence or antagonist-II. She was initially diagnosed as rupture of hepatocellular carcinoma (HCC) and then treated with transarterial chemoembolization (TACE) since bloody ascites and formation of hematoma were seen around hyper-vascular liver tumors on computed tomography. However, the clinical course of this case after TACE was atypical for HCC rupture, as shown by the development of a huge intra-abdominal abscess extending from the liver tumor. Immuno-histochemical analysis of the tumor biopsy specimen revealed massive infiltration of plasma cells expressing IgA and lambda chain. To our knowledge, this is the first case of rupture of extramedullary liver plasmacytoma.

    PubMed

    researchmap

  • Colonic polyposis associated with autoimmune pancreatitis. Reviewed International journal

    Hiroyuki Matsui, Tomohiro Watanabe, Kenji Ueno, Satoru Ueno, Yoshihisa Tsuji, Kayoko Matsumura, Masato Nakatsuji, Yoshihide Ueda, Tsutomu Chiba

    Pancreas   38 ( 7 )   840 - 2   2009.10

     More details

  • Massive jejunal bleeding due to Heyde syndrome successfully treated with double balloon endoscopy. Reviewed

    Sakiko Ohta, Tomohiro Watanabe, Shuko Morita, Satoru Ueno, Yoshihisa Tsuji, Hiroshi Nakase, Tsutomu Chiba

    Clinical journal of gastroenterology   2 ( 3 )   187 - 189   2009.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    There is a well-documented relationship between aortic valve stenosis and recurrent gastrointestinal bleeding from angiodysplasia in elderly patients, called Heyde syndrome. We report a case of Heyde syndrome with massive jejunal bleeding. Capsule endoscopy showed bleeding from jejunal angiodysplasia. Spurting bleeding from jejunal angiodysplasia was identified and treated by double balloon endoscopy. No gastrointestinal bleeding was seen after the endoscopic treatment and aortic valve replacement was performed. This case suggests that capsule endoscopy and double balloon endoscopy were very useful for the diagnosis and treatment of small intestinal bleeding due to Heyde syndrome.

    DOI: 10.1007/s12328-009-0069-9

    PubMed

    researchmap

  • Simultaneous occurrence of inflammatory bowel disease and myelodysplastic syndrome due to chromosomal abnormalities in bone marrow cells. Reviewed International journal

    Fumiyasu Nakamura, Tomohiro Watanabe, Kimiko Hori, Yoshiaki Ohara, Kouhei Yamashita, Yoshihisa Tsuji, Yoshihide Ueda, Sakae Mikami, Hiroshi Nakase, Tsutomu Chiba

    Digestion   79 ( 4 )   215 - 9   2009

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND/AIMS: Although chromosomal abnormalities in bone marrow (BM) cells, such as trisomy 8, are risk factors for the development of inflammatory bowel diseases (IBD) as well as myelodysplastic syndrome (MDS), the mechanisms of how these cytogenetic abnormalities cause intestinal inflammation are poorly understood. METHODS AND RESULTS: A 55-year-old man with a 3-month history of watery diarrhea, fever and abdominal pain was admitted. Blood examinations revealed pancytopenia. Pathological analysis and endoscopic images of the entire colon led to the diagnosis of IBD of unclassified type. BM examination showed that the pancytopenia was due to MDS and that his BM cells had dual chromosomal abnormalities: 47, XY, +1, der(1;7)(q10;p10), +8. Immunological studies using peripheral blood monocytes from this patient revealed that the dual chromosomal abnormalities of BM cells led to the development of colitogenic monocytes producing a large amount of pro-inflammatory cytokines and showing resistance to apoptosis upon stimulation with microbial antigens. CONCLUSION: An abnormal karyotype of BM cells is not only responsible for the development of MDS, but also for IBD in this case.

    DOI: 10.1159/000213486

    PubMed

    researchmap

  • 重症急性膵炎症例における腹部臓器血流障害

    辻喜久, 山本博, 千葉勉

    日本消化器病学会雑誌   106   2009

  • 急激な経過を辿った胆石性膵炎の一症例

    久保敦司, 辻喜久, 辻喜久, 菊池理, 松枝和宏, 山本博

    膵臓   24 ( 3 )   2009

  • ヒストン脱アセチル化阻害剤による胆道癌細胞株におけるRUNX3発現回復およびTGF-β経路の活性化

    塩せいじ, 依田広, 多田真輔, 長谷川和範, 辻喜久, 上野憲司, 八隅秀二郎, 千葉勉

    日本消化器病学会雑誌   106   2009

  • IgG4-related autoimmune pancreatitis involving the colonic mucosa. Reviewed International journal

    Kenji Ueno, Tomohiro Watanabe, Yukiko Kawata, Tomoyuki Gotoh, Yoshihisa Tsuji, Hiroshi Ida, Shinsuke Tada, Shujiro Yazumi, Tsutomu Chiba

    European journal of gastroenterology & hepatology   20 ( 11 )   1118 - 21   2008.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We report a case of autoimmune pancreatitis involving the colonic mucosa. Although serum level of IgG4 was normal, computed tomography and endoscopic retrograde cholangiopancreatography showed diffuse enlargement of the pancreas and irregular narrowing of the pancreatic ducts, respectively. Colonoscopy revealed a polypoidal lesion in the ascending colon. A lymphoplasmacytic infiltration was seen both in the pancreas and in the polypoidal lesion of the colon. Furthermore, immunohistochemical analysis showed abundant IgG4-positive plasma cells in these lesions. This is the first case report of a simultaneous occurrence of autoimmune pancreatitis and a colonic polypoidal lesion, both of which are characterized with increased IgG4 responses.

    DOI: 10.1097/MEG.0b013e3282f82970

    PubMed

    researchmap

  • Are prophylactic antibiotics really ineffective in reducing the risk of pancreatic necrosis? Reviewed International journal

    Yoshihisa Tsuji, Tsutomu Chiba

    The American journal of gastroenterology   103 ( 8 )   2145 - 6   2008.8

     More details

  • Biliary complications in donors for living donor liver transplantation. Reviewed International journal

    Seiji Shio, Shujiro Yazumi, Kohei Ogawa, Kazunori Hasegawa, Yoshihisa Tsuji, Masaya Kida, Junichi Yamauchi, Hiroshi Ida, Shinsuke Tada, Shinji Uemoto, Tsutomu Chiba

    The American journal of gastroenterology   103 ( 6 )   1393 - 8   2008.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    OBJECTIVES: With the increasing number of living donor liver transplantations, biliary complications in donors have emerged as a major postoperative problem. The aim of the present study was to characterize the features of the biliary complications that occur in donors. METHODS: The study subjects comprised 731 consecutive patients who donated liver grafts (434 right-lobe and 297 left-lobe grafts) for transplantation at Kyoto University Hospital from July 1999 to December 2006. Donors whose biliary complications could not be cured by conservative therapy were referred for endoscopic treatment. RESULTS: Postoperative biliary complications occurred in 55 (7.5%) donors. Initially, 48 of these 55 donors had biliary leakage and 7 had biliary stricture. Subsequently, 5 of 48 donors with leakage developed biliary stricture. The respective incidences of biliary leakage and overall biliary complications were significantly higher among donors of right-lobe grafts (9.9% and 11.1%) than among donors of left-lobe grafts (1.7% and 2.4%). Among 55 donors with biliary complications, 24 were cured by conservative therapy, and 1 was converted to surgical repair due to ileus. Endoscopic treatment was successful in 24 of 30 (80%) donors treated by endoscopic retrograde cholangiography, while the remaining 6 (20%) patients underwent surgery due to difficulties with cannulation (N = 2), excessive biliary leakage (N = 2), or complete biliary obstruction (N = 2). CONCLUSIONS: Donors of right-lobe grafts have a significantly higher incidence of biliary complications than donors of left-lobe grafts. When conservative therapy fails, endoscopic treatment is effective for these complications, and should be attempted as the first-line therapy before surgical repair.

    DOI: 10.1111/j.1572-0241.2008.01786.x

    PubMed

    researchmap

  • Small bowel anisakiasis with self-limiting clinical course. Reviewed

    Tomohiro Watanabe, Sakiko Ohta, Satoru Iwamoto, Yoshihisa Tsuji, Shuko Morita, Isao Doi, Yasunori Ueda, Tsutomu Chiba

    Internal medicine (Tokyo, Japan)   47 ( 24 )   2191 - 2   2008

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PubMed

    researchmap

  • Perfusion computerized tomography can predict pancreatic necrosis in early stages of severe acute pancreatitis. Reviewed International journal

    Yoshihisa Tsuji, Hiroshi Yamamoto, Shujiro Yazumi, Yuji Watanabe, Kazuhiro Matsueda, Hiroyuki Yamamoto, Tsutomu Chiba

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association   5 ( 12 )   1484 - 92   2007.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND & AIMS: The mortality rate associated with severe acute pancreatitis (SAP) with necrosis remains high because early prediction of pancreatic necrosis is difficult. We evaluated whether perfusion computerized tomography (CT), which is used to identify early stage ischemia in the brain, could detect ischemic changes in the pancreas in the early stages of SAP and predict development of necrosis. PATIENTS AND METHODS: Thirty consecutive patients with a diagnosis of SAP according to the Atlanta criteria and whose score was greater than 6 were enrolled in this study. All patients were hospitalized within 3 days after onset of symptoms indicative of acute pancreatitis and underwent perfusion CT. Three weeks later, all patients underwent conventional contrast-enhanced CT to detect progression of their disease. RESULTS: Perfusion CT showed that 10 of the 30 patients had pancreatic ischemia at the time of diagnosis. Contrast-enhanced CT disclosed that pancreatic necrosis developed in 9 of these 10 patients, but not in the 20 patients who did not have pancreatic ischemia. The sensitivity and specificity of perfusion CT for predicting pancreatic necrosis was calculated to be 100% and 95.3%, respectively. CONCLUSIONS: Perfusion CT is a useful tool for early detection of ischemic changes in the pancreas that lead to pancreatic necrosis.

    PubMed

    researchmap

  • Changes in the Treatment of Severe Acute Pancreatitis in a Japanese Emergency Room After the Implementation of the JPN Guidelines Reviewed

    Tsuji Yoshihisa, Yamamoto Hiroshi

    Nihon Fukubu Kyukyu Igakkai Zasshi (Journal of Abdominal Emergency Medicine)   27 ( 3 )   463 - 467   2007

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:Japanese Society for Abdominal Emergency Medicine  

    Background & Aims : In spite of treatment advances, the mortality rate for severe acute pancreatitis remains high. In July 2003, the JPN (define) guidelines were published in an attempt to reduce the mortality rate in Japan. These practical guidelines have been useful and popular in Japan. Here, we examined the changes in a Japanese emergency room after the adoption of the JPN guidelines. Patients & Methods : The clinical records of 209 consecutive patients with a diagnosis of acute pancreatitis who were treated at Kurashiki Central Hospital either 24 months before or after the publication of the JPN guidelines were retrospectively examined. The number of patients, the number of patients who were transported from another hospital, the period between disease onset and hospital admission, the severity, the length of the hospital stay, the mortality rate, and the cost of treatment were then compared between these two treatment periods. Results : Eighty patients with acute pancreatitis were treated at our hospital in the 24-month period before the JPN guidelines were published, whereas 129 patients were treated in a 24-month period after the guidelines were published (P<0.05). The number of patients transported from other hospitals, severity, length of hospital stay, and treatment cost all increased after the implementation of the JPN guidelines (P<0.05). On the other hand, the period between disease onset and hospital admission was shorted (P<0.05), and the mortality rate decreased from 17.6% to 4.1%. Conclusion : A large number of cases were transported to our hospital both before and after the implementation of the JPN guidelines, but the period between disease onset and hospital admission was shortened and the mortality rate decreased after guideline implementation. Early diagnosis, early transport, and the early recognition of indications for intensive care may have contributed to the reduction in the mortality rate for severe acute pancreatitis.

    Other Link: https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-07J06222/

    DOI: 10.11231/jaem.27.463

    CiNii Research

    J-GLOBAL

    researchmap

  • Perfusion Computed Tomography for the Diagnosis of Severe Acute Pancreatitis Reviewed

    Tsuji Yoshihisa, Yamamoto Hiroshi

    Nihon Fukubu Kyukyu Igakkai Zasshi (Journal of Abdominal Emergency Medicine)   27 ( 4 )   587 - 593   2007

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:Japanese Society for Abdominal Emergency Medicine  

    Although the early detection of pancreatic ischemia in patients with severe acute pancreatitis remains difficult, we successfully visualized ischaemic areas of the pancreas body using perfusion computed tomography (CT). Perfusion CT is widely used for the early detection of brain ischaemia but has not been previously used to evaluate pancreatic blood flow. In our study, perfusion CT was successfully used to detect early ischaemia with the potential to progress to pancreatic necrosis in patients with acute pancreatitis, possibly predicting the prognosis. Here, we report the utility of perfusion CT and describe the clinical importance of evaluating pancreatic blood flow during the early stage of pancreatitis.

    Other Link: https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-07J06222/

    DOI: 10.11231/jaem.27.587

    CiNii Research

    J-GLOBAL

    researchmap

  • Effectiveness of Early Indication of Continual Regional Arterial Infusion for Severe Acute Pancreatitis Reviewed

    鳥橋孝一, 辻喜久, 山本博

    倉敷中央病院年報   69   247 - 249   2007

     More details

    Publishing type:Research paper (scientific journal)  

    Other Link: https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-07J06222/

    CiNii Research

    J-GLOBAL

    researchmap

  • Usefulness of perfusion computed tomography for early detection of pancreatic ischemia in severe acute pancreatitis. Reviewed International journal

    Yoshihisa Tsuji, Yuji Watanabe, Kazuhiro Matsueda, Hiroyuki Yamamoto, Etsuji Ishida, Hiroshi Yamamoto

    Journal of gastroenterology and hepatology   21 ( 9 )   1506 - 8   2006.9

     More details

    Language:English  

    PubMed

    researchmap

  • Trial to Improve the Prognosis of Severe Acute Pancreatitis by Early Induction Intensive Care

    辻喜久, 山本直樹, 畑貴子, 酒井章裕, 青山育雄, 光藤大地, 合原彩, 新井修, 清輔良江, 中辻正人, 片山幸子, 大西秀樹, 中西崇, 石田悦嗣, 三好正嗣, 毛利裕一, 金吉俊彦, 池田弘, 下村宏之, 松枝和宏, 山本博

    倉敷中央病院年報   68   2006

  • [A case of goblet cell carcinoid of the appendix presented as a metastatic ovarian tumor and peritoneal dissemination, and diagnosed by autopsy]. Reviewed

    Atsushi Yamada, Hiroshi Yamamoto, Osamu Arai, Yoshie Kiyosuke, Yoshihisa Tsuji, Masato Nakatsuji, Hirotoshi Fukatsu, Masatsugu Miyoshi, Hiroyuki Kono, Hirokazu Mouri, Kazuhiro Matsueda, Takashi Tezen, Junnosuke Shimamura, Choutatsu Tsukayam

    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology   102 ( 7 )   905 - 11   2005.7

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:The Japanese Society of Gastroenterology  

    DOI: 10.11405/nisshoshi.102.905

    DOI: 10.5833/jjgs.2020.0164_references_DOI_C2Z5FUpwD909KkKIH43zIsAifza

    CiNii Research

    PubMed

    researchmap

  • Effectiveness of Extracorporeal Shock Wave Lithotripsy (ESWL) for Patients with Pancreatic Duct Stones

    三好正嗣, 清野哲司, 山本博, 毛利裕一, 新井修, 清輔良江, 辻喜久, 中辻正人, 山田敦

    倉敷中央病院年報   67   2005

  • A Case of Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic Purpura Associated with Enterohemorrhagic Escherichia coli O157

    遠藤英樹, 辻喜久, 山本博

    倉敷中央病院年報   67   2005

  • Two Cases of Amoebic Colitis Restricted to the Cecum

    清輔良江, 山本博, 新井修, 辻喜久, 中辻正人, 山田敦, 深津裕寿, 河野博行, 三好正嗣

    倉敷中央病院年報   67   2005

  • Heidenhain variant of Creutzfeldt-Jakob disease: diffusion-weighted MRI and PET characteristics. Reviewed International journal

    Yoshihisa Tsuji, Hiroshi Kanamori, Gaku Murakami, Masayuki Yokode, Takahiro Mezaki, Katsumi Doh-ura, Ken Taniguchi, Kozo Matsubayashi, Hidenao Fukuyama, Toru Kita, Makoto Tanaka

    Journal of neuroimaging : official journal of the American Society of Neuroimaging   14 ( 1 )   63 - 6   2004.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Creutzfeldt-Jakob disease (CJD) is characterized by rapidly progressive dementia with a variety of neurological disorders and a fatal outcome. The authors present a case with visual disturbance as a leading symptom and rapid deterioration in global cognitive functions. The cerebrospinal fluid was positive for 14-3-3 protein, and diffusion-weighted magnetic resonance imaging (MRI) showed marked hyperintensity in the parieto-occipital cortices, where hypometabolism was clearly detected on positron emission tomography (PET). Pattern-reversal visual evoked potentials showed prolonged P100 latencies and increased N/5/P100 amplitudes. All these findings supported a diagnosis of the Heidenhain variant of CJD, whereas a long clinical course, a lack of myoclonus, and an absence of periodic synchronous discharges on electroencephalography were atypical. Diffusion-weighted MRI and PE1 in combination with visual evoked potential recording and 14-3-3 protein detection may be useful for the early diagnosis of CJD.

    PubMed

    researchmap

  • 自己免疫関連性すい炎の4症例

    若林肇, 新井修, 清輔良江, 辻喜久, 中辻正人, 山田敦, 深津裕寿, 三好正嗣, 河野博行

    日本消化器病学会雑誌   101   2004

  • Hypothyroidismのoverlapにより病態が複雑化した慢性肝疾患の2例

    中辻正人, 池田弘, 新井修, 清輔良江, 辻喜久, 若林肇, 金吉俊彦, 清野哲司, 島村淳之輔

    岡山済生会総合病院雑誌   35   2003

▼display all

MISC

  • Direct electrohydraulic lithotripsy with a novel peroral cholangioscope through the overtube for surgically-altered anatomy. International journal

    Kosuke Hiroe, Shuhei Shintani, Takuya Okamoto, Hidenori Kimura, Takaaki Eguchi, Yoshihisa Tsuji, Osamu Inatomi

    Endoscopy   56 ( S 01 )   E644-E645   2024.12

     More details

  • 膵癌腫瘍内血流速度による術前治療戦略(会議録)

    前平 博充, 辻 喜久, 森 治樹, 新田 信人, 前川 毅, 石川 原, 竹林 克士, 貝田 佐知子, 三宅 亨, 新谷 修平, 稲富 理, 谷 眞至

    日本消化器外科学会雑誌   57 ( 2 )   379   2024.11

     More details

  • 急性膵炎に対する早期からの栄養開始が入院期間および治療費に与える影響(会議録)

    上野 真行, 辻 喜久, 竹山 宜典

    日本消化器病学会雑誌   121 ( 臨 )   A488   2024.10

     More details

  • 膵癌における術前化学療法に対する腫瘍内血流速度の臨床的意義(会議録/英語)

    前平 博充, 辻 喜久, 森 治樹, 新田 信人, 前川 毅, 石川 原, 竹林 克士, 小島 正継, 貝田 佐知子, 三宅 亨, 新谷 修平, 稲富 理, 谷 眞至

    日本癌治療学会学術集会抄録集62回   62nd   O48-3   2024.10

  • 急性膵炎発症が生活の質に及ぼす影響についての多施設共同前向きコホート研究

    上野 真行, 辻 喜久, 江口 考明, 福田 晃久, 栗田 裕介, 高山 敬子, 石田 悦嗣, 山上 裕機, 正宗 淳, 里井 壯平, 竹山 宜典, 水野 元夫

    膵臓   39 ( 3 )   A149 - A149   2024.7

     More details

    Language:Japanese   Publisher:(一社)日本膵臓学会  

    Ichushi

    researchmap

  • 重症急性膵炎と被包化壊死のベストプラクティス 重症急性膵炎に対する早期からの栄養開始が入院期間および治療費に与える影響

    上野 真行, 辻 喜久, 江口 考明, 福田 晃久, 栗田 裕介, 高山 敬子, 石田 悦嗣, 山上 裕機, 正宗 淳, 里井 壯平, 竹山 宜典, 水野 元夫

    膵臓   39 ( 3 )   A248 - A248   2024.7

     More details

    Language:Japanese   Publisher:(一社)日本膵臓学会  

    Ichushi

    researchmap

  • 検診2週間後に発症したバリウム虫垂炎の一例

    村田 直哉, 真部 建郎, 市来 智子, 江口 考明, 大島 侑, 辻 喜久

    日本病院総合診療医学会雑誌   20 ( 臨増1 )   122 - 122   2024.3

     More details

    Language:Japanese   Publisher:(一社)日本病院総合診療医学会  

    Ichushi

    researchmap

  • 造影CTで肝実質に特異的な所見を示した門脈・脾静脈・上腸間膜静脈血栓症の1例

    津久井 麟, 真部 建郎, 市来 智子, 江口 考明, 高橋 憲一郎, 辻 喜久

    日本病院総合診療医学会雑誌   20 ( 臨増1 )   236 - 236   2024.3

     More details

    Language:Japanese   Publisher:(一社)日本病院総合診療医学会  

    Ichushi

    researchmap

  • Nutritional support for acute pancreatitis

    上野真行, 上野真行, 辻喜久, 辻喜久, 宇座徳光, 妹尾浩

    肝胆膵   88 ( 1 )   97 - 101   2024.1

     More details

  • 急性膵炎発症が生活の質に及ぼす影響についての多施設共同前向きコホート研究

    上野真行, 上野真行, 辻喜久, 辻喜久, 江口考明, 福田晃久, 栗田裕介, 高山敬子, 石田悦嗣, 山上裕機, 正宗淳, 里井壯平, 竹山宜典, 水野元夫

    膵臓(Web)   39 ( 3 )   2024

  • 各種化学療法における腫瘍内血行動態が化学療法後後組織学的効果判定に与える影響

    前平博充, 辻喜久, 森治樹, 新田信人, 前川毅, 石川原, 竹林克士, 貝田佐知子, 三宅亨, 谷眞至

    日本胆膵病態・生理研究会プログラム・抄録集   41st   2024

  • 急性膵炎患者のQOL維持に向けて:長期入院の予測因子

    上野真行, 上野真行, 羽田綾子, 辻喜久, 辻喜久, 石田悦嗣, 毛利裕一, 水野元夫

    日本胆膵病態・生理研究会プログラム・抄録集   41st   2024

  • 急性膵炎診療における画像診断のPitfall

    辻喜久, 辻喜久

    日本集中治療医学会学術集会(Web)   51st   2024

  • 下肢筋力低下と深部腱反射亢進からバセドウ病を想起し診断に結びついた一例

    蔦原壮平, 三原弘, 神野敦, 永幡研, 野村和史, 佐藤健太, 辻喜久

    日本プライマリ・ケア連合学会学術大会(Web)   15th   2024

  • 重症急性膵炎患者における早期死亡と後期死亡の臨床的特徴の検討

    江口考明, 辻喜久, 稲富理

    膵臓(Web)   39 ( 3 )   2024

  • 重症急性膵炎に対する早期からの栄養開始が入院期間および治療費に与える影響

    上野真行, 上野真行, 辻喜久, 辻喜久, 江口考明, 福田晃久, 栗田裕介, 高山敬子, 石田悦嗣, 山上裕機, 正宗淳, 里井壯平, 竹山宜典, 水野元夫

    膵臓(Web)   39 ( 3 )   2024

  • 早期慢性膵炎における超音波内視鏡所見とShear wave velocityの相関

    新谷修平, 稲富理, 江口考明, 辻喜久

    日本胆膵病態・生理研究会プログラム・抄録集   41st   2024

  • 検診2週間後に発症したバリウム虫垂炎の一例

    村田直哉, 真部建郎, 市来智子, 江口考明, 大島侑, 辻喜久

    日本病院総合診療医学会雑誌(Web)   20   2024

  • 地域・救急医療自己評価尺度(C-CEP)における地域・救急医療実習の教育プログラム評価の検討-第一報

    三原弘, 佐藤健太, 神野敦, 野村和史, 永幡研, 若林崇雄, 若林崇雄, 辻喜久

    日本病院総合診療医学会雑誌(Web)   20   2024

  • 造影CTで肝実質に特異的な所見を示した門脈・脾静脈・上腸間膜静脈血栓症の1例

    津久井麟, 真部建郎, 市来智子, 江口考明, 高橋憲一郎, 辻喜久

    日本病院総合診療医学会雑誌(Web)   20   2024

  • 急性膵炎に対する早期からの栄養開始が入院期間および治療費に与える影響

    上野真行, 辻喜久, 竹山宜典

    肝臓   65 ( Supplement 2 )   2024

  • Usability of the simulated doctor video content for training of simulated patients

    磯山響子, 三原弘, 三原弘, 長南行浩, 辻喜久, 杉村政樹

    医学教育   55 ( Suppl. )   2024

  • 差異に着目した地域医療教育のデザインとその実践報告

    神野 敦, 佐藤 健太, 風間 友江, 野村 和史, 三原 弘, 杉原 伸明, 中川 貴史, 真部 建郎, 市来 智子, 辻 喜久

    日本病院総合診療医学会雑誌   19 ( 臨増2 )   172 - 172   2023.8

     More details

    Language:Japanese   Publisher:(一社)日本病院総合診療医学会  

    Ichushi

    researchmap

  • 差異に着目した地域医療教育のデザインとその実践報告

    神野 敦, 佐藤 健太, 風間 友江, 野村 和史, 三原 弘, 杉原 伸明, 中川 貴史, 真部 建郎, 市来 智子, 辻 喜久

    日本病院総合診療医学会雑誌   19 ( 臨増2 )   172 - 172   2023.8

     More details

    Language:Japanese   Publisher:(一社)日本病院総合診療医学会  

    Ichushi

    researchmap

  • 関節症状の乏しいリウマチ性髄膜炎の診断にエコー所見が有用であった一例 Reviewed

    岩倉 伸昂, 眞部 建郎, 安場 遥香, 仲 郁子, 中澤 隆, 辻 喜久

    日本病院総合診療医学会雑誌   19 ( 臨増2 )   143 - 143   2023.8

     More details

    Language:Japanese   Publisher:(一社)日本病院総合診療医学会  

    Ichushi

    researchmap

  • The development and clinical application of novel natriuretic peptide therapeutics

    市来智子, 沼田泰尚, 佐々木茂, 辻喜久, 仲瀬裕志

    月刊細胞   55 ( 9 )   714 - 717   2023.8

  • 急性膵炎における高齢者医療の現状と課題

    上野 真行, 辻 喜久, 羽田 綾子, 眞野 俊史, 沖 健太朗, 石田 悦嗣, 水野 元夫

    膵臓   38 ( 3 )   A412 - A412   2023.7

     More details

    Language:Japanese   Publisher:(一社)日本膵臓学会  

    Ichushi

    researchmap

  • 急性膵炎発症が生活の質に及ぼす影響についての多施設共同前向きコホート研究

    上野 真行, 辻 喜久, 江口 考明, 福田 晃久, 栗田 裕介, 高山 敬子, 石田 悦嗣, 山上 裕機, 正宗 淳, 里井 壯平, 竹山 宜典, 水野 元夫

    膵臓   38 ( 3 )   A288 - A288   2023.7

     More details

    Language:Japanese   Publisher:(一社)日本膵臓学会  

    Ichushi

    researchmap

  • 急性膵炎発症が生活の質に及ぼす影響についての多施設共同前向きコホート研究

    上野 真行, 辻 喜久, 江口 考明, 福田 晃久, 栗田 裕介, 高山 敬子, 石田 悦嗣, 山上 裕機, 正宗 淳, 里井 壯平, 竹山 宜典, 水野 元夫

    膵臓   38 ( 3 )   A288 - A288   2023.7

     More details

    Language:Japanese   Publisher:(一社)日本膵臓学会  

    Ichushi

    researchmap

  • The design of rural medical education based on the concept of ”difference”

    神野敦, 辻喜久

    Bio Clinica   38 ( 8 )   682 - 686   2023.7

  • Acute pancreatitis in elderly patients

    上野真行, 上野真行, 辻喜久, 辻喜久, 宇座徳光, 妹尾浩

    肝胆膵   86 ( 6 )   743 - 748   2023.6

     More details

  • 【症例から学ぶ 疾患と検査値の推移】(1章)消化器疾患 急性膵炎

    辻 喜久

    検査と技術   51 ( 3 )   210 - 215   2023.3

     More details

    Language:Japanese   Publisher:(株)医学書院  

    DOI: 10.11477/mf.1543208919

    CiNii Research

    Ichushi

    J-GLOBAL

    researchmap

  • 在宅終末期ケアを受けた患者家族(遺族)1事例から見えた訪問診療同行看護師の役割

    奥岡由美, 本田日奈子, 古山悦子, 神野敦, 日下勝博, 辻喜久

    日本死の臨床研究会年次大会(CD-ROM)   44th   160 - 160   2023

     More details

    Language:Japanese   Publisher:一般社団法人 日本死の臨床研究会  

    DOI: 10.34317/jjardsho.44.0_160_2

    CiNii Research

    J-GLOBAL

    researchmap

  • Importance of reforming case and clinical clerkship reflections during each departmental clerkship

    三原弘, 元尾伊織, 田尻和人, 安田一朗, 高村昭輝, 神野敦, 佐藤健太, 市来智子, 辻喜久

    医学教育   54 ( Suppl. )   2023

  • 医学生に対するWhole Person Careプログラムの有効性の実証研究プロトコール

    三原弘, 神野敦, 佐藤健太, 風間友江, 市来智子, 沼田泰尚, 土屋静馬, 三好智子, 恒藤暁, 辻喜久

    日本プライマリ・ケア連合学会学術大会(Web)   14th   2023

  • 差異に着目した地域医療教育のデザインとその実践報告

    神野敦, 佐藤健太, 佐藤健太, 風間友江, 野村和史, 三原弘, 杉原伸明, 中川貴史, 真部建郎, 市来智子, 辻喜久, 辻喜久, 辻喜久

    日本病院総合診療医学会雑誌(Web)   19   2023

  • 関節症状の乏しいリウマチ性髄膜炎の診断にエコー所見が有用であった一例

    岩倉伸昂, 眞部建郎, 安場遥香, 仲郁子, 中澤隆, 辻喜久

    日本病院総合診療医学会雑誌(Web)   19   2023

  • 化学療法導入後に脳梗塞を発症した膵癌患者に関する検討

    羽田綾子, 上野真行, 辻喜久, 池田有希, 上西陽介, 戸川文子, 眞野俊史, 沖健太朗, 石田悦嗣, 水野元夫

    日本胆膵病態・生理研究会プログラム・抄録集   40th   2023

  • 急性膵炎発症が生活の質に及ぼす影響についての多施設共同前向きコホート研究

    上野真行, 上野真行, 辻喜久, 江口考明, 福田晃久, 栗田裕介, 高山敬子, 石田悦嗣, 山上裕機, 正宗淳, 里井壯平, 竹山宜典, 水野元夫

    膵臓(Web)   38 ( 3 )   2023

  • これからの敗血症DIC治療戦略 地域医療を支える薬剤師への期待

    辻喜久, 辻喜久

    日本医療薬学会年会講演要旨集(Web)   33rd   2023

  • 急性膵炎における高齢者医療の現状と課題

    上野真行, 上野真行, 辻喜久, 辻喜久, 羽田綾子, 眞野俊史, 沖健太朗, 石田悦嗣, 水野元夫

    膵臓(Web)   38 ( 3 )   2023

  • 地域医療実習と救急医療実習の実践に対する自己評価スケール(C-CEP)の開発

    若林崇雄, 辻喜久, 山本武志, 相馬仁, 山本和利

    日本プライマリ・ケア連合学会学術大会(Web)   14th   2023

  • Considering community medicine

    辻喜久, 辻喜久

    Bio Clinica   38 ( 8 )   656 - 658   2023

  • Prognosis of acute pancreatitis: transition to recurrent and chronic pancreatitis.

    上野真行, 上野真行, 石田悦嗣, 辻喜久, 水野元夫

    月刊消化器・肝臓内科   12 ( 5 )   512 - 516   2022.11

  • 急性膵炎診療の進歩・実際と展望 急性膵炎に対するトロンボモジュリンアルファの早期投与による膵血流改善への有用性検討

    江口 考明, 辻 喜久, 岡田 明彦

    日本外科感染症学会雑誌   19 ( 1 )   187 - 187   2022.10

     More details

    Language:Japanese   Publisher:(一社)日本外科感染症学会  

    Ichushi

    researchmap

  • 急性膵炎発症が生活の質に及ぼす影響についての多施設共同前向きコホート研究

    上野 真行, 辻 喜久, 江口 考明, 栗田 裕介, 高山 敬子, 澤井 勇悟, 石田 悦嗣, 山上 裕機, 正宗 淳, 里井 壯平, 水野 元夫

    膵臓   37 ( 3 )   A296 - A296   2022.9

     More details

    Language:Japanese   Publisher:(一社)日本膵臓学会  

    Ichushi

    researchmap

  • 急性膵炎発症が生活の質に及ぼす影響についての多施設共同前向きコホート研究

    上野 真行, 辻 喜久, 江口 考明, 栗田 裕介, 高山 敬子, 澤井 勇悟, 石田 悦嗣, 山上 裕機, 正宗 淳, 里井 壯平, 水野 元夫

    膵臓   37 ( 3 )   A296 - A296   2022.9

     More details

    Language:Japanese   Publisher:(一社)日本膵臓学会  

    Ichushi

    researchmap

  • 急性膵炎発症が生活の質に及ぼす影響についての多施設共同前向きコホート研究

    上野真行, 上野真行, 辻喜久, 江口考明, 栗田裕介, 高山敬子, 澤井勇悟, 石田悦嗣, 山上裕機, 正宗淳, 里井壯平, 水野元夫

    膵臓(Web)   37 ( 3 )   2022

  • 看取りまでのケアの展開

    田村宗之, 小管明美, 有木善門, 永松恵子, 荻野悦子, 成瀬恵子, 木村薫, 辻喜久子

    洛和会ヘルスケア学会集録   31st   2022

  • ナトリウム利尿ペプチドを用いた非アルコール性脂肪性肝疾患診断における新規バイオマーカーの開発

    市来智子, 沼田泰尚, 沼田泰尚, 濱田修平, 佐藤健太, 風間友江, 風間友江, 杉本貴子, 平山大輔, 平山大輔, 佐々木茂, 辻喜久

    日本プライマリ・ケア連合学会学術大会(Web)   13th   2022

  • 未治療統合失調症により診断に苦慮した急性腎盂腎炎の一例

    杉本貴子, 市来智子, 濱田修平, 佐藤健太, 風間友江, 沼田泰尚, 平山大輔, 辻喜久

    日本プライマリ・ケア連合学会学術大会(Web)   13th   2022

  • 在宅終末期ケアを受ける患者に対する訪問診療同行看護師の役割はどのように認識されているか

    奥岡由美, 本田日奈子, 古山悦子, 日下勝博, 濱田修平, 濱田修平, 佐藤健太, 杉本貴子, 風間知江, 沼田泰尚, 市来智子, 辻喜久

    日本プライマリ・ケア連合学会学術大会(Web)   13th   2022

  • Severe acute pancreatitis, SIRS and CARS

    辻喜久

    日本臨床   別冊 ( 膵臓症候群 )   285 - 289   2021.6

     More details

  • 急性膵炎臨床研究の日本における進行

    堀部昌靖, 堀部昌靖, 岩崎栄典, 辻喜久, 讃井將満, 真弓俊彦, 竹山宜典, 岡崎和一, 金井隆典

    日本集中治療医学会学術集会(Web)   48th   2021

  • ANC合併急性膵炎患者へのrTM早期投与におけるWON抑制効果の検討

    江口考明, 辻喜久, 岡田明彦, 児玉裕三, 妹尾浩

    膵臓(Web)   36 ( 3 )   2021

  • 急性膵炎発症が生活の質に及ぼす影響についての多施設共同前向きコホート研究

    上野真行, 辻喜久, 江口考明, 大塚奈央, 田村崇, 田中秀憲, 澤井勇悟, 栗田裕介, 石田悦嗣, 正宗淳, 山上裕機, 水野元夫

    膵臓(Web)   36 ( 3 )   2021

  • 造影CTによる膵癌術前治療の組織学的効果判定予測因子の検討

    前平博充, 辻喜久, 飯田洋也, 森治樹, 新田信人, 前川毅, 貝田佐知子, 三宅亨, 竹林克士, 谷眞至

    日本消化器外科学会雑誌(Web)   54 ( Supplement2 )   2021

  • 看取りまでのケアの展開

    田村宗之, 小管明美, 有木善門, 永松恵子, 荻野悦子, 成瀬恵子, 中村裕子, 木村薫, 辻喜久子

    洛和会ヘルスケア学会総会抄録   31st   2021

  • 膵癌における腫瘍内血行動態と術前治療後組織学的効果判定との関連性

    前平博充, 辻喜久, 飯田洋也, 森治樹, 新田信人, 前川毅, 竹林克士, 貝田佐知子, 三宅亨, 谷眞至

    膵臓(Web)   36 ( 3 )   2021

  • Long-term outcomes of acute pancreatitis: risk factors for recurrent and chronic pancreatitis

    上野真行, 辻喜久, 上西陽介, 石田悦嗣, 水野元夫

    肝胆膵   82 ( 1 )   2021

  • Role of contrast enhanced CT in primary care for acute pancreatitis

    辻喜久

    肝胆膵   82 ( 1 )   2021

  • 膵炎再発は急性膵炎後新規糖尿病発症のリスク因子である

    上西陽介, 上野真行, 辻喜久

    日本消化器病学会雑誌(Web)   118   2021

  • 座談会 臓器横断的に線維化疾患を紐解く

    仲瀬 裕志, 松本 久子, 辻 喜久, 井戸 章雄

    消化器病学サイエンス = Science of gastroenterology / 「消化器病学サイエンス」編集委員会 編   4 ( 4 )   189 - 197   2020.12

     More details

    Language:Japanese   Publisher:東京 : 先端医学社  

    Other Link:: https://ndlsearch.ndl.go.jp/books/R000000004-I031200365

    CiNii Research

    researchmap

  • 重症急性膵診療の医療費上昇における予後因子とWalled-off necrosis(WON)

    新谷 修平, 竹田 善也, 稲富 理, 藤本 剛英, 辻 喜久, 安藤 朗

    日本消化器病学会雑誌   117 ( 臨増総会 )   A298 - A298   2020.7

     More details

    Language:Japanese   Publisher:(一財)日本消化器病学会  

    Ichushi

    researchmap

  • 径10mm以下膵嚢胞性病変の経時的変化の検討

    藤本 剛英, 稲富 理, 竹田 善哉, 新谷 修平, 村田 雅樹, 大塚 武人, 大野 将司, 高橋 憲一郎, 松本 寛史, 園田 文乃, 馬場 重樹, 杉本 光繁, 辻 喜久, 久津見 弘, 安藤 朗

    日本消化器病学会雑誌   117 ( 臨増総会 )   A216 - A216   2020.7

     More details

    Language:Japanese   Publisher:(一財)日本消化器病学会  

    Ichushi

    researchmap

  • 切除膵癌における腹腔洗浄細胞診の意義の検討 日本膵臓学会プロジェクト研究結果より

    藤井 努, 土田 浩喜, 水間 正道, 里井 壯平, 江口 英利, 五十嵐 久人, 北野 雅之, 黒木 保, 清水 泰博, 谷 眞至, 丹野 誠志, 辻 喜久, 廣岡 芳樹, 正宗 淳, 海野 倫明, 山上 裕機, 岡崎 和一

    膵臓   35 ( 3 )   A101 - A101   2020.7

     More details

    Language:Japanese   Publisher:(一社)日本膵臓学会  

    Ichushi

    researchmap

  • 80歳以上高齢者膵癌に対する治療法 日本膵臓学会アンケート調査

    里井 壯平, 山本 智久, 内田 一茂, 藤井 努, 金 俊文, 浅野 賢道, 花田 敬士, 糸井 隆夫, 五十嵐 久人, 江口 英利, 黒木 保, 清水 泰博, 谷 眞至, 丹野 誠志, 辻 喜久, 廣岡 芳樹, 正宗 淳, 下川 敏雄, 山上 裕機, 岡崎 和一, 日本膵臓学会膵疾患臨床研究推進委員会

    膵臓   35 ( 3 )   A104 - A104   2020.7

     More details

    Language:Japanese   Publisher:(一社)日本膵臓学会  

    Ichushi

    researchmap

  • 80歳以上高齢者切除可能・境界型膵癌患者の至適治療法:切除か化学療法か?-多施設共同研究からの提言-

    里井壯平, 山本智久, 内田一茂, 藤井努, 浅野賢道, 村上義昭, 五十嵐久人, 江口英利, 黒木保, 清水泰博, 谷眞至, 丹野誠志, 辻喜久, 廣岡芳樹, 正宗淳, 下川敏雄, 山上裕機, 岡崎和一

    日本外科学会定期学術集会(Web)   120th   2020

  • 径10mm以下膵嚢胞性病変の経時的変化の検討

    藤本剛英, 稲富理, 竹田善哉, 新谷修平, 村田雅樹, 大塚武人, 大野将司, 高橋憲一郎, 松本寛史, 園田文乃, 馬場重樹, 杉本光繁, 辻喜久, 久津見弘, 安藤朗

    日本消化器病学会雑誌(Web)   117   2020

  • 80歳以上高齢者膵癌に対する治療法-日本膵臓学会アンケート調査-

    里井壯平, 山本智久, 内田一茂, 藤井努, 金俊文, 浅野賢道, 花田敬士, 糸井隆夫, 五十嵐久人, 江口英利, 黒木保, 清水泰博, 谷眞至, 丹野誠志, 辻喜久, 廣岡芳樹, 正宗淳, 下川敏雄, 山上裕機, 岡崎和一

    膵臓(Web)   35 ( 3 )   2020

  • 線維化疾患の病態解明に挑む 膵疾患と線維化

    辻喜久

    消化器病学サイエンス   4 ( 4 )   214 - 219   2020

     More details

    Language:Japanese   Publisher:東京 : 先端医学社  

    Other Link:: https://ndlsearch.ndl.go.jp/books/R000000004-I031200430

    CiNii Research

    J-GLOBAL

    researchmap

  • 免疫チェックポイント阻害薬投与後に生じる膵障害について

    上西陽介, 上野真行, 辻喜久, 池田有希, 戸川文子, 眞野俊史, 石川将, 金谷崇史, 南麻里子, 清輔良江, 石田悦嗣, 水野元夫

    膵臓(Web)   35 ( 3 )   2020

  • Nutrition support for pancreatic disease and its relationship with sarcopenia

    上野真行, 辻喜久, 平大地, 石田悦嗣, 守本洋一, 水野元夫

    膵臓(Web)   35 ( 2 )   2020

  • 切除膵癌における腹腔洗浄細胞診の意義の検討~日本膵臓学会プロジェクト研究結果より

    藤井努, 土田浩喜, 水間正道, 里井壯平, 江口英利, 五十嵐久人, 北野雅之, 黒木保, 清水泰博, 谷眞至, 丹野誠志, 辻喜久, 廣岡芳樹, 正宗淳, 海野倫明, 山上裕機, 岡崎和一

    膵臓(Web)   35 ( 3 )   2020

  • 副乳頭アプローチの経口膵管鏡が有用であった主膵管型IPMNの1例

    柴田直季, 竹田善哉, 新谷修平, 藤本剛英, 前平博充, 飯田洋也, 稲富理, 辻喜久, 久津見弘, 谷眞至, 安藤朗

    膵臓(Web)   35 ( 3 )   2020

  • 超音波内視鏡検査が術前診断に有用であったSolid pseudopapillary neoplasmの1例

    吉田恵理奈, 藤本剛英, 福井萌子, 竹田善哉, 新谷修平, 稲富理, 辻喜久, 久津見弘, 前平博充, 飯田洋也, 谷眞至, 安藤朗

    膵臓(Web)   35 ( 3 )   2020

  • 膵癌患者に発症した血栓症の検討

    藤本剛英, 稲富理, 竹田善哉, 新谷修平, 辻喜久, 久津見弘, 安藤朗

    膵臓(Web)   35 ( 3 )   2020

  • 重症急性膵診療の医療費上昇における予後因子とWalled-off necrosis(WON)

    新谷修平, 竹田善也, 稲富理, 藤本剛英, 辻喜久, 安藤朗

    日本消化器病学会雑誌(Web)   117   2020

  • 結腸に穿破した重症急性膵炎後急性液体貯留(ANC)の1例

    小嶋克, 竹田善哉, 新谷修平, 村田雅樹, 大塚武人, 大野将司, 藤本剛英, 高橋憲一郎, 松本寛史, 園田文乃, 稲富理, 杉本光繁, 前平博充, 辻喜久, 久津見弘, 谷眞至, 安藤朗

    日本消化器病学会近畿支部例会プログラム・抄録集   112th   2020

  • 急性膵炎局所合併症の定義の再検討

    辻喜久, 池浦司, 糸井隆夫, 岩崎栄典, 岸和田昌之, 北村勝哉, 阪上順一, 白井邦博, 鈴木裕, 竹中完, 廣田衛久, 正宗淳, 真弓俊彦, 堀部昌靖, 能登原憲司, 入江裕之, 蒲田敏文, 竹山宜典

    膵臓(Web)   34 ( 3 )   A109‐A110(J‐STAGE) - A110   2019.6

     More details

    Language:Japanese   Publisher:日本膵臓学会  

    Ichushi

    J-GLOBAL

    researchmap

  • 重症度判定基準の改訂中間報告

    廣田 衛久, 竹山 宜典, 池浦 司, 糸井 隆夫, 伊藤 鉄英, 岩崎 栄典, 堀部 昌靖, 岸和田 昌之, 北村 勝哉, 阪上 順一, 白井 邦博, 鈴木 裕, 竹中 完, 辻 喜久, 正宗 淳, 真弓 俊彦

    膵臓   34 ( 3 )   A108 - A108   2019.6

     More details

    Language:Japanese   Publisher:日本膵臓学会  

    Ichushi

    researchmap

  • 重症度判定基準の改訂中間報告 Reviewed

    廣田 衛久, 竹山 宜典, 池浦 司, 糸井 隆夫, 伊藤 鉄英, 岩崎 栄典, 堀部 昌靖, 岸和田 昌之, 北村 勝哉, 阪上 順一, 白井 邦博, 鈴木 裕, 竹中 完, 辻 喜久, 正宗 淳, 真弓 俊彦

    膵臓   34 ( 3 )   A108 - A108   2019.6

     More details

    Language:Japanese   Publisher:日本膵臓学会  

    Ichushi

    researchmap

  • SANADA study(急性膵炎症例前向き多施設コホート研究)の進捗状況

    岩崎 栄典, 堀部 昌靖, 辻 喜久, 讃井 將満, 真弓 俊彦, 池浦 司, 北村 勝哉, 阪上 順一, 廣田 衛久, 正宗 淳, 竹山 宜典, 岡崎 和一, 金井 隆典

    膵臓   34 ( 3 )   A109 - A109   2019.6

     More details

    Language:Japanese   Publisher:日本膵臓学会  

    Ichushi

    researchmap

  • 急性膵炎局所合併症の定義の再検討

    辻 喜久, 池浦 司, 糸井 隆夫, 岩崎 栄典, 岸和田 昌之, 北村 勝哉, 阪上 順一, 白井 邦博, 鈴木 裕, 竹中 完, 廣田 衛久, 正宗 淳, 真弓 俊彦, 堀部 昌靖, 能登原 憲司, 入江 裕之, 蒲田 敏文, 竹山 宜典

    膵臓   34 ( 3 )   A109 - A110   2019.6

     More details

    Language:Japanese   Publisher:日本膵臓学会  

    Ichushi

    researchmap

  • SANADA study(急性膵炎症例前向き多施設コホート研究)の進捗状況

    岩崎 栄典, 堀部 昌靖, 辻 喜久, 讃井 將満, 真弓 俊彦, 池浦 司, 北村 勝哉, 阪上 順一, 廣田 衛久, 正宗 淳, 竹山 宜典, 岡崎 和一, 金井 隆典

    膵臓   34 ( 3 )   A109 - A109   2019.6

     More details

    Language:Japanese   Publisher:(一社)日本膵臓学会  

    Ichushi

    researchmap

  • 急性膵炎局所合併症の定義の再検討 Reviewed

    辻 喜久, 池浦 司, 糸井 隆夫, 岩崎 栄典, 岸和田 昌之, 北村 勝哉, 阪上 順一, 白井 邦博, 鈴木 裕, 竹中 完, 廣田 衛久, 正宗 淳, 真弓 俊彦, 堀部 昌靖, 能登原 憲司, 入江 裕之, 蒲田 敏文, 竹山 宜典

    膵臓   34 ( 3 )   A109 - A110   2019.6

     More details

    Language:Japanese   Publisher:日本膵臓学会  

    Ichushi

    researchmap

  • 径10mm以下の膵嚢胞性病変における経時的変化の検討

    藤本剛英, 稲富理, 竹田善哉, 新谷修平, 馬場重樹, 辻喜久, 久津見弘, 安藤朗

    膵臓(Web)   34 ( 3 )   2019

  • SANADA study(急性膵炎症例前向き多施設コホート研究)の進捗状況

    岩崎栄典, 堀部昌靖, 辻喜久, 讃井將満, 真弓俊彦, 池浦司, 北村勝哉, 阪上順一, 廣田衛久, 正宗淳, 竹山宜典, 岡崎和一, 金井隆典

    膵臓(Web)   34 ( 3 )   2019

  • 栄養サポートを検討すべき膵機能低下患者の現状

    辻喜久, 辻喜久, 平松香織, 上野真行, 稲富理

    膵臓(Web)   34 ( 3 )   2019

  • 非アルコール性早期慢性膵炎に対する膵酵素補充療法の臨床成績

    稲富理, 新谷修平, 藤本剛英, 辻喜久, 久津見弘, 馬場重樹, 安藤朗

    膵臓(Web)   34 ( 3 )   2019

  • サルコペニアが膵癌化学療法患者のQOLに与える影響と早期リハビリ介入の有効性

    上野真行, 辻喜久, 山崎辰洋, 平大地, 石川将, 角南智彦, 森本光作, 清輔良江, 石田悦嗣, 水野元夫

    膵臓(Web)   34 ( 3 )   2019

  • 重症急性膵診療の医療費上昇における予後因子とWalled-off necrosis(WON)

    新谷修平, 稲富理, 竹田善哉, 藤本剛英, 辻喜久, 久津見弘, 安藤朗

    膵臓(Web)   34 ( 3 )   2019

  • 重症急性膵炎後に生じる骨格筋量の変化に関する検討

    平大地, 辻喜久, 上野真行, 森本光作, 清輔良江, 石田悦嗣, 水野元夫

    膵臓(Web)   34 ( 3 )   2019

  • 重症度判定基準の改訂中間報告

    廣田衛久, 竹山宜典, 池浦司, 糸井隆夫, 伊藤鉄英, 岩崎栄典, 堀部昌靖, 岸和田昌之, 北村勝哉, 阪上順一, 白井邦博, 鈴木裕, 竹中完, 辻喜久, 正宗淳, 真弓俊彦

    膵臓(Web)   34 ( 3 )   2019

  • 結腸穿破した急性壊死性貯留(ANC)の1例

    竹田善哉, 新谷修平, 藤本剛英, 稲富理, 辻喜久, 久津見弘, 安藤朗

    膵臓(Web)   34 ( 3 )   2019

  • 卒前卒後を通してのシームレスな評価表作成の経験 Reviewed

    辻 喜久, 伊藤 俊之

    医学教育   49 ( Suppl. )   144 - 144   2018.7

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    Ichushi

    J-GLOBAL

    researchmap

  • 発症早期の膵壊死診断とAPACHEIIスコアの重症化予測の精度の比較

    辻喜久, 児玉祐三, 千葉勉

    膵臓   33 ( 3 )   2018

  • 重症急性膵炎におけるCTでの造影不良域と予後の関係

    江崎麻衣子, 山本朋納, 西村哲郎, 溝端康光, 岩崎栄典, 辻喜久, 讃井將満, 真弓俊彦, 堀部昌靖, 金井隆典

    日本集中治療医学会学術集会(Web)   45th   2018

  • DIC合併重症急性膵炎へのThrombomodulin α投与に対するPerfusion CTの検討

    江口 考明, 辻 喜久, 辻前 正弘, 橋村 弘毅, 加納 千勢, 金森 厚志, 松本 慶, 吉崎 哲也, 百瀬 健次, 小畑 大輔, 山下 博司, 藤田 幹夫, 岡田 明彦

    日本消化器病学会雑誌   114 ( 臨増大会 )   A749 - A749   2017.9

     More details

    Language:Japanese   Publisher:(一財)日本消化器病学会  

    Ichushi

    J-GLOBAL

    researchmap

  • 予後告知に関する医学生の準備状態 臨床実習前の学生の意識調査結果から Reviewed

    山木 照子, 辻 喜久, 服部 哲久, 植村 和正, 伊藤 俊之

    医学教育   48 ( Suppl. )   144 - 144   2017.8

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    Ichushi

    researchmap

  • 自作アプリケーションを用いたOSCE評価環境の構築の有用性 Reviewed

    服部 哲久, 辻 喜久, 山木 照子, 伊藤 俊之

    医学教育   48 ( Suppl. )   154 - 154   2017.8

     More details

    Language:Japanese   Publisher:(一社)日本医学教育学会  

    Ichushi

    J-GLOBAL

    researchmap

  • 感染性WONならびにそれ以外の後期合併症の予後と治療の現状

    岩根康祐, 辻喜久, 山崎辰洋, 清輔良江, 石田悦嗣

    膵臓   32 ( 3 )   2017

  • 急性膵炎多施設後ろ向き研究における後期合併症に対する侵襲的処置の現状と今後の展望

    岩崎栄典, 堀部昌靖, 南一洋, 福原誠一郎, 清野隆史, 松下美紗子, 片山正, 玉川空樹, 池浦司, 北村勝哉, 辻喜久, 真弓俊彦, 金井隆典

    膵臓   32 ( 3 )   2017

  • 疾患と検査値の推移 急性膵炎

    辻喜久, 辻喜久

    検査と技術   45 ( 6 )   630 - 636   2017

     More details

    Publisher:株式会社医学書院  

    DOI: 10.11477/mf.1543206872

    CiNii Research

    J-GLOBAL

    researchmap

  • 造影ダイナミックCTとフッ素18フルオロミソニダゾール陽電子放出断層撮像法を用いた、腫瘍間質の評価および腫瘍低酸素との関連性の評価

    子安 翔, 辻 喜久, 原田 浩, 中本 裕士, 野橋 智美, 木村 寛之, 佐野 紘平, 小泉 幸司, 濱路 政嗣, 富樫 かおり

    核医学   53 ( Suppl. )   np2 - np3   2016.10

     More details

    Language:Japanese   Publisher:(一社)日本核医学会  

    Ichushi

    researchmap

  • Chemokine CXCL16 Plays a Critical Role in the Development of Severe Acute Pancreatitis

    Yojiro Sakuma, Yuzo Kodama, Tomoaki Matsumori, Teruko Tomono, Nobuyuki Kakiuchi, Atsushi Mima, Yuki Yamauchi, Yoshihiro Nishikawa, Motoyuki Tsuda, Tatsuki Ueda, Katsutoshi Kuriyama, Takahisa Maruno, Yuji Ota, Masahiro Shiokawa, Yoshihisa Tsuji, Norimitsu Uza, Tomohiro Watanabe, Hiroshi Nakase, Hiroshi Seno, Tsutomu Chiba

    GASTROENTEROLOGY   150 ( 4 )   S327 - S327   2016.4

     More details

    Language:English   Publishing type:Research paper, summary (international conference)  

    Web of Science

    researchmap

  • perfusion CTの基礎と臨床 膵臓のperfusion CT

    辻喜久, 辻喜久

    臨床画像   32 ( 5 )   2016

  • 難治性膵疾患に関する調査研究 急性膵炎時の膵虚血早期診断におけるperfusion CTの有用性に関する多施設共同研究

    武田和憲, 竹山宜典, 辻喜久, 廣田衛久, 伊藤鉄英, 乾和郎, 片岡慶正, 片岡慶正, 阪上順一, 木村憲治, 吉田仁, 森岡千恵, 桐山勢生, 佐田尚宏

    難治性膵疾患に関する調査研究 平成27年度 総括・分担研究報告書   2016

  • 難治性膵疾患に関する調査研究 急性膵炎診療における地域連携モデルの構築

    北野雅之, 杉山政則, 大本俊介, 片岡慶正, 片岡慶正, 辻喜久, 佐田尚宏, 西野博一, 平出敦, 古屋智規, 真弓俊彦, 村瀬貴昭, 亀井敬子, 松本逸平, 竹山宜典

    難治性膵疾患に関する調査研究 平成27年度 総括・分担研究報告書   2016

  • 難治性膵疾患に関する調査研究 急性膵炎重症度判定基準の見直し

    杉山政則, 武田和憲, 竹山宜典, 廣田衛久, 木村憲治, 堀部昌靖, 吉田仁, 西野博一, 桐山勢生, 横江正道, 辻喜久, 五十嵐久人, 鈴木裕, 中里徹矢, 横山政明, 小暮正晴

    難治性膵疾患に関する調査研究 平成27年度 総括・分担研究報告書   2016

  • 難治性膵疾患に関する調査研究 急性膵炎治療のチーム医療モデルの確立

    北野雅之, 杉山政則, 大本俊介, 片岡慶正, 片岡慶正, 辻喜久, 佐田尚宏, 西野博一, 平出敦, 古屋智規, 真弓俊彦, 村瀬貴昭, 亀井敬子, 松本逸平, 竹山宜典

    難治性膵疾患に関する調査研究 平成27年度 総括・分担研究報告書   2016

  • 造影ダイナミックCTとフッ素<sup>18</sup>フルオロミソニダゾール陽電子放出断層撮像法を用いた,腫瘍間質の評価および腫瘍低酸素との関連性の評価

    子安翔, 辻喜久, 原田浩, 中本裕士, 野橋智美, 木村寛之, 佐野紘平, 小泉幸司, 濱路政嗣, 富樫かおり

    核医学(Web)   53 ( Supplement )   2016

  • 発症早期の集学的治療は、Walled-off necrosisに対する侵襲的治療の必要性を減ずる

    森田 敏広, 辻 喜久, 児玉 裕三

    日本消化器病学会雑誌   112 ( 臨増大会 )   A555 - A555   2015.9

     More details

    Language:Japanese   Publisher:(一財)日本消化器病学会  

    Ichushi

    researchmap

  • 【microbiome(腸内細菌)と肝胆膵領域の新世紀】膵臓とmicrobiome 良性膵疾患と腸内細菌 Reviewed

    森田 敏広, 児玉 裕三, 大田 悠司, 辻 喜久, 渡邉 智裕

    肝・胆・膵   70 ( 6 )   895 - 900   2015.6

     More details

    Language:Japanese   Publisher:(株)アークメディア  

    Ichushi

    J-GLOBAL

    researchmap

  • 壊死性膵炎の予後改善を目指した治療の新展開 早期壊死診断および入院時臓器不全に基づいた重症急性膵炎診断予測

    辻 喜久, 児玉 裕三, 千葉 勉

    日本消化器病学会雑誌   112 ( 臨増総会 )   A83 - A83   2015.3

     More details

    Language:Japanese   Publisher:(一財)日本消化器病学会  

    Ichushi

    researchmap

  • 難治性膵疾患に関する調査研究 IV.急性膵炎 急性膵炎治療のチーム医療モデルの確立

    北野雅之, 片岡慶正, 片岡慶正, 佐田尚宏, 辻喜久, 平出敦, 古屋智規, 真弓俊彦, 竹山宜典

    難治性膵疾患に関する調査研究 平成26年度 総括・分担研究報告書   2015

  • 発症早期の集学的治療は,Walled-off necrosisに対する侵襲的治療の必要性を減ずる

    森田敏広, 辻喜久, 児玉裕三

    肝臓   56 ( Supplement 2 )   2015

  • 胆膵-膵臓-4.膵Perfusion CTによる膵壊死の早期予測

    辻喜久, 千葉勉

    Annual Review 消化器   2015   2015

  • 難治性膵疾患に関する調査研究 IV.急性膵炎 急性膵炎時の膵虚血早期診断におけるperfusion CTの有用性に関する多施設共同研究

    武田和憲, 竹山宜典, 辻喜久, 廣田衛久, 伊藤鉄英, 乾和郎, 片岡慶正, 片岡慶正, 阪上順一, 木村慶治, 吉田仁, 森岡千恵, 桐山勢生

    難治性膵疾患に関する調査研究 平成26年度 総括・分担研究報告書   2015

  • Pancreatic perfusion CTの臨床応用—Multislice CT 2014 BOOK ; CT画像の定量評価

    辻 喜久

    映像情報medical : a monthly journal of medical imaging and information   46 ( 10 )   151 - 159   2014.9

     More details

    Language:Japanese   Publisher:東京 : 産業開発機構映像情報メディカル編集部  

    Other Link:: https://ndlsearch.ndl.go.jp/books/R000000004-I025914738

    CiNii Research

    researchmap

  • 重症急性膵炎の病態と有効な初期治療をめざして 急性膵炎初期治療における早期壊死診断の臨床への影響

    辻 喜久, 児玉 裕三, 千葉 勉

    日本消化器病学会雑誌   111 ( 臨増大会 )   A598 - A598   2014.9

     More details

    Language:Japanese   Publisher:(一財)日本消化器病学会  

    Ichushi

    researchmap

  • 【肝胆膵・術後病態を學ぶ】肝移植後の病態・必要な治療 肝移植後胆管吻合部狭窄の頻度・治療法

    栗山 勝利, 栗田 亮, 上田 樹, 津田 喬之, 西川 義浩, 山内 雄揮, 佐久間 洋二朗, 大田 悠司, 丸野 貴久, 塩川 雅広, 澤井 勇悟, 辻 喜久, 宇座 徳光, 児玉 裕三, 八隅 秀二郎, 千葉 勉

    肝・胆・膵   69 ( 1 )   85 - 91   2014.7

     More details

    Language:Japanese   Publisher:(株)アークメディア  

    Ichushi

    J-GLOBAL

    researchmap

  • 早期動注療法およびトロンボモジュリンが奏功した重症急性膵炎の一例

    岩井 眞紗子, 辻 喜久, 平野 智紀, 船越 太郎, 福田 晃久, 児玉 裕三, 仲瀬 裕志, 千葉 勉

    日本消化器病学会雑誌   111 ( 臨増総会 )   A374 - A374   2014.3

     More details

    Language:Japanese   Publisher:(一財)日本消化器病学会  

    Ichushi

    researchmap

  • Trisomy8 MDSを合併した腸管型Behcet病にadalimumabが奏功した1例

    木村昌倫, 辻喜久, 岩井真紗子, 吉野琢哉, 松浦稔, 仲瀬裕志, 千葉勉

    日本消化器病学会大会(Web)   56th   2014

  • 急性膵炎初期治療における早期壊死診断の臨床への影響

    辻喜久, 児玉裕三, 千葉勉

    Gastroenterological Endoscopy   56 ( Supplement 2 )   2014

  • 難治性膵疾患に関する調査研究 急性膵炎重症化の早期予知としてのperfusion CTの有用性

    武田和憲, 下瀬川徹, 廣田衛久, 伊藤鉄英, 乾和郎, 片岡慶正, 片岡慶正, 竹山宜典, 阪上順一, 木村憲治, 桐山勢生, 吉田仁, 児玉祐三, 辻喜久, 森岡千恵

    難治性膵疾患に関する調査研究 平成25年度 総括・分担研究報告書   2014

  • CT画像の定評評価 Pancreatic perfusion CTの臨床応用

    辻喜久

    映像情報Medical   46 ( 10 )   2014

  • 難治性膵疾患に関する調査研究 急性膵炎初期治療における膵壊死診断の影響

    児玉裕三, 塩川雅広, 上田樹, 津田喬之, 西川義浩, 山内雄揮, 南竜城, 栗山勝利, 佐久間洋二郎, 大田悠司, 田辺渉, 丸野貴久, 栗田亮, 澤井勇悟, 辻喜久, 宇座徳光, 千葉勉

    難治性膵疾患に関する調査研究 平成25年度 総括・分担研究報告書   146 - 147   2014

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 難治性膵疾患に関する調査研究 急性膵炎・重症急性膵炎の治療と予後に関する国際比較

    阪上順一, 片岡慶正, 片岡慶正, 保田宏明, 児玉裕三, 辻喜久, 平野賢二, 武田和憲, 竹山宜典, 伊佐地秀司, 丹藤雄介, 真弓俊彦, 江川新一, 北川元二, 佐藤晃彦, 古屋智規, 吉田仁, 下瀬川徹, 正宗淳

    難治性膵疾患に関する調査研究 平成25年度 総括・分担研究報告書   2014

  • 腸管共生菌と膵炎—Intestinal microflora and pancreatitis

    渡邉 智裕, 辻 喜久, 千葉 勉

    臨床免疫・アレルギー科 = Clinical immunology & allergology / 臨床免疫・アレルギー科編集委員会 編   60 ( 4 )   435 - 438   2013.10

     More details

    Language:Japanese   Publisher:東京 : 科学評論社  

    Other Link:: https://ndlsearch.ndl.go.jp/books/R000000004-I024947965

    CiNii Research

    researchmap

  • Accuracy of Perfusion Computed Tomography for Predicting Pancreatic Necrosis in Acute Pancreatitis Patients in Extremely Early Stage

    Tsukasa Yoshida, Yoshihisa Tsuji, Yoshiko Ohara, Atsushi Kubo, Osamu Kikuchi, Yoshie Kiyosuke, Etsuji Ishida, Kazuhiro Matsueda, Yuji Watanabe, Hiroshi Yamamoto

    GASTROENTEROLOGY   144 ( 5 )   S274 - S274   2013.5

     More details

    Language:English   Publishing type:Research paper, summary (international conference)  

    Web of Science

    researchmap

  • Prediction for Complications of Severe Acute Pancreatitis Using Perfusion CT in the Early Stage

    Yoshihisa Tsuji, Tsubasa Watanabe, Hiroshi Yamamoto, Tsutomu Chiba

    GASTROENTEROLOGY   144 ( 5 )   S276 - S276   2013.5

     More details

    Language:English   Publishing type:Research paper, summary (international conference)  

    Web of Science

    researchmap

  • 難治性膵疾患に関する調査研究 急性膵炎・重症急性膵炎の治療と予後に関する国際比較

    阪上順一, 片岡慶正, 片岡慶正, 保田宏明, 児玉裕三, 辻喜久, 辻喜久, 平野賢二, 武田和憲, 竹山宜典, 伊佐地秀司, 丹藤雄介, 真弓俊彦, 江川新一, 北川元二, 佐藤晃彦, 古屋智規, 吉田仁, 正宗淳

    難治性膵疾患に関する調査研究 平成24年度 総括・分担研究報告書   2013

  • 難治性膵疾患に関する調査研究 急性膵炎重症化の早期予知としてのperfusion CTの有用性

    武田和憲, 下瀬川徹, 伊藤鉄英, 乾和郎, 片岡慶正, 片岡慶正, 竹山宜典, 木原康之, 阪上順一, 丹藤雄介, 峯徹哉, 五十嵐良典, 木村憲治, 植村正人, 桐山勢生, 田妻進, 吉田仁, 児玉裕三, 廣田衛久, 辻喜久

    難治性膵疾患に関する調査研究 平成24年度 総括・分担研究報告書   2013

  • 腸管共生菌と膵炎

    渡邉智裕, 渡邉智裕, 辻喜久, 千葉勉

    月刊臨床免疫・アレルギー科   60 ( 4 )   2013

  • 腹部 I 急性膵炎におけるPerfusion & Subtraction CT Imageの有用性

    辻喜久

    Definition Symposium Report   5th   2013

  • イヌ脳Perfusion CTにおいて異なる解析条件が解析値に与える影響

    櫛田和哉, 辻喜久, 福島隆治, 志津田陽平, 唐鎌周平, 鈴木基史, 丸井祐巳, 佐々木一昭, 下田実, 小林正行, 伊藤博, 山田一孝, 清水美希, 岸本海織

    日本獣医学会学術集会講演要旨集   155th   2013

  • 当院におけるリンパ節に対するEUS-FNAの検討-最適な治療方針決定に向けて-

    澤井勇悟, 栗山勝利, 佐久間洋二郎, 南竜城, 田邊渉, 大田悠司, 丸野貴久, 塩川雅広, 栗田亮, 辻喜久, 宇座徳光, 児玉裕三, 千葉勉

    Gastroenterological Endoscopy   55 ( Supplement 2 )   2013

  • 知っていますか?急性膵炎はこう治す!造影CTおよびperfusion CTによる膵壊死診断の現状

    辻喜久, 児玉裕三, 千葉勉

    胆と膵   34 ( 10 )   2013

  • Non-Occlusive Mesenteric Ischemia Diagnosed by Angiography at the Beginning of Continuous Regional Arterial Infusion Therapy is a Strong Predictive Factor for Mortality Due to Severe Acute Pancreatitis

    Tsukasa Yoshida, Osamu Kikuchi, Yoshihisa Tsuji, Akira Okumura, Kazuhiro Matsueda, Hiroshi Yamamoto

    GASTROENTEROLOGY   142 ( 5 )   S851 - S851   2012.5

     More details

    Language:English   Publishing type:Research paper, summary (international conference)  

    Web of Science

    researchmap

  • 難治性膵疾患に関する調査研究 I.急性膵炎 急性膵炎・重症急性膵炎の治療と予後に関する国際比較

    阪上順一, 片岡慶正, 片岡慶正, 保田宏明, 児玉裕三, 辻喜久, 辻喜久, 平野賢二, 武田和憲, 竹山宜典, 伊佐地秀司, 丹藤雄介, 真弓俊彦, 江川新一, 北川元二, 佐藤晃彦, 古屋智規, 吉田仁, 正宗淳, 下瀬川徹

    難治性膵疾患に関する調査研究 平成23年度 総括・分担研究報告書   2012

  • 難治性膵疾患に関する調査研究 I.急性膵炎 重症急性膵炎・局所/全身合併症の診断におけるPerfusion CTの有用性

    児玉裕三, 辻喜久, 塩川雅広, 栗田亮, 澤井勇吾, 宇座徳光, 千葉勉, 渡邉翼, 小泉幸司, 磯田裕義, 山本博

    難治性膵疾患に関する調査研究 平成23年度 総括・分担研究報告書   126 - 127   2012

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 膵臓の画像診断update 膵Perfusion Imageの膵良性疾患における有用性

    辻喜久, 児玉裕三, 千葉勉

    胆と膵   33 ( 7 )   2012

  • 膵炎の診断基準・診療ガイドライン改訂とValidation 急性膵炎の診断基準・診療ガイドライン改訂のポイント:成果が待たれる課題 急性膵炎重症度判定においてPerfusion CTは造影CTより予後判定に有用か

    廣田衛久, 辻喜久, 下瀬川徹

    肝胆膵   64 ( 6 )   2012

  • Perfusion CT imageの膵疾患への応用の現状と今後

    辻喜久

    日本医学放射線学会総会抄録集   71st   2012

  • 異なる解析アルゴリズム間におけるデジタルファントムを用いた膵Perfusion CT解析の検討

    小泉幸司, 松田晃, 榎直美, 鮫島季美子, 東村享治, 辻喜久

    日本放射線技術学会総会学術大会予稿集   68th   2012

  • 自己免疫性膵炎の臨床像の検討

    塩川 雅広, 栗田 亮, 澤井 勇悟, 辻 喜久, 宇座 徳光, 児玉 裕三, 河南 智晴, 千葉 勉

    日本消化器病学会雑誌   108 ( 臨増総会 )   A268 - A268   2011.3

     More details

    Language:Japanese   Publisher:(一財)日本消化器病学会  

    Ichushi

    J-GLOBAL

    researchmap

  • 【重症急性膵炎の病態解明と治療の新展開】重症急性膵炎における膵虚血、非閉塞性腸間膜虚血と肝血流との関係

    辻 喜久, 子安 翔, 磯田 裕義, 渡邉 翼, 塩川 雅広, 栗田 亮, 澤井 勇悟, 上野 憲司, 塩 せいじ, 宇座 徳光, 児玉 裕三, 小泉 幸司, 渡邊 祐司, 山本 博, 千葉 勉

    消化器内科   52 ( 2 )   214 - 218   2011.2

     More details

    Language:Japanese   Publisher:(有)科学評論社  

    CiNii Research

    Ichushi

    J-GLOBAL

    researchmap

  • 難治性膵疾患に関する調査研究 重症急性膵炎・局所/全身合併症の診断におけるPerfusion CTの有用性

    児玉裕三, 辻喜久, 渡邉翼, 塩川雅広, 栗田亮, 澤井勇悟, 上野憲司, 塩せいじ, 宇座徳光, 千葉勉, 小泉幸司, 磯田裕義, 山本博

    難治性膵疾患に関する調査研究 平成20-22年度 総合研究報告書   132 - 134   2011

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 難治性膵疾患に関する調査研究 重症急性膵炎・局所/全身合併症の診断におけるPerfusion CTの有用性

    児玉裕三, 辻喜久, 渡邉翼, 塩川雅広, 栗田亮, 澤井勇悟, 上野憲司, 塩せいじ, 宇座徳光, 千葉勉, 小泉幸司, 磯田裕義, 山本博

    難治性膵疾患に関する調査研究 平成22年度 総括・分担研究報告書   104 - 106   2011

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • 難治性膵疾患に関する調査研究 急性膵炎重症化の早期予知としてのperfusion CTの有用性の検討

    武田和憲, 片岡慶正, 片岡慶正, 竹山宜典, 廣田昌彦, 辻喜久, 木村憲治, 桐山勢生, 乾和郎, 植村正人, 下瀬川徹, 廣田衛久

    難治性膵疾患に関する調査研究 平成22年度 総括・分担研究報告書   2011

  • 重症急性膵炎におけるPerfusion CTの有用性

    辻喜久

    Clinician   58 ( 597 )   2011

  • 当院における超音波内視鏡ガイド下穿刺吸引法(EUS-FNA)導入後の評価

    澤井勇悟, 塩川雅広, 栗田亮, 上田憲司, 辻喜久, 宇座徳光, 児玉裕三, 千葉勉

    Gastroenterological Endoscopy   53 ( Supplement 1 )   2011

  • Perfusion computed tomography imaging of autoimmune pancreatitis

    HIROTA Morihisa, TSUDA Masashi, TSUJI Yoshihisa, SHIMOSEGAWA Tooru

    Suizo   26 ( 1 )   54 - 58   2011

     More details

    Language:Japanese   Publisher:Japan Pancreas Society  

    Perfusion computed tomography(P-CT) is now available for the analysis of pancreatic blood flow. The aim of this study was to clarify pancreatic blood perfusion in AIP patients and the changes after steroid treatment. Color map imaging of P-CT and pancreatic time CT density curve(TDC) demonstrated that the pancreatic blood flow was attenuated in AIP patients. Pancreatic volumetric blood flow F<sub>V</sub> values of 11 AIP patients (82.7/min) were significantly lower than those of 12 normal controls (163.5/min, <i>p</i>=0.0006). AIP patients received steroid treatment and were re-examined, of these, 9 patients showed significantly elevated F<sub>V</sub> values after treatment (76.2/min and 109.8/min, <i>p</i>=0.0391, respectively). However, the changes of the values after the treatment differed in varying degrees among the individuals. P-CT is a useful method for the analysis of the blood flow in pancreatic diseases.<br>

    DOI: 10.2958/suizo.26.54

    DOI: 10.5833/jjgs.2012.0243_references_DOI_I4hCT2VJfpihfDiT5s8jelElptc

    CiNii Research

    J-GLOBAL

    researchmap

  • 緊急帝王切開術を行い良好な経過をたどった妊娠合併急性膵炎の一例

    吉田司, 菊池理, 辻喜久, 石田悦嗣, 松枝和宏, 山本博

    膵臓   26 ( 3 )   2011

  • 難治性膵疾患に関する調査研究 急性膵炎重症化の早期予知としてのperfusion CTの有用性の検討

    武田和憲, 片岡慶正, 片岡慶正, 竹山宜典, 廣田昌彦, 辻喜久, 木村憲治, 桐山勢生, 乾和郎, 植村正人, 下瀬川徹, 廣田衛久

    難治性膵疾患に関する調査研究 平成20-22年度 総合研究報告書   2011

  • 消化器画像診断における4D画像が持つ意義と意味—The usefulness of 4-dimension image for diagnosing digestive disease—なぜ今、4D画像が注目されるのか

    辻 喜久

    月刊新医療   37 ( 2 )   136 - 140   2010.2

     More details

    Language:Japanese   Publisher:東京 : エム・イー振興協会  

    資料形態 : テキストデータ プレーンテキスト
    コレクション : 国立国会図書館デジタルコレクション > デジタル化資料 > 雑誌

    Other Link:: https://ndlsearch.ndl.go.jp/books/R000000004-I10513138

    CiNii Research

    researchmap

  • 膵臓PCT(Perfusion CT)撮像条件に関する基礎的検討(第66回総会学術大会放射線防護・管理関連演題発表後抄録)

    小泉 幸司, 大狩 興司, 鮫島 季美子, 藤 利栄, 松田 晃, 山田 晃寛, 辻 喜久

    放射線防護分科会会誌   31   52   2010

     More details

    Language:Japanese   Publisher:公益社団法人 日本放射線技術学会  

    DOI: 10.18973/protectionjsrt.31.0_52

    CiNii Research

    researchmap

  • 重症急性膵炎における肝血流とNOMIの関係について

    辻喜久, 子安翔, 山本博

    日本腹部救急医学会雑誌   30 ( 2 )   2010

  • 重症急性膵炎におけるperfusion CTの現状と将来

    辻喜久, 多田真輔, 千葉勉

    Annual Review 消化器   2010   2010

  • クラウドとモバイル時代に解き放たれる3Dの無限の可能性 消化器画像診断における時間軸画像の有用性-Time axis imaging for diagnosing digestive disease

    辻喜久

    Innervision   25 ( 2 )   2010

  • なぜ今,4D画像が注目されるのか 画像解析の発展がもたらした最新技術 消化器画像診断における4D画像が持つ意義と意味

    辻喜久

    月刊新医療   37 ( 2 )   2010

  • 臨床検査の分子生物学 第6回 消化器領域における血液凝固検査とその臨床的意義

    辻喜久, 千葉勉

    分子消化器病   7 ( 2 )   2010

  • 難治性膵疾患に関する調査研究 膵Perfusion CTにおける解析アルゴリズムの特徴

    多田真輔, 辻喜久, 上野憲司, 千葉勉, 小泉幸司, 磯田裕義

    難治性膵疾患に関する調査研究 平成21年度 総括・分担研究報告書   2010

  • 難治性膵疾患に関する調査研究 急性膵炎重症化の早期予知としてのperfusion CTの有用性の検討-とくに膵perfusion CT施行時の被曝線量の低減について-

    武田和憲, 片岡慶正, 片岡慶正, 竹山宜典, 廣田昌彦, 多田真輔, 辻喜久, 木村憲治, 桐山勢生, 古屋智規, 下瀬川徹

    難治性膵疾患に関する調査研究 平成21年度 総括・分担研究報告書   2010

  • 膵臓PCT(Perfusion CT)撮像条件に関する基礎的検討

    小泉幸司, 大狩興司, 鮫島季美子, 藤利栄, 松田晃, 山田晃寛, 辻喜久

    日本放射線技術学会総会学術大会予稿集   66th   2010

  • Pancreatic perfusion CT for severe acute pancreatitis

    辻喜久, 辻喜久, 山本博, 菊地理, 濱口京子, 山本浩之, 渡邉祐司, 磯田裕義, 小泉幸司, 上野憲司, 多田真輔, 塩せいじ, 依田広, 千葉勉

    肝胆膵   59 ( 2 )   2009

  • 難治性膵疾患に関する調査研究 I.急性膵炎 膵Perfusion CTにおける被曝線量と安全性

    多田真輔, 辻喜久, 上野憲司, 千葉勉, 小泉幸司, 磯田裕義

    難治性膵疾患に関する調査研究 平成20年度 総括・分担研究報告書   2009

  • 重症急性膵炎・非閉塞性腸間膜虚血合併例に対する選択的消化管除菌は予後を改善するか?

    菊池理, 山下茂樹, 辻喜久, 濱口京子, 衣笠秀明, 松枝和宏, 山本博

    日本集中治療医学会雑誌   16 ( Supplement )   2009

  • 自然免疫は急性膵炎の発症にどのようにかかわるのか

    辻喜久

    分子消化器病   7 ( 3 )   121 - 128   2009

  • Continuous regional arterial infusion of protease inhibitor and antibiotic for severe acute pancreatitis

    11 ( 2 )   167 - 174   2009

  • Perfusion CTによる膵血流解析におけるdeconvolution法の有用性

    方波見奈々, 辻喜久, 岸本海織, 清水純一郎, 八隅秀二郎, 千葉勉, 山田一孝

    日本消化器病学会雑誌   105   2008

  • Marked Effect of Combination Chemotherapy with Tegafur-Gimeracil-Oteracil Potassium and Gemcitabine on a Suspected Case of Pancreas Cancer or Gallbladder Cancer Metastasis to Bone: Further Diagnosis of Disseminated Carcinomatosa of Bone Marrow Recurrence after the 23 Years of Gastric Cancer Operation by Autopsy Findings

    酒井章裕, 辻喜久, 菊池理, 神野亜希子, 田邊渉, 寺島禎彦, 前田有紀, 土井顕, 畑貴子, 山本直樹, 青山育雄, 新井修, 清輔良江, 片山幸子, 平尾謙, 三好正嗣, 毛利裕一, 松枝和宏, 山本博

    癌と化学療法   35 ( 3 )   2008

  • 急性膵炎をめぐる最近の動向 急性膵炎画像診断におけるPerfusion CTの有用性

    辻喜久, 山本博, 千葉勉

    胆と膵   29 ( 4 )   2008

  • 当院における薬剤性膵炎の現状

    衣笠秀明, 辻喜久, 菊池理, 山本直樹, 松枝和宏, 下村宏之, 山本博

    膵臓   23 ( 3 )   2008

  • 急性膵炎新重症度判定基準案に基づく重症度スコアの旧基準との比較

    菊池理, 辻喜久, 濱口京子, 山本直樹, 酒井章裕, 清輔良江, 堤康一郎, 平尾謙, 松枝和宏, 山本博

    日本消化器病学会雑誌   105   2008

  • 急性膵炎の重症化 1 重症急性膵炎の急性期治療

    辻喜久

    侵襲と免疫   17 ( 3 )   2008

  • 重症急性膵炎における腹部臓器虚血についての考察

    濱口京子, 辻喜久, 山本博

    日本腹部救急医学会雑誌   28 ( 2 )   2008

  • Endoscopic treatment of biliary complications after right-lobe living-donor liver transplantation with duct-to-duct biliary anastomosis

    Shujiro Yazumi, Shinsuke Tada, Masaya Kida, Junichi Yamauchi, Seiji Shio, Hiroshi Ida, Yoshihisa Tsuji, Shinji Uemoto, Tsutomu Chiba

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   22   A228 - A228   2007.10

     More details

    Language:English   Publishing type:Research paper, summary (international conference)  

    Web of Science

    researchmap

  • 消化管手術後の内視鏡〔合併症治療〕肝移植術後の胆道合併症の内視鏡治療

    八隅秀二郎, 多田真輔, 依田広, 吉本貴宣, 貴田雅也, 山内淳一, 塩せいじ, 辻喜久, 千葉勉

    消化器内視鏡   19 ( 6 )   2007

  • DPC導入前後にみる急性膵炎の画像診断

    辻喜久, 辻喜久, 関本美穂, 千葉勉

    日本消化器病学会雑誌   104   2007

  • 急性膵炎の診療update 第4回:急性膵炎の病態 急性膵炎におけるperfusion CT(膵血流量の評価)

    辻喜久, 辻喜久, 山本博, 千葉勉

    医薬の門   47 ( 1 )   2007

  • Perfusion CTによる急性膵炎早期壊死予測

    辻喜久, 渡辺祐司, 山本博, 山本浩之, 千葉勉

    日本腹部救急医学会雑誌   27 ( 2 )   2007

  • Perfusion CTによる犬の膵血流測定法の検討

    岸本海織, 岸本海織, 山田一孝, 山田一孝, 方波見奈々, 辻喜久, 清水純一郎, 清水純一郎, 森下康之, 岩佐亜紀子, 岩崎利郎, 岩崎利郎, 三宅陽一, 三宅陽一

    日本獣医学会学術集会講演要旨集   144th   2007

  • Perfusion CTを用いた犬の膵血流測定の試み

    岸本海織, 山田一孝, 辻喜久, 方波見奈々, 清水純一郎, 森下康之, 岩崎利郎, 三宅陽一

    動物臨床医学会年次大会プロシーディング   28th ( 2 )   2007

  • 重症急性膵炎の急性期治療-当院における経験から-

    辻喜久, 辻喜久, 山本博, 山本直樹, 松枝和宏, 千葉勉

    月刊消化器科   45 ( 2 )   2007

  • Perfusion CTを用いた動注療法適応基準の有効性の検討

    辻喜久, 山本博, 千葉勉

    日本消化器病学会雑誌   104   2007

  • NSAID胃粘膜障害 予防・治療 抗潰瘍薬の投与 PPI

    辻喜久, 伊藤俊之, 千葉勉

    日本臨床   65 ( 10 )   2007

  • 重症急性膵炎重症化における膵虚血の重要性

    辻喜久, 辻喜久, 山本博, 千葉勉

    膵臓   22 ( 3 )   2007

  • 重症急性膵炎における真菌およびサイトメガロウイルス感染症合併の現状

    辻喜久

    消化器科   44 ( 3 )   338 - 341   2007

  • 重症急性膵炎に対する動注療法の経験

    辻喜久

    医薬の門   47 ( 4 )   359 - 363   2007

  • 重症急性膵炎早期における虚血の意味とプロテアーゼインヒビター

    辻喜久, 山本博, 千葉勉

    Surgery Frontier   14 ( 4 )   2007

  • 当院における急性A型肝炎の動向-1994~2005年-

    池田弘, 青山育雄, 辻喜久, 下村宏之

    感染症学雑誌   80 ( 6 )   2006

  • A Case of Acute Pancreatitis Caused by L-Asparaginase during Acute Lymphatic Leukemia Therapy

    村下貴志, 辻喜久, 山本博, 水谷知里, 上田恭典

    倉敷中央病院年報   68   2006

  • 膵がんとの鑑別が困難であった自己免疫性膵炎(AIP)の2例

    中西崇, 松枝和宏, 下村宏之, 池田弘, 金吉俊彦, 毛利裕一, 三好正嗣, 大西秀樹, 片山幸子, 新井修, 清輔良江, 中辻正人, 辻喜久, 酒井章裕, 青山育雄, 光藤大地, 合原彩, 畑貴子, 山本直樹, 山本博

    岡山済生会総合病院雑誌   38   2006

  • 急激な経過をたどったAeromonas hydrophilia敗血症の1例

    合原彩, 辻喜久, 青山育雄, 毛利裕一, 池田弘

    感染症学雑誌   80 ( 6 )   2006

  • 日本の河川にて感染したと考えられ,重篤な経過をたどるも救命されたVibrio cholerae non O1による敗血症の1例

    林健太郎, 辻喜久, 本郷俊治, 余明順, 石田直

    感染症学雑誌   80 ( 6 )   2006

  • 経乳頭的ドレナージ術が有効であった縦隔内へ進展した仮性すい嚢胞の2例の検討

    青山育雄, 松枝和宏, 毛利裕一, 河野博行, 三好正嗣, 石田悦嗣, 中西崇, 片山幸子, 新井修, 清輔良江, 中辻正人, 辻喜久, 合原彩, 酒井章裕, 光藤大地, 畑貴子, 山本直樹, 山本博

    Gastroenterological Endoscopy   48 ( Supplement 1 )   2006

  • 急性すい炎にTTPを合併した一例

    島津裕, 辻喜久, 辰巳晴規, 上田恭典, 山本博

    日本消化器病学会雑誌   103   2006

  • Perfusion CTにて早期虚血を判別しえた重症急性すい炎の一剖検例

    辻喜久, 松枝和宏, 石田悦嗣, 中西崇, 下村宏之, 池田弘, 金吉俊彦, 毛利裕一, 三好正嗣, 大西秀樹, 片山幸子, 山本博

    日本消化器病学会雑誌   103   2006

  • 急性懐死性膵炎,非閉塞性腸間膜虚血へのnafamostat mesilate+papaverine動注の一例

    辻喜久, 辻喜久, 山本博, 横田満, 山本直樹, 中西崇, 渡邊祐司, 松枝和宏

    膵臓   21 ( 3 )   2006

  • Idiopathic duct-centric chronic pancreatitisは自己免疫性膵炎か?

    辻喜久, 能登原憲司, 千葉勉

    日本消化器病学会雑誌   103   2006

  • nafamostat mesilate,papaverineの動注療法を施行した非閉塞性腸間膜虚血を伴う重症急性膵炎の3例

    山本直樹, 辻喜久, 畑貴子, 青山育雄, 酒井章裕, 光藤大地, 新井修, 清輔良江, 片山幸子, 中西崇, 三好正嗣, 毛利裕一, 松枝和宏, 山本博

    日本消化器病学会雑誌   103   2006

  • 重症急性すい炎に対するPerfusion CTの有効性と問題点

    辻喜久, 渡辺祐司, 山本浩之

    日本腹部救急医学会雑誌   26 ( 2 )   2006

  • 重症急性すい炎における真菌及びサイトメガロウイルス感染症合併の現状

    辻喜久, 松枝和宏, 山本博

    日本消化器病学会雑誌   103   2006

  • 敗血症患者から分離されたビブリオの同定と回復期血清を用いた病原因子の解析

    余明順, 本田武司, 本郷俊治, 林健太郎, 辻喜久, 石田直

    感染症学雑誌   80 ( 6 )   2006

  • 「急性すい炎の診療ガイドライン」前後における市中病院の変化

    辻喜久, 山本博

    日本腹部救急医学会雑誌   26 ( 2 )   2006

  • Perfusion CTによる急性膵炎早期壊死予測における有用性

    辻喜久, 渡邊祐司, 千葉勉

    日本消化器病学会雑誌   103   2006

  • 重症急性すい炎 重症急性すい炎におけるPerfusion CTを用いた血流評価と予後予測

    辻喜久, 渡辺祐司, 山本浩之, 青山育雄, 山本博, 石田悦嗣, 松枝和宏

    日本集中治療医学会雑誌   13 ( Supplement )   2006

  • Alport症候群を背景とした慢性膵炎の1例

    畑貴子, 辻喜久, 大目祐介, 山本直樹, 中西崇, 渡邊祐司, 松枝和宏, 山本博

    膵臓   21 ( 3 )   2006

  • 急性肝不全を呈した自己免疫性肝炎例の検討

    池田弘, 新井修, 青山育雄, 合原彩, 酒井章裕, 光藤大地, 清輔良江, 辻喜久, 中辻正人, 金吉俊彦, 下村宏之, 島村淳之輔, 山本博

    肝臓   46 ( 11 )   2005

  • サイトメガロウィルス感染が関与したと考えられた特発性すい炎の1例

    浅野真由美, 辻喜久, 石田悦嗣, 青山育雄, 合原彩, 酒井章裕, 光藤大地, 新井修, 清輔良江, 中辻正人, 山田敦, 河野博行, 三好正嗣, 毛利裕一, 金吉俊彦, 池田弘, 松枝和宏, 下村宏之, 山本博

    日本消化器病学会雑誌   102   2005

  • 過去10年間の当科におけるウイルス性急性肝炎の動向

    池田弘, 青山育雄, 辻喜久, 下村宏之

    感染症学雑誌   79 ( 8 )   2005

  • B群溶血性連鎖球菌によるtoxic shock-like syndrome(TSLS)の1例

    水口真由美, 辻喜久, 石田直, 橋本徹, 有田真知子, 東条泰典, 橘洋正, 陣内牧子, 丸毛聡

    感染症学雑誌   79 ( 3 )   2005

  • Perfusion CTによる重症急性すい炎・集学的治療適応の検討

    辻喜久, 松枝和宏, 渡辺祐司

    日本消化器病学会雑誌   102   2005

  • 胆管内腫よう栓による胆道出血・急性すい炎を合併し,肝動脈塞栓術および放射線化学療法併用が奏効した肝細胞癌の1例

    新井修, 池田弘, 清輔良江, 辻喜久, 中辻正人, 若林肇, 金吉俊彦, 清野哲司, 下村宏之

    Liver Cancer   11 ( 1 )   2005

  • Morganella morganii敗血症により壊死性軟部組織感染症をきたした1例

    青山育雄, 辻喜久, 池田弘, 下村宏之, 本郷俊治

    感染症学雑誌   79 ( 3 )   2005

  • 過去10年間の当科におけるウイルス性急性肝炎の動向

    池田弘, 青山育雄, 辻喜久, 下村宏之

    感染症学雑誌   79   2005

  • いわゆる“sessile serated polyp”から発生したと考えられた大腸粘膜内癌の2例

    山田敦, 能登原憲司, 山本博, 青山育雄, 合原彩, 酒井章裕, 光藤大地, 新井修, 清輔良江, 辻喜久, 中辻正人, 石田悦嗣, 河野博行, 三好正嗣, 毛利裕一, 松枝和宏, 手銭高志

    Gastroenterological Endoscopy   47 ( Supplement 2 )   2005

  • 当院における消化管GVHDの検討

    河野博行, 前田猛, 上田恭典, 山本博, 松枝和宏, 毛利裕一, 三好正嗣, 石田悦嗣, 山田敦, 新井修, 清輔良江, 中辻正人, 辻喜久, 酒井章裕, 青山育雄, 合原彩, 光藤大地

    Gastroenterological Endoscopy   47 ( Supplement 2 )   2005

  • 重症度スコアにおける予後予測因子の再検討

    辻喜久, 松枝和宏, 山本博

    日本消化器病学会雑誌   102   2005

  • 重症急性すい炎におけるすい酵素阻害剤・抗菌薬持続動注療法導入後の予後予測の検討

    辻喜久, 山本博, 新井修, 清輔良江, 中辻正人, 深津裕寿, 三好正嗣, 河野博行, 毛利裕一

    日本消化器病学会雑誌   101   2004

  • 小児の食道静脈りゅうに対する内視鏡的硬化療法の有

    松枝和宏, 山本博, 新井修, 清輔良江, 辻喜久, 中辻正人, 山田敦, 深津裕寿, 河野博行

    Gastroenterological Endoscopy   46 ( Supplement 1 )   2004

  • 当科における自己免疫性肝炎(AIH)・原発性胆汁性肝硬変(PBC)overlap症候群の臨床病理学的検討

    新井修, 池田弘, 清輔良江, 辻喜久, 中辻正人, 若林肇, 金吉俊彦, 清野哲司, 山本博

    肝臓   45 ( Supplement 2 )   2004

  • 総胆管浸潤を確認したすい管内乳頭粘液性腫ようの1例

    河野博行, 山本博, 新井修, 清輔良江, 辻喜久, 中辻正人, 山田敦, 深津裕寿, 三好正嗣

    Gastroenterological Endoscopy   46 ( Supplement 2 )   2004

  • hypothyroidismのoverlapにより病態が複雑化した慢性肝疾患の3例

    中辻正人, 池田弘, 新井修, 清輔良江, 辻喜久, 若林肇, 金吉俊彦, 清野哲司, 島村淳之輔

    肝臓   45 ( Supplement 2 )   2004

  • ステロイドが著効し組織学的に改善を認めたcollagenous colitisの1例

    山田敦, 松枝和宏, 山本博, 新井修, 清輔良江, 辻喜久, 中辻正人, 深津裕寿, 三好正嗣

    Gastroenterological Endoscopy   46 ( Supplement 2 )   2004

▼display all

Awards

  • 平成30年度 ベストティーチャー賞

    2019   滋賀医科大学  

     More details

  • 奨励賞

    2018   第31回 日本消化器病学会  

     More details

  • Poster Distinction

    2013   Pancreas Club 2013(オーランド、米国)  

     More details

  • Travel Award

    2012   National Pancreas Foundation(アトランタ、米国)  

     More details

  • 研究奨励賞

    2007   膵臓財団  

     More details

  • 優秀ポスター賞

    2007   Japan Digestive Disease Week  

     More details

▼display all

Research Projects

  • 非救急医の救急診療スキル向上のための遠隔教育プログラムの開発と教育効果の検証

    Grant number:25K13417  2025.4 - 2029.3

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    神野 敦, 辻喜久

      More details

    Authorship:Coinvestigator(s) 

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    researchmap

  • A system for training doctors for gastrointestinal cancer screening in Palau

    2025.4 - 2026.3

    Japan International Cooperation Agency 

      More details

    Authorship:Principal investigator 

    researchmap

  • Development of natriuretic peptide-based novel diagnosis and therapy for non-alcoholic fatty liver disease

    Grant number:22K08675  2022.4 - 2025.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant amount:\4290000 ( Direct Cost: \3300000 、 Indirect Cost:\990000 )

    researchmap

  • Perfusion CT to evaluate pancreatic stroma in pancreatic cancer mice model

    Grant number:25893105  2013.8 - 2015.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Research Activity Start-up

    TSUJI Yoshihisa

      More details

    Grant amount:\2730000 ( Direct Cost: \2100000 、 Indirect Cost:\630000 )

    In the present study, a significantly strong correlation was found between the imaging parameter (Fis) of perfusion CT, which targeted the contrast accumulation in the intstitial space and relects tumor-associated stroma in this model, and stromal density quantified using immunohistochemistry; this finding supported our hypothesis that perfusion CT had the potential to depict a similar spatial distribution of tumor-associated stroma to that confirmed using histopathological analysis. In terms of the association between tumor hypoxia and tumor-associated stroma, FMISO uptake had a negative correlation with Fis and stromal density, as well as with vascular parameters. These results suggest that tumor hypoxia was complementarily localized to tumor-associated stroma and the vascular component.

    researchmap

  • Perfusion CTによる重症膵炎早期膵虚血と血管透過性亢進についての研究

    Grant number:10J06594  2010 - 2012

    日本学術振興会  科学研究費助成事業  特別研究員奨励費

    辻 喜久

      More details

    Grant amount:\2800000 ( Direct Cost: \2800000 )

    研初年度は、各参加施設問で共通の重症急性膵炎患者登録データベースを作成した。ついで、各参加施設での倫理委員会の承認を経て多施設共同研究を開始し、UMINに登録、StudyDesignを公開した。研究期間を通して臨床データは採取し続け(膵局所血流障害の診断、血管透過性亢進の評価)は各症例にて、毎回評価しデータベースに登録を継続し、2012年12月78例の登録され、統計学的に十分なサンプル数であったため症例の集積は終了し、現在、解析中である。
    また、1年目の目標であったヒト重症急性膵炎患者における局所(膵実質)血流障害の有無と血清Angiopoietin(ANG)2値の上昇が関係の検討を行ったところ、両者の間に有意な差を認めず、むしろ、Perfusion CTによって診断された全身性の血流異常とANG2との間で有意な相関を得た。ANG1、VEGF-A,VEGF-Bは、局所(膵実質)血流異常および全身性の血流異常のどちらとも相関を認めなかった(Watanabe T, Tsuji Y et a1. Am J Gastroenterol. 2011)。また、高ANG2を伴った重症急性膵炎患者における全身循環不全は実際に多臓器不全と有意に関係することを論文発表した(Watanabe T, Tsuji Y et al. Pancreas 2013)。
    重症急性膵炎における全身性血流異常は多臓器不全の原因となり、これを改善するために一日6-10Lもの輸液を要すると治療ガイドラインにも指摘されている。こうした大量輸液はともすると輸液過剰になり、生命予後の悪化の一因にもなりうる。適切な輸液量を決めるために、全身性の血流異常を簡便に評価する必要があるが、有用なマーカーが存在せず積年の問題であった。一方、我々の結果では、Ang-2が全身性の血流異常の評価の指標となりうる可能性が示唆された。

    researchmap

  • Perfusion CTを用いた重症急性膵炎における早期の膵実質血流の解析

    Grant number:07J06222  2007 - 2009

    日本学術振興会  科学研究費助成事業  特別研究員奨励費

    辻 喜久

      More details

    Grant amount:\2700000 ( Direct Cost: \2700000 )

    ヒト重症急性膵炎を対象として、発症早期における膵虚血の有無をPerfusion CTを用いて定性的に評価すれば、膵壊死の予測が可能であり、ひいては予後予測に大変有用であることを論文発表した。(Clin Gastroenterol Hepatol.2007 Dec;5(12):1484-92.)同様の研究を米国のMayo Clinicといった世界的に高名な施設も行っていたが、発表においては我々が先んじた。つまり、Perfusion CTを用いることで、"ヒト急性壊死性膵炎における膵壊死の全段階として、膵虚血が存在する。"という説のPriorityを有することに成功した。ついで、平成19年度の目標であったPerfusion CTによる膵血流測定における定量性をイヌ膵にて確認し(Eur J Radiol 2009 Jul17.Epub ahead of print)、また、放射線被ばくに関する安全性について(Pancreas.2010 in press.)論文として報告した。このような、我々自身によるPilot Studyや動物実験、安全性の検証を行った後、これら結果に基づいて、重症急性膵炎・発症早期における膵壊死予測法としてのPerfusion CTの有用性を明らかにすべく、2009年7月より、2年間の予定で、前向きの多施設共同のコホート研究を開始した。(UMIN000001926)2010年3月に行った、中間解析では、40例の症例が登録されたが、Perfusion CTの壊死予測法の感度は100%、一方、通常の造影CTの感度は50%であり、有用性が示された。感度の差から必要とされる登録症例数は約80名と計算され、重症急性膵炎臨床における興味深い結果が得られると推測された。

    researchmap

▼display all